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Transcription of protein-coding genes occurs when RNA polymerase II (RNAPII) and 
general transcription factors (GTFs) assemble at genomic promoter regions, forming 
a transcription pre-initiation complex (PIC), which initiates DNA opening and DNA-
directed RNA synthesis. Upstream of promoters, gene-specific transcription 
activators bind upstream activation sequences (UASs), and they relay their activation 
signal to the RNAPII transcription initiation machinery through an intermediary 
complex of proteins known as the Mediator complex, which is found universally on all 
protein-coding genes in eukaryotes. The Mediator complex is a large multisubunit 
complex of 25 subunits in yeast, and 30 in human, amounting to a total of near 1.5 
MDa, and 2 MDa in molecular mass, respectively. Mediator is divided into four 
structural and functional modules: the head, the middle, the tail, and the Cdk8 kinase 
modules. The head and middle modules, together known as the core Mediator 
(cMed), are essential for viability in yeast, and act as a GTF, engaging directly with 
the PIC and supporting its assembly and function. The tail module is responsible for 
the majority of interactions with activators, thereby connecting the bridge that allows 
communication between UASs and promoters. Disorder in the tail accommodates the 
versatility of Mediator-activator interactions. The Cdk8 kinase module (CKM) is 
dissociable, and occupies only a subpopulation of Mediator complexes in the cell. It 
contains the Cdk/cyclin pair Cdk8/cyclin C, which is the only catalytic activity within 
the Mediator complex. Generally thought to regulate Mediator function by repressing 
transcription, the exact role of the CKM and its mode of action remain enigmatic. 
Here, we aimed to investigate the role of the CKM in transcription initiation by a 
combination of biochemical and structural analyses. We established a new method 
for recombinant expression and purification of the complete S.cerevisiae CKM. We 
investigated CKM binding to the PIC and cMed in an in vitro reconstituted system 
with purified transcription initiation components, and found that CKM is excluded 
from the PIC, but binds cMed. Using crosslinking-mass spectrometry, we determined 
that the reason for that was an overlapping binding interface on cMed between the 
CKM and RNAPII. Furthermore, we explored CKM phosphorylation targets, and 
found novel targets within the PIC. We modeled the UAS-activator-Mediator 
interaction in vitro, and found that CKM phosphorylation of activators disrupts both 
UAS-activator and activator-Mediator interactions and attenuates their phase 
separated droplets. Taking our findings together with knowledge from published in 
vivo studies, we propose a hypothetical model for CKM function, which we believe 
can guide future experiments. Finally, to illuminate the CKM-Mediator interaction, we 
tried to solve the structures of recombinant CKM and CKM-cMed complexes by cryo-






Cells in a multicellular organism all carry the same genetic information. Yet, 
morphological and functional heterogeneity are an indispensable preliminary to the 
evolution of complex life. How such divergence arises from the same genetic 
information is the subject of the cardinal question of molecular biology. The answer 
to this question lies in the way genetic information is processed.  
 
The central dogma of molecular biology states that genetic information is stored 
stably in the form of genomic DNA, copied transiently in the form of RNA 
(transcription), and read and translated into proteins (translation), which make up the 
cell’s repertoire of molecular effectors [1]. Differential regulation of processes along 
the flux of information from genes to proteins in response to environmental changes 
makes diversity possible. 
 
2.1 Epigenetic regulation 
 
To fit into the limited spatial confines of the eukaryotic nucleus, genomic DNA is 
wrapped around an octameric core of histone proteins, forming units called 
nucleosomes, which are further arranged into compact higher order structures [2]. 
DNA sequences buried within these structures are inaccessible to processing, and 
are thus silenced. This gives the cell the first means of regulatory control over the 
processing of genetic information. Various enzymes and structural proteins are 
involved in gene silencing. On the other hand, histone acetyl transferases (HATs) 
acetylate histone tails, neutralizing their charge, and weakening their interaction with 
DNA [3]. This primes nucleosomes for remodeling by specialized chromatin 
remodeling complexes, such as SWI/SNF, ISWI, CHD and INO80 family remodelers, 
that slide, eject or substitute nucleosomes in an ATP-dependent manner to create 




Exposure of promoter regions allows transcription, the first step in the processing of 
genetic information, to take place. In this process, RNA is synthesized using genomic 
DNA as a template, catalyzed by DNA-dependent RNA polymerases [5]. These 
enzymes catalyze the formation of phosphodiester bonds between incoming 
ribonucleotides that have base-paired with an unwound DNA coding strand by a 
classical two-metal ion mechanism [6]. One magnesium ion present in the active 
center, and a second provided by the incoming nucleotide, are held in place during 
the catalysis reaction by conserved aspartate residues in the polymerase active site 
[6]. The first magnesium ion enhances the nucleophilicity of the 3’ hydroxyl group of 
the last nucleotide of the growing RNA chain, thereby activating it for nucleophilic 
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attack on the α-phosphate of the incoming ribonucleotide triphosphate. The second 
magnesium ion stabilizes the pyrophosphate that results from the nucleophilic 
substitution reaction. As such, each new ribonucleotide is added to the 3’ end of the 
pre-existing one, and the RNA chain is extended by repetition of the nucleotide 
addition cycle, as the polymerase translocates on the DNA template in a 5’ to 3’ 
direction.   
 
Eukaryotes possess three DNA-dependent RNA polymerases that are highly 
conserved across species; RNA polymerase I transcribes the ribosomal RNA 
precursor (rRNA), RNA polymerase II transcribes messenger RNA (mRNA) from 
protein-coding genes, and RNA polymerase III transcribes transfer RNA (tRNA), and 
other small non-coding RNAs [7].    
 
In this work, we focus on transcription of protein-coding genes by RNA polymerase II 
(RNAPII) and its associated processes. Yeast RNAPII is composed of 12 subunits 
designated Rpb1 to Rpb12. Structural characterization of RNAPII revealed four 
mobile elements; the core, shelf, clamp and jaw lobe elements; as well as a less 
tightly associated stalk (figure 2.1). Together, these elements form a deep cleft with 
the active site buried at its base. DNA enters from one side of the cleft, which can 
open or close by virtue of a large swinging motion of the clamp domain in the 
absence of the dissociable stalk, to accommodate the passage of DNA through it [8]. 
When the stalk is present, however, the clamp is wedged in place, and only single-
stranded DNA can insert into the deeply buried active site [9]. Newly synthesized 
RNA exits the cleft through an opening between the wall and the clamp, and along 
the stalk protruding from the base of the clamp. Rpb1 and Rpb2 make up the 
catalytic cleft, Rpb4 together with Rpb7 make up the polymerase stalk, and Rpb9 is 
involved in RNA cleavage, whereas the remaining subunits serve scaffolding and 





2.2.1 The transcription cycle 
 
RNAPII transcription commences at promoter regions and institutes a transcription 
cycle, which can be viewed in three distinct stages; initiation, in which RNAPII and its 
associated factors are positioned at the right place, DNA is opened, and transcription 
begins; elongation, in which the RNAPII extends its pre-mRNA product while 
migrating along the gene body, and coordinates the co-transcriptional processes of 5’ 
capping and splicing into mature mRNA; and termination, in which the RNAPII 
encounters sequences that trigger cleavage and 3’ polyadenylation of mRNA, and 
exonuclease digestion of the remaining RNAPII-associated RNA (figure 2.2). Post-
translational modifications and an exchange of factors elicit the transitions from one 





2.2.2 The RNAPII CTD and transcriptional kinases  
 
The largest subunit of RNAPII, Rpb1, has a long unstructured C-terminal domain 
(CTD), comprising a repetition of the seven amino acid consensus sequence Tyr1-
Ser2-Pro3-Tyr4-Ser5-Pro6-Ser7 (Y1S2P3T4S5P6S7). The number of tandem heptad 
repeats correlates to the complexity of the organism, with 26 repeats present in 
yeast, 44 in drosophila, and 52 in human [10]. The RNAPII CTD serves as a landing 
platform for transcription-associated factors.  
 
Throughout the transcription cycle, the RNAPII CTD is subject to phosphorylation by 
transcriptional kinases, which orchestrate the binding and dissociation of factors with 
the elongating and terminating polymerase. Three cyclin-dependent kinases have 
been linked to transcription; Cdk7, Cdk8 and Cdk9. Their roles, targets, homologs, 




Table 2.1 | Transcriptional kinases. An overview of the kinases involved in transcription, their homologs, targets 
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After initiation, phosphorylation of the RNAPII CTD by Cdk7 at Ser5 instigates 
dissociation of the initiation complex and promoter escape [11]. Ser5-phosphorylated 
RNAPII CTD recruits the mRNA capping complex, which caps the 5’ end of mRNA 
as it emerges from the RNAPII exit channel [12]. Additionally, this modification helps 
recruit the histone H3K4 methyl transferase Set1, which marks transcriptionally 
active genes [13]. As RNAPII elongates further downstream, Ser5 phosphorylation 
tapers, and is replaced by Ser2 phosphorylation [14]. On the one hand, a Ser5 
phosphatase, Rtr1, removes phosphorylation from Ser5 [15]. On the other hand, 
Cdk9 in mammals [16], or Ctk1 and Bur1 in yeast [17], are recruited to Ser5-
phosphorylated CTD and the capping complex, respectively, and deposit 
phosphorylation on Ser2. Additionally, the mammalian and yeast kinases 
phosphorylate the elongation factors DRB-sensitivity factor (DSIF) and Spt4/5, 
respectively, prompting the transition into late elongation. In metazoans, after 
transcribing 20 to 100 nucleotides, elongating RNAPII pauses due to the binding of 
the Negative Elongation Factor (NELF). Coordinated release from this pause into 
productive elongation provides an additional level of regulatory control, not present in 
lower eukaryotes. Cdk9 additionally phosphorylates NELF and alleviates this pause 
in response to the appropriate signal [16].  
 
Cdk8 phosphorylates the RNAPII CTD at the initiation stage at Ser5, but its role 
remains unclear. Conflicting reports have indicated repressive [18], and activating 
[19] effects of the Cdk8 kinase phosphorylation of the RNAPII CTD redundant with 
Cdk7. In vitro, Cdk8 can substitute for Cdk7, and inhibition of both Cdk7 and Cdk8 in 
vivo is required for maximal transcription inhibition [19].  
 
RNAPII has been observed in granules that distribute throughout the nucleus. 
Recent studies have shown that the RNAPII CTD is responsible for the formation of 
these condensates, and that the size and stability of these condensates correspond 
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to the number of CTD heptad repeats [20]. Moreover, Cdk7 phosphorylation of the 
RNAPII CTD releases it from these condensates, suggesting a possible mechanism 
by which Cdk7 phosphorylation of the RNAPII CTD results in promoter escape.  
 
2.2.3 Transcription initiation 
 
On its own, RNAPII is not able to complete a transcription reaction from a DNA 
template. Rather, it requires assistance from associated factors that help it find the 
position to initiate transcription, unwind DNA, translocate, and maintain an open 
transcription bubble. Seminal studies in the early 1990s identified the minimal set of 
factors needed to reconstitute transcription in vitro as the five factors now known as 
TBP, TFIIB, TFIIF, TFIIE and TFIIH [21]. These factors, together with TFIIA, and the 
Mediator complex, which were identified later, are called general transcription factors 
(GTFs). The roles that these factors play are described in the following sections, 
introduced in the order of their recruitment. Structural characterization (figure 2.3) of 
all the intermediates of initiation complex assembly has made it possible to visualize 
transitions at a formidable level of detail, and to rationalize biochemically observed 
functions of transcription factors [22]. Resource table 2.2 summarizes all the factors 




Transcription initiation complex assembly begins when TBP (TATA-box binding 
protein) binds to TATA or TATA-like elements in the genome [23]. TBP has a saddle-
shaped structure, with a hydrophobic inner surface. Insertion of a β-sheet into the 
minor groove of its DNA recognition element widens the minor groove resulting in a 
90° bend of the DNA, which is stabilized by intercalation of two TBP aromatic 
residues at the edges [24]. TBP is a subunit of the GTF TFIID (transcription factor 




TFIIA (transcription factor IIA) is not an essential GTF, but can stabilize the TBP-
DNA interaction [25], by contacting DNA upstream of the TATA element, and the 




Next, TFIIB (transcription factor IIB) binds to the TBP-DNA complex. The C-terminal 
part of TFIIB, called the B-core, and the N-terminal part, called the B-ribbon, play 
roles in stabilization of the TBP-DNA interaction, and RNAPII recruitment, 
respectively [27]. Oriented recognition by the B-core of B-recognition DNA elements 
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(BREs) upstream and downstream of the TATA-box may explain the directionality in 
the initiation complex assembly even though the TBP-DNA complex is pseudo-
symmetrical [28]. The B-ribbon interaction with the dock domain of RNAPII tethers it 
to the TBP-DNA-TFIIB complex and facilitates its recruitment [29]. 
 
Upon RNAPII recruitment, a long linker region connecting the B-core and the B-
ribbon of TFIIB is threaded through the RNAPII cleft [30]. The structure of the 
RNAPII-TFIIB complex revealed that, in the RNAPII cleft, the TFIIB linker forms two 
distinct elements; the B-reader and the B-linker elements. Whereas the B-linker 
helps to open DNA for insertion of single-stranded coding DNA into the RNAPII cleft, 
the B-reader helps to position this DNA for initiation of RNA synthesis, recognize the 
transcription start site (TSS), and then separates newly synthesized RNA from DNA 




RNAPII is recruited together with TFIIF (transcription factor IIF), which plays a role in 
stabilization of RNAPII and TFIIB in the PIC [32] and TSS selection [33]. TFIIF is 
composed of two conserved subunits (Tfg1 and Tfg2), and an additional one that is 
only present in yeast (Tfg3), which is not essential. Tfg1 and Tfg2 each have a 
dimerization domain, together constituting a dimerization module, which binds to the 
RNAPII protrusion. Both subunits additionally have a winged helix domain. The Tfg2 
winged helix contacts DNA near the RNAPII cleft, as well as the B-ribbon of TFIIB, 
explaining its role in the TFIIB-RNAPII complex stabilization. On the other hand, the 





TFIIE (transcription factor IIE), is composed of two subunits, and binds the RNAPII 




TFIIH (transcription factor IIH) is a 10-subunit complex composed of the translocase 
Ssl2 (XPB in human), the helicase Rad3 (XPD in human), the three-subunit kinase 
module Kin28-Ccl1-Tfb3 (CDK7-cyclin H-MAT1 in human) and other structural 
subunits [34]. TFIIH adopts a horse-shoe shaped structure, contacting TFIIE via 
Tfb3-Rad3, and downstream DNA via one of the two lobes of its translocase subunit 
Ssl2, pushed into place by two TFIIE helices on an extended loop [35]. The ATPase 
Ssl2 is proposed to open DNA by ATP-dependent ratcheting of its DNA-bound lobe 
against the second lobe, which is anchored in place within the rest of the TFIIH 
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structure. The main role of TFIIH is to open promoters by virtue of its ATPase [36], 
and to phosphorylate the RNAPII CTD resulting in promoter escape [37]. Although 
AT-rich promoters can spontaneously open in vitro, the majority require TFIIH in vivo 
[38]. This may be due to chromatinization, which is frequently absent in in vitro 
studies. Additionally, TFIIH has a function in DNA repair, unrelated to transcription 
[39]. 
 
Structure of the transcription Pre-initiation complex (PIC) 
 
The complex of TBP, TFIIA, TFIIB, RNAPII and TFIIF on promoter DNA is called the 
core pre-initiation complex (core PIC or cPIC). Addition of TFIIE and TFIIH results in 
the pre-initiation complex (PIC). Before promoter DNA opening (if ATP is not added 
and the promoter is GC-rich), this is called a closed PIC, whereas a PIC with an open 
DNA bubble is called an open PIC. A PIC with an open bubble that has started to 
transcribe, thus contains a DNA-RNA hybrid with a short RNA chain is called an 
initially transcribing complex (ITC). Following the same pattern, an ITC that lacks 
TFIIE and TFIIH is called a core ITC (cITC).  
Figure 2.3 shows the described complexes, 25 years in the making, from the first 
crystal structure of DNA-bound TBP, to the cryo-EM structure of a complete yeast 
PIC. Shown in this figure is the final structure of the complete yeast PIC [35], 
successively revealing different factors in the sequence of their recruitment, meant 
as a schematic visual aid, and not the true structures of intermediates that were 
solved over the years. Nevertheless, the structures of factors within the PIC and the 
intermediates in the PIC assembly process are highly resemblant.   
 
When we started this study, TFIIH was not available, and therefore, what we refer to 
as a PIC in the following sections, is actually the cPIC plus TFIIE. This should be 




Table 2.2 | Canonical transcription initiation factors. CTD, C-terminal domain; NA, not available; Pol, RNA 
polymerase; TAF, TBP-associated factor; TBP, TATA-box-binding protein; TFIIA, transcription initiation factor IIA; 
TSS, transcription start site. * Archaeal homologue. ‡ Factor shared between Pol I, Pol II, and Pol III. § No known 
archaeal homologue. II Component of TFIID, TFIIF and chromatin remodeling complexes. ¶ Approximate molecular 
weight. # TFG3 is a component of TFIID, TFIIF and chromatin remodeling complexes; the yeast-specific subunit is 
non-essential as part of TFIIF and as part of TFIID [22] 
Factor Gene name Mass (kDa) 
 Yeast Human Yeast Human 
Pol II (RNAP*): transcribing enzyme 
RPB1 RPO21 POLR2A 191.1 217.2 
RPB2 RPB2 POLR2B 138.8 133.9 
RPB3 RPB3 POLR2C 35.3 31.4 
RPB4 RPB4 POLR2D 25.4 16.3 
RPB5‡ RPB5 POLR2E 25.1 24.6 
RPB6‡ RPO26 POLR2F 17.9 14.5 
RPB7 RPB7 POLR2G 19.1 19.3 
RPB8‡ RPB8 POLR2H 16.5 17.1 
RPB9 RPB9 POLR2I 14.3 14.5 
RPB10‡ RPB10 POLR2L 8.3 7.6 
RPB11 RPB11 POLR2J 13.6 13.3 
RPB12‡ RPB12 POLR2K 7.7 7.0 
Total 
(12 subunits)   513.6 516.7 
TFIIA§: TBP stabilization and counteracts repressive effects of negative co-factors 
Large subunit TOA1 GTF2A1 32.2 41.5 
Small subunit TOA2 GTF2A2 13.5 12.5 
Total 
(2 subunits)   45.7 54.0 
TFIIB: Pol II recruitment, TBP binding and TSS selection 
TFIIB (TFB*) SUA7 GTF2B 38.2 34.8 
TFIID: Pol II recruitment and promoter recognition 
TBP (TBP*): recognition of the TATA 
box TBP TBP 27.0 37.7 
TAF1 TAF1 TAF1 120.7 212.7 
TAF2 TAF2 TAF2 161.5 137.0 
TAF3 TAF3 TAF3 40.3 103.6 
TAF4 TAF4 TAF4 42.3 110.1 
TAF5 TAF5 TAF5 89.0 86.8 
TAF6 TAF6 TAF6 57.9 72.7 
TAF7 TAF7 TAF7 67.6 40.3 
TAF8 TAF8 TAF8 58.0 34.3 
TAF9 TAF9 TAF9 17.3 29.0 
TAF10 TAF10 TAF10 23.0 21.7 
TAF11 TAF11 TAF11 40.6 23.3 
TAF12 TAF12 TAF12 61.1 17.9 
TAF13 TAF13 TAF13 19.1 14.3 
TAF14II TAF14 NA 27.4 NA 
Total 
(14 – 15 subunits)   1,200
¶ 1,300¶ 
TFIIE: recruitment of TFIIH and open DNA stabilization 
TFIIEα (TFE*) TFA1 GTF2E1 54.7 49.5 
TFIIEβ TFA2 GTF2E2 37.0 33.0 
Total 
(2 subunits)   91.7 82.5 
TFIIF§: TSS selection and stabilization of TFIIB 
TFIIFα TFG1 GTF2F1 82.2 58.2 
TFIIFβ TFG2 GTF2F2 46.6 28.4 
TFG3# TAF14 NA 27.4 NA 
Total 
(2 – 3 subunits)   156.2 86.6 
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Factor Gene name Mass (kDa) 
 Yeast Human Yeast Human 
TFIIH§ (core): promoter opening and DNA repair 
Subunit 1 (p62) TFB1 GTF2H1 72.9 62.0 
Subunit 2 (p44) SSL1 GTF2H2 52.3 44.4 
Subunit 3 (p34) TFB4 GTF2H3 37.5 34.4 
Subunit 4 (p52) TFB2 GTF2H4 58.5 52.2 
Subunit 5 (p8) TFB5 GTF2H5 8.2 8.1 
XPD subunit: ATPase; 
DNA repair 
RAD3 ERCC2 89.8 86.9 
XPB subunit: ATPase; 
promoter opening 
SSL2 ERCC3 95.3 89.3 
Total 
(7 subunits) 
  414.5 377.3 
TFIIH (kinase module): CTD phosphorylation 
Cyclin H CCL1 CCNH 45.2 37.6 
CDK7 KIN28 CDK7 35.2 39.0 
MAT1 TFB3 MNAT1 38.1 35.8 
Total 
(7 subunits) 






Architecture of promoters 
 
The genomic sites at which polymerases and associated factors assemble to initiate 
transcription are called promoters. The core promoter is defined as “the minimal DNA 
element required for basal transcription” [40]. Characteristic sequence elements 
distinguish core promoters; the TATA-box element is the recognition site for TATA-
box binding protein (TBP); the initiator (INR) – which contains the transcription start 
site (TSS), the motif 10 element (MTE) and the downstream promoter element 
(DPE), together called the downstream core element (DCE) are additional 
recognition sites of the co-activator TFIID; and upstream and downstream TFIIB 
recognition elements (BREu and BREd) are recognition sites for the GTF TFIIB (found 
in higher eukaryotes). In TATA-containing promoters, TBP nucleates the assembly of 
the transcription pre-initiation complex (PIC), and this places the RNAPII active sites 
roughly 30 base pairs from the TATA element. In metazoans, this is the transcription 
start site (TSS) [41]. However, in yeast, the RNAPII scans 50 to 120 base pairs 
downstream of the TATA element before it initiates from a preferred AT-rich 
consensus sequence [42]. When fully assembled, the PIC covers approximately 60 
base pairs of promoter DNA. Promoters occur in nucleosome-depleted regions 
(NDRs), which span roughly 140 base pairs of naked DNA, bounded by +1 and -1 
nucleosomes [43]. The architecture of core promoters is schematically depicted in 





2.2.4 Transcription activation 
 
While possible in vitro from a DNA template, basal transcription does not occur in 
vivo. Virtually all RNAPII transcription in vivo is activated, and requires the binding of 
gene-specific transcription activators to DNA elements found upstream of promoters, 
known as upstream activation sequences (UASs) [44]. This is likely due to 
chromatinization, making the default state of genes “off” unless activated. 
 
Architecture of upstream activation sequences (UASs) 
 
UASs contain one or multiple recognition motifs for different transcription activators, 
and often allow for combinatorial control of gene activation. In yeast UASs are 
usually present within nucleosome-depleted regions (NDRs), or displayed on the 
surface of nucleosomes [45]. In human, UASs are called enhancers, and can operate 
from both 5’ and 3’ or promoters, whereas in yeast, they can only function if present 
on the 5’ side [44]. 
UASs communicate with promoter regions by looping, and can thus achieve spatial 
proximity despite being remotely located on a linear DNA sequence [46]. Structural 




The yeast genome database Yeastract [47] reports 118 defined transcription factors 
in the yeast genome. Transcription factors are characteristically modular, and often 
contain structurally and functionally distinct DNA-binding domains (DBDs) and 
activation domains (ADs). Based on their DNA binding domains, they can be 
classified into three main classes: zinc-stabilized, helix-turn-helix and zipper type 
[44]. The zinc-binding type can be further divided into; C2H2 zinc fingers, in which 
tetrahedral coordination of a zinc ion by two Cys and two His residues stabilizes the 
DBD; C6 zinc knuckles in which coordination of two zinc ions by six Cys residues 
stabilizes the DBD; and C4 or GATA type in which tetrahedral coordination by Cys 
residues stabilize the DBD. The zipper type include bZIP or leucine zippers, in which 
hydrophobic interaction between several Leu residues is involved in 
homodimerization of the DBD, and the bHLH type in which two amphipathic helices 
often result in heterodimerization [44]. Structures of representatives from each class, 
adapted from [44], are shown in figure 2.5 (adapted from [44]). The histidine 
deficiency response activator general control protein 4 (Gcn4), which we have used 
as a model in this study, is of the bZIP (leucine zipper) type.       
 
Because of their modular nature, chimeras of DBDs of various factors with the very 
potent viral AD VP16, have often been employed as tool to study gene activation 




Mechanism of activator function 
 
The commonly accepted mechanism of activator function is physical recruitment. 
This is based on the observation that more coactivators, RNAPII and GTFs were 
found on genes upon gene induction [49],[50],[51]. Recently, several transcription 
activators have been shown to undergo liquid-liquid phase separation by virtue of 
their disordered activation domains, and this has been proposed as a general 




Before PIC assembly, UAS-bound activators recruit huge multisubunit coactivator 
complexes called TFIID and SAGA (Spt–Ada–Gcn5 acetyltransferase), which are 
both responsible for delivering TBP to promoters to nucleate PIC assembly [53]. 
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TFIID is made up of TBP and 14 TBP-associated factors (TAFs), which hold together 
via highly recurrent histone fold domains. TFIID binds promoters at elements 
upstream and downstream of the TBP binding site forming an arched structure, and 
the mechanism by which it deposits TBP remains unknown [54]. Moreover, whether 
coactivators deposit TBP to recruit PIC factors, and leave, or whether they remain 
bound and perform downstream functions in the PIC assembly progression awaits 
elucidation. One possibility is that the TFIID arch extends over the PIC and is 
therefore a part of the PIC structure.  
  
The composition of SAGA is highly similar to that of TFIID, sharing a lot of the same 
TAF subunits, although it associates TBP less tightly [55]. Additionally, SAGA 
contains a histone acetyl transferase (HAT) subunit called Gcn5, which participates 
in gene activation by priming chromatin remodeling to deplete nucleosomes from 
downstream promoter regions.    
 
SAGA binds at TATA-containing promoters, which make up only 20% of the yeast 
coding genome and are generally found at regulated, stress responsive genes. On 
the other hand, TFIID binds the majority of promoters, which lack a TATA element, 
and contain TATA-like AT-rich elements instead [56]. The exact roles of TFIID and 
SAGA, and the events that occur at activating sequences before PIC assembly are 
among the biggest open questions in transcription initiation. They have remained 
thus far elusive in part because they are mediated by huge, multisubunit complexes 
that are not straightforward to isolate, and in part because these events are 
frequently governed by “fuzzy” unstructured micromolar-affinity interactions, making 
them challenging to capture.  
 
The Mediator complex 
 
Contrary to what was observed in vivo, UAS-bound activators failed to stimulate 
transcription by purified PIC components from a DNA template in vitro, indicating that 
there is a missing component [57]. A tour-de-force of genetics and biochemistry in 
the 1990s led to the identification of this missing component, when an activity was 
isolated that rendered purified PIC components responsive to stimulation by 
transcription activators [58]. Genetic screening contemporaneously identified this 
activity as belonging to a group of RNAPII CTD-interacting genes [59],[60]. This 
activity, which mediates between activators and the PIC, was thereafter fittingly 
named the “Mediator”.  
 
Mediator acts universally on all protein-coding genes [61], and is a huge complex 
composed of 25 subunits in yeast, and 30 subunits in human [62]. The function and 
composition of Mediator are depicted in figure 2.6. The subunit composition is 
detailed in resource table 2.3. Early studies of its structural and functional 
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architecture allowed the distinction of four modules; the head, the middle, the tail and 
the kinase modules. Whereas the head and middle modules, together called the core 
Mediator (cMed), are essential for viability in yeast, the tail and kinase modules are 
not [63]. This means that, inasmuch as it is essential for general transcription, 
Mediator is a GTF, whereas its interaction with activators additionally gives it a 
coactivator function. The GTF function can be pinned down to the head and middle 
modules (cMed), while the tail module is responsible for the majority of Mediator-
activator interactions in yeast [63].  
 
Mediator conveys the activation signal from UAS-bound activators to the PIC by 
Mediator-dependent stabilization of the PIC, and stimulation of the activity of the 
TFIIH kinase (by up to 12 times in vitro), resulting in RNAPII CTD phosphorylation 
and promoter escape [57]. 
 
Table 2.3 | Subunit composition of the Mediator complex. * Metazoan specific subunits. ¶ Approximate molecular 
weight. 
Factor Gene name Mass (kDa) 
 Yeast Human Yeast Human 
Head module 
MED6 MED6 MED6 32.8 28.4 
MED8 MED8 MED8 25.2 29.1 
MED11 MED11 MED11 13.3 13.1 
MED17 SRB4 MED17 78.5 72.9 
MED18 SRB5 MED18 34.3 23.7 
MED20 SRB2 MED20 22.9 23.2 
MED22 SRB6 MED22 13.9 22.2 
MED28* - MED28 - 19.5 
MED30* - MED30 - 20.3 
Total 
(7 / 11 subunits)   220.8 252.4 
Middle module 
MED1 MED1 MED1 64.3 168.5 
MED4 MED4 MED4 32.2 29.7 
MED7 MED7 MED7 25.6 27.2 
MED9 CSE2 MED9 17.4 16.4 
MED10 NUT2 MED10 17.9 15.7 
MED19 ROX3 MED19 24.9 26.3 
MED21 SRB7 MED21 16.1 15.6 
MED31 SOH1 MED31 14.7 15.8 
MED26* - MED26 - 65.4 
Total 
(8 / 9 subunits)   213.1 380.6 
Tail module 
MED2 / MED29 MED2 MED29 47.7 21.1 
MED3 / MED27 PGD1 MED27 43.1 35.4 
MED5 / MED24 NUT1 MED24 128.8 110.3 
MED14 RGR1 MED14 123.4 160.6 
MED15 GAL11 MED15 120.3 86.8 
MED16 SIN4 MED16 111.3 96.8 
MED23 * - MED23 - 156.5 
MED25 * - MED25 - 78.2 
Total 




Factor Gene name Mass (kDa) 
 Yeast Human Yeast Human 
Kinase module 
MED12 / MED12 or MED12L SRB8 MED12 or MED12L 166.9 243.1 or 240.1 
MED13 / MED13 or MED13L SSN2 MED13 or MED13L 160.0 239.3 or 242.6 
CDK8 / CDK8 or CDK19 SSN3 CDK8 or CDK19 62.8 53.3 or 56.8 
CycC SSN8 CCNC 37.8 33.2 
Total 
(4 subunits) 







Mediator structural biology 
 
Owing to its large size, flexibility and laborious preparation, attaining a high-
resolution structure of the Mediator complex is still an ongoing endeavor, more than 
two decades after its first two-dimensional EM projection map [64]. Since then, a 
modular approach has been undertaken, solving piece by piece of the Mediator 
structure puzzle. Initially, single subunit structures and binary subunit interactions 
were solved [65]. More recently, the first structure of a complete Mediator module 
was demonstrated when the S.pombe head module structure was solved [66],[67]. 
Soon after, the crystal structure of the complete S.pombe core Mediator was solved 
at atomic resolution [68]. This structure allowed the accurate delineation of subunit 
assignment to the different modules, and illuminated the role of the long scaffolding 
subunit Med14, which traverses the length of Mediator, and acts as a backbone 
connecting the head, middle and tail modules together. Notably, the S.pombe 
	 23	
Mediator naturally lacks a tail module. Figure 2.7 shows a homology model of the 
S.cerevisiae cMed derived from the abovementioned structure, which we will use 
throughout this work for modeling different interactions. Structural elements that will 
be referred to later are also indicated.  
 
 
Cryo-EM structures of free and RNAPII-bound S.pombe Mediator demonstrated a 
dramatic structural rearrangement that occurs upon binding [69]. Moreover, cryo-EM 
structures of the PIC-bound [35],[70] and cITC-bound cMed [71] uncovered the 
nature of the interaction of Mediator with the transcription initiation machinery and 
shed light on the GTF aspect of its function. Although not seen in these structures, 
the location of cMed indicates that it is positioned to possibly interact with the TFIIH 
kinase module, and thereby stimulate its activity. Moreover, together with the 
remainder of TFIIH, the Mediator hook domain creates a gulf that can cradle the 
RNAPII CTD and direct it towards the TFIIH kinase [35]. cMed interacts with RNAPII 
at two main interaction hubs; between the arm/spine of the cMed head module and 
the Rpb4/7 stalk of RNAPII, and between the moveable jaw of the cMed head 
module (Med18/Med20 heterodimer) and the dock of RNAPII (figure 2.8). 
Additionally, there is a transient interaction between the mobile plank of the cMed 
middle module and the foot of RNAPII.  
 
Although the Mediator-PIC interaction has been extensively characterized, 
comparatively little is known about the other end of the PIC-Mediator-activator 
bridge.  Whereas cMed is highly structured, disorder prevails in the activator-
interacting tail module [72]. 118 annotated transcription activators in the yeast 
genome, means that the Mediator tail has at least 118 interaction partners. Disorder, 
which allows for sequence degeneracy, may be nature’s economic solution to this 
problem, allowing the evolution of malleable interactions with a plethora of 
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unstructured activation domains. Indeed, this structural plasticity is a conserved part 
of Mediator function [73]. The ability of the mediator tail subunit Med15 to undergo 
liquid-liquid phase separation with the activation domains of various interaction 
partners is further testament to that [52]. 
 
The Mediator kinase module 
 
The dissociable Cdk8-kinase module (CKM) of Mediator was identified in the same 
genetic screen for RNAPII CTD interactors as the other Mediator subunits, and co-
purifies with them in some preparations [74]. Likewise, only a subpopulation of 
Mediator contains CKM in vivo [61]. Even though it is composed of only four 
subunits, the CKM is about the same size as cMed, and makes up almost a third by 
mass of the full Mediator complex. The CKM contains the kinase/cyclin pair 
Cdk8/CycC, which is the only catalytic activity within the Mediator complex [75],[76].  
 
Like the other transcriptional kinases, Cdk8 phosphorylates the CTD of RNAPII [19]. 
Unlike the TFIIH kinase Cdk7, however, this is thought to be a repressive effect, 
occurring prior to PIC assembly [18]. Cdk8 additionally phosphorylates the activators 
Gcn4, Msn2, Phd1 and Ste12, resulting in their increased turnover, supporting the 
idea of its role as a repressive molecule [77]. On the other hand, it is required for 
complete activation of the activators Gal4, Skn7 and Sip4, contradicting that idea 
[77]. It has also been found to both activate and repress gene transcription in human 
[78].  
 
Biochemical studies in human implicated a kinase-independent repression of 
transcription in vitro [79]. Recent reports have indicated that the CKM is not found on 
promoter sequences, but is found at UASs, as opposed to other Mediator subunits, 
which are found at both [80]. Although generally construed as repressive, 
counteracting the effect of Mediator, the exact role that the CKM plays is the subject 
of longstanding controversy.  
 
The structure of the CKM and the CKM-Mediator are among the biggest open 
questions in transcription initiation. So far, the crystal structure of Cdk8/CycC from 
human has been solved [81], as a low-resolution map of the S.cerevisiae CKM is 











The observation that cells can concentrate proteins in membraneless compartments 
led to the rise of phase separation as a concept for the organization of cellular 
biochemistry, by confining reactions in liquid droplets that have phase separated 
from the cytoplasm [83]. These droplets are characterized by thermodynamic 
reversibility and are often composed of proteins of low sequence complexity. Various 
interactions are possible to maintain these droplets, including both structured and 
unstructured interactions, stabilized by electrostatic or hydrophobic contacts, 
between one or multiple proteins [84]. Cells can regulate the degree to which 
proteins phase separate by expending energy to pay off the entropic cost of their 
local enrichment, or by tuning post-translational modifications (PTMs), such as 
phosphorylations and methylations, which alter the solubility, affinity and valency of 
phase separating molecules. 
In recent years, in vitro phase separation studies have emerged as a tool to study 
intrinsically disordered proteins, and learn about factors that may influence the 
behavior of phase-separating proteins and nucleic acids in the cell.   
 
Components of transcription, such as the CTD of RNAPII [20], several Mediator 
subunits [85],[86], and transcription activators have been shown to undergo liquid-
liquid phase separation in cells [52], and that this property relates to their 
characterized functions.  
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2.3 Aims of this study 
 
The fundamental components of the transcription machinery are well understood.  
However, how this machinery is regulated in response to signaling remains largely 
obscure. Understanding gene regulation hinges on understanding the events that 
precede the assembly of transcriptional complexes. These include binding of 
activators to UASs, recruitment of coactivators, and signal transduction to the central 
transcription machinery.      
 
Here, we aimed to understand the role that the Cdk8 kinase module (CKM) of the 
Mediator complex plays in transcription regulation; what complexes does it partake 
in, what are its phosphorylation targets, how does it interact with the rest of the 
Mediator complex, how does it affect transcription activators, and what does that 
mean about its enigmatic function. Furthermore, we aimed to solve the structures of 
the CKM and the CKM-cMed complex by cryo-electron microscopy to elucidate the 
nature of its interaction with Mediator, with the aim of deriving mechanistic insights 
from that. 
  
To make that possible, we first needed to establish a recombinant expression and 
purification system for the S.cerevisiae CKM. After extensive trials, we successfully 
set up a novel method for its production, which is scalable and yields sufficient 
material of high quality for both functional and structural studies. 
 
Using a combination of biochemical and structural techniques, we aimed to dissect 
the binding of CKM to the PIC and cMed. We set up exploratory phosphoproteomics 
studies to discover new targets of the CKM within the transcription machinery, and 
provided putative meanings for these phosphorylations using in vitro phase 
separation studies. Our findings will be presented in the following sections. From our 
data, we were able to venture a new model for CKM function. We were not 
successful at solving the structures of CKM or CKM-cMed. The outcomes of our trials 
and future directions will be presented in the next sections.  
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Table 3.1 | Vectors used in this study. A compilation of the vectors used for cloning, which form the vector 
backbones of all recombined plasmids used in this study. 
Plasmid Source/vendor Selection 
Expression 
Host 



















Amp E.coli T7  26043 




Kan E.coli T7  71406 
pCDFDuet EMD Biosciences Strep E.coli T7  71340 
pETDuet EMD Biosciences Amp E.coli T7  71146 
pET28b EMD Biosciences Kan E.coli T7  69865 










Amp Mammalian  18696 
 
3.2 Recombined plasmids  
 
Table 3.2 | Plasmids used in this study. A compilation of all recombinant plasmids used, describing the genes they 
contain, fusion tags and their locations, linkers and vector backbones.   













































ScGcn4 1-281 N-His(x6)-thrombin pET28b Kan H.Wang 
mEGFP-Gcn4/ 


























ScTBP 1-240  - pOPINE Amp [71] 







































































































Additionally, the following should be noted. The cMedΔ4,9 subunit sequences are 
present on three different plasmids (cMedΔ4,9_1, cMedΔ4,9_2 and cMedΔ4,9_3) 
co-transformed together into a single E.coli strain, which is maintained as a frozen 
stock.  
CO means that the gene sequence had been codon optimized for the respective 
expression host. 3C and TEV refer to sequences encoding 3C protease and TEV 
protease cleavable linkers between the tag and the gene, respectively. 
The mEGFP and mCherry tags were amplified from the mEGFP and 6B vectors 
(table 3.1), respectively. The mEGFP-Gcn4 and mCherry-Med15 sequences are 
connected via the artificially added linker sequence “GGSAGSGGSG”, which is not a 
part of the vector backbone. 
 
3.3 DNA Scaffolds 
 
DNA scaffolds used for immobilized template assays (ITAs) and other biochemical 
assays were modeled on the natural yeast HIS4 gene promoter, with modifications 
added for the intended application.  
 
Sense and antisense strands were synthesized separately as Ultramers® from 
Integrated DNA Technologies (IDT), with the needed 5’ modifications. 
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Table 3.3 | DNA scaffolds used in this study. A compilation of the sense (top) and antisense (bottom) strands that 
were annealed together to obtain the DNA scaffolds used in this study, both shown in a 5’ to 3’ orientation. The 
experiments that the respective scaffolds were used for are indicated. The legend below the table explains the color-
coding. 
Gcn4 binding site 
Linker + EcoRV restriction site 
TATA Box…TSS 




Chemicals were procured from Sigma-Aldrich, Roth, Thermo Fisher Scientific and 
Merck. It can be generally assumed that chemicals of the same grade from different 
qualified sources were used interchangeably. Situations where the source or grade 





Used in Sense/antisense sequence (5’ to 3’) 








































3.5 Cell culture 
 
3.5.1 E.coli strains 
 
Table 3.4 | E.coli strains used in this study. Listing of the bacterial strains used in this study, together with their 
supplier and genotype. 
Strain Supplier Genotype 
XL1-Blue Agilent 







DH10EMBacY Geneva biotech 
F
- 
mcrA ∆(mrr-hsdRMS-mcrBC) φ80dlacZ∆M15 ∆lacX74 endA1 recA1 
deoR ∆(ara, leu)7697 araD139 galU galK λ- rpsL nupG / bMON14272
‡ 
yfp+/ pMON7124  
BL21-CodonPlus 
(DE3) RIL Agilent 








E. coli gal λ (DE3) endA 
Hte [argU ileY leuW Cam
r
]  








E. coli gal λ (DE3) endA 
Hte [argU ileY leuW Cam
r
] (ArnA, SlyD knockout) 
 
3.5.2 S.cerevisiae strains 
 
Table 3.5 | S.cerevisiae strains used in this study. Listing of the yeast strains used in this study for purification of 
endogenous S.cerevisiae protein complexes, together with their source and genotype.  
Factor Strain Genotype Source 
RNAPII BJ5464  
Rpb3-His6-Bio 
BJ5464; MATalpha; ura3-52 trp1 leu2-delta1 his3-delta200 









BJ5464; MATalpha ura3-52 trp1 leu2-delta1 his3-delta200 





3.5.3 Insect cell lines 
 
Table 3.6 | Insect cell lines used in this study. Listing of the insect cell lines used in this study together with their 
source of origin and vendors.  
Cell line Species Source Supplier 
Sf9 S.frugiperda 
Pupal ova(derived from 
strain (IPLB-Sf21-AE) [89] 
Thermo Fisher 
Scientific 
Sf21(IPLB-Sf21-AE)  S.frugiperda Pupal ova [89] 
Thermo Fisher 
Scientific 
Hi5(BTI-TN-5B1-4)  T.ni Pupal ova [90] Expression Systems 
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3.5.4 Cell culture media 
 
Table 3.7 | Cell culture media and components. Details of the media used for making liquid cultures or plates of 
bacterial, yeast and insect cells, together with their chemical composition and supplier.  
Media Culture type Composition Supplier 
LB E.coli (liquid culture +plates) 
1% (w/v) tryptone, 0.5% (w/v) yeast extract,  
0.5% (w/v) NaCl  







2% (w/v) peptone, 2% (w/v) glucose, 1.5% (w/v) yeast 
extract  
(1.8% (w/v) agar for plates)  
homemade 





Sf9/Sf21 adherent  
and liquid culture 
Low-hydrolysate, serum-free, protein-free, animal origin-
free insect cell culture medium 
Thermo Fisher 
Scientific 
ESF921TM  Hi5 liquid culture 
Serum-free, protein-free insect cell culture media, 





3.5.5 Antibiotics and additives 
 
Table 3.8 | Antibiotics and additives to cell culture media. Listing of antibiotics and additives used in cell culture 
media with their solvent, application, stock and final concentrations.  
Substance Added to Stock concentration Final concentration 
Ampicillin (in water) E.coli culture+plates 100 mg/mL 100 µg/mL 
Kanamycin (in water) E.coli culture+plates 50 mg/mL 50 µg/mL 
Chloramphenicol (in 96% ethanol) E.coli culture+plates 30 mg/mL 30 µg/mL 
Gentamycin (in water) 
E.coli culture+blue-white 
selection plates 
10 mg/mL 10 µg/mL 
Tetracycline (in water) E.coli culture+plates 10 mg/mL 10 µg/mL 




150 mg/mL 150 µg/mL 
IPTG (in water) 
E.coli culture+blue-white 
selection plates 
1M 0.1-1 mM 
Streptomycin (in water) E.coli culture+plates 30 mg/mL 30 µg/mL 
X-tremeGENETM 9 
(in 80% ethanol)  
 
Insect cell  
transfection 
Not stated 1.5 µL/mL 
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3.6 Antibodies  
 
3.6.1 Primary antibodies 
 
Table 3.9 | Primary antibodies used in this study. Listing of primary antibodies used in this study, together with 
their target, supplier, dilution for western blot analysis, and the organism in which they were produced.  
 
3.6.2 Secondary antibodies 
 
Table 3.10 | Secondary antibodies used in this study. Listing of secondary antibodies used in this study, together 
with their target, supplier, dilution for western blot analysis, and the organism in which they were produced. 














rabbit IgG Santa Cruz 1:2,000 goat 
 
3.7 Standard buffers and dyes 
 
Table 3.11 | Standard buffers and dyes. Components of standard buffers and dyes that have been used throughout 
this study. 
Buffer Composition/source 
SDS-PAGE loading dye NuPAGE® 4X LDS loading buffer/Thermo Fisher Scientific 
PBS 137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, pH 7.4, 1.76 mM KH2PO4, pH 7.4  
TAE 5 mM EDTA, 2.5 M Tris-acetate, pH 8.0  





Antibody  Target Supplier Dilution Production 
Organism 
α-Gcn4 Sc Gcn4 Absolute Antibody 
C11L34 
1:10,000 mouse 
α-Srb4 Sc Med17 Abcam ab63812 1:5,000 rabbit 


































To generate the DNA plasmid constructs for expression and purification of the 
proteins in this study in their respective heterologous expression systems, several 
cloning methods and vector systems were used.  These included Ligation-
Independent Cloning (LIC), In-fusion cloning and Gibson Assembly. 
 
All steps were carried out at room temperature, unless otherwise indicated. All DNA 
constructs and intermediate DNA products were stored at -20°C. All water used in 
reactions was Milli-Q (Merck-Millipore) water, deionized and filter-sterilized through a 
0.22 µm membrane filter, and additionally autoclaved. All bacterial cultures were 




For all the abovementioned methods, linearization of an acceptor plasmid with 
restriction endonucleases was needed. In digestion reactions, 20 µL of plasmid DNA 
(50 ng-2 µg) were mixed with 6 µL of the appropriate10X buffer (e.g. NEB CutSmart), 
4 µL of restriction enzyme, made up to 60 µL with water, and incubated according to 
the commercial recommendations for the used restriction endonuclease at either 
37°C or 25°C, for 1-3 hours or overnight. The linearized plasmid was then purified by 
gel extraction.  
 
Insert generation by PCR  
 
Genes or gene fragments of interest were amplified, either from genomic DNA, cDNA 
or a different plasmid, by polymerase chain reaction (PCR), using forward and 





Forward and reverse PCR primers were designed such that they are identical to the 
5’ (beginning), and reverse complementary to the 3’ (end), regions of the sequence 
to be amplified. As a rule of thumb, primers were designed to be between 12 and 30 
nucleotides in length (of the template binding part), to have a melting temperature 
(Tm) between 55°C and 70°C, and to have a GC-content of 20-60% where possible. 
	 34	
Also, all primers were designed to end with (the 3’-most base) either a Guanine or a 
Cytosine.   
For LIC cloning, 5’ tags were added to the primers depending on the intended 
recipient vector. For insertion into the series-438 MacroBac insect cell transfer 
vectors (Macrolab), the tags v1 F and v1 rv (table) were added to the forward and 
reverse primers, respectively, for vectors 438-B and 438-C, whereas the tags vBac F 
and v1 rv were added for vector 438-A. 
For insertion into the series-1 E.coli T7 expression vectors 1B and 1C (Macrolab), 
primer extensions v1 F and v1 rv were added to the forward and reverse primers, 
respectively.  
 
Table 4.1 | LIC tags added to primers. Sequences of LIC tags added to the 5’ ends of primers designed for cloning 
into the series-438 vectors. 
LIC Tag Sequence to be added 5’ to PCR primers 
v1 F 5’-TACTTCCAATCCAATGCA-3’ 
v1 rv 5’-TTATCCACTTCCAATGTTATTA-3’ 
vBac F 5’-TACTTCCAATCCAATCG-3’ 
 
For In-fusion cloning and Gibson assembly, where multiple fragments (or insert and 
linearized vector) were ligated, primers were designed such that they overlapped by 
at least 15 base pairs with each of the two fragments to be joined, and to have a Tm 




When S.cerevisiae genomic DNA was used as a sequence template, it was first 
extracted from wild-type yeast colonies. Single colonies from a YPD plate, or cells 
from 100 µL of YPD culture at an OD600 of 0.4, were resuspended in 100 µL of 200 
mM lithium acetate and 1% SDS. The cells were vortexed then incubated for 5 
minutes at 70°C. 300 µL of 96% ethanol were added to precipitate the DNA. The 
mixture was briefly vortexed, and the DNA was pelleted by centrifugation at 15,000xg 
for 3 minutes. The supernatant was carefully removed, and the DNA pellet washed 
with 500 µL of 70% ethanol. Care was taken not to disrupt the pellet with shearing 
forces. The pellet was then dissolved in 100 µL of water (the water was added gently 
to the top and the DNA was allowed to dissolve without pipetting up and down). 
Debris was removed by centrifugation at 15,000xg for 1 minute. 1 µL of the clarified 
supernatant was used as a template for PCR reactions. This preparation was not 





In a typical PCR reaction, 1 µL of template DNA (50-100 ng), was mixed with 3 µL of 
100 mM dNTP mix (dATP, dCTP, dGTP, dTTP - NEB), 3 µL of 100 µM forward 
primer, 3 µL of 100 µM reverse primer, 30 µL of 5x phusion polymerase buffer (NEB), 
and 0.5 µL of phusion polymerase enzyme (NEB), and made up to 150 µL with 
water. The 150 µL reaction was then divided into 3 (50 µL per PCR tube).      
 
A typical PCR program had an initial template denaturation step at 95°C for 4 
minutes, followed by an iterative program of denaturation (94°C for 45 seconds), 
annealing (55-60°C depending on the Tm of the designed primers, for 1 minute), and 
primer extension (72°C for 3 minutes). This was done for 30 iterations to amplify the 
product, followed by a final elongation step at 72°C for 10 minutes.  A Tprofessional 
TRIO thermocycler (analytik jena) was used to vary the temperature as described.  
The PCR extension time was adjusted according to the length of the sequence to be 
amplified, and the speed of the DNA polymerase used. 
 
For difficult PCR reactions (particularly for genes approaching 5000 base pairs in 
length or longer), the reactions were optimized by: Applying a gradient of annealing 
temperatures, using different polymerases optimized for longer reactions such as Q5 
(NEB) or ExpandTM20kbPLUS (Sigma-Aldrich), addition of 1-10% DMSO or Betaine for 
better extension from GC-rich templates, or changing the PCR protocol to a two-step 
or touchdown PCR, where the annealing step was omitted, or set 5°C above the Tm  




Round-the-horn PCR (RTH PCR) was used to insert substitutions or deletions in a 
given sequence. In this method, the template is a circular plasmid, and primers are 
designed facing away from each other, and flanking the sequence to be modified. 
Thus the full plasmid sequence is amplified, excluding the sequence to be modified. 
The new, modified sequence is then encoded via an additional 5’ overhang in one of 
the two primers, resulting in a product composed of a linearized copy of the template 
with the modification on one of its ends. 5’-phosphorylations on the primers allow re-
circularization by ligation. 
 
To perform round-the-horn PCR, the PCR reactions and programs were set up and 
optimized as previously described using Q5 (NEB) as a polymerase. 1 µL DpnI 
(NEB) was added per PCR reaction to digest the original template.   
The product was circularized after purification by gel extraction, by incubation of 50 
ng with 1 µL of T4 ligase (NEB) and 1 µL of 10X T4 ligase buffer (NEB) for 1 hour or 
overnight at room temperature. This could then be used to transform XL1-Blue cells.  
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Agarose gel electrophoresis for product size verification 
 
1% (w/v) agarose was dissolved in 1x TAE buffer by boiling, and allowed to 
polymerize by cooling down. 3 µL of the DNA-intercalating stain SybrTMSafe 
(Invitrogen) per 50 mL of gel were mixed in the gel matrix to allow UV visualization of 
the DNA bands. Samples were loaded in the wells, together with a DNA ladder as a 
size fiducial, and the gels were run in an electrophoresis chamber. Gels were 
visualized using a GEL iX20 Imager system (Intas).  
 
Gel extraction of product 
 
Bands corresponding to the expected size were extracted from the gel by excising 
the gel area, and further processed using a QIAquick® gel extraction kit (QIAGEN) 




DNA was quantified by absorbance measurement at a wavelength of 260 nm using a 
Nanodrop 2000 spectrophotometer (Thermo Scientific). The concentration was 
calculated from the absorbance measurement according to Beer’s Law.  
 
Combining vector and insert 
 
For recombination by LIC cloning, vectors and inserts were treated separately with 
T4 polymerase supplemented with dGTP or dCTP, respectively. T4 polymerase is an 
enzyme that has conditional polymerase and exonuclease activities. In the absence 
of dNTPs, its exonuclease activity prevails, and vice versa. By addition of only one 
dNTP (either dCTP or dGTP), the T4 exonuclease chews back the ends of the linear 
fragments until it encounters the first G or C in the sequence, where its exonuclease 
activity gets inhibited due to the abundance of the complementary nucleotide. This 
creates complementary overhangs between vectors and inserts, which can then be 
annealed together.  
 
In the T4 treatment reaction, a minimum of 50 ng of linearized vector or insert DNA 
were mixed with 2 µL of 10x T4 DNA polymerase buffer (Novagen), 1 µL of 100 mM 
DTT, 2 µL dNTP (dCTP for inserts and dGTP for vectors) and 0.4 µL of LIC-qualified 
T4 DNA polymerase (Novagen). The total reaction volume should not exceed 20 µL, 
and it is important to have roughly equal amounts (by mass) of vectors and inserts. 
The reaction was incubated for 40 minutes at room temperature, followed by an 
enzyme inactivation step at 75°C for 20 minutes. The reaction can then be stored at -
20°C until needed.  
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T4-treated vectors and inserts were annealed by mixing together 2 µL from each 
reaction, and incubating at room temperature for 10 minutes. The entire reaction was 
used to transform 50-100 µL chemically competent XL1-Blue E.coli cells.         
 
For recombination of fragments (whether vector and insert, or multiple pieces of 
insert) by In-fusionTM cloning, 10-100 ng of purified insert, and 100 ng of purified 
vector in a total of volume 9 µL were mixed with 1 µL 10X In-FusionTM cloning 
reaction mix (Clontech), and incubated at 37°C for 15 minutes, followed by 15 
minutes at 50°C. 2.5 µL of the cloning reaction were then used to transform 50-100 
µL of XL1-Blue competent cells by heat shock. 
 
For recombination of fragments (whether vector and insert, or multiple pieces of 
insert) by Gibson assembly, 0.02-0.5 pmols of fragment(s) + linearized vector in the 
case of 2-3 fragment assembly, or 0.2-1 pmols of fragments + linearized vector in the 
case of 4-6 fragment assembly, were mixed together with 10 µL 2X Gibson Assembly 
Master Mix (NEB), and the final volume adjusted to 20 µL with water. The samples 
were incubated at 50°C for 15 minutes for 2-3 fragment assembly, or 1 hour for 4-6 
fragment assembly. 2 µL of the assembly reaction were then used to transform 5-
alpha competent cells (NEB), by heat shock. 
 
Preparation of chemically competent XL1-blue E.coli cells 
 
Cells were streaked on LB plates and grown at 37°C. Single colonies were grown in 
a 50 mL overnight LB pre-culture. 1 mL of pre-culture was used to inoculate 250 mL 
SOB media with 10 mM magnesium chloride, and grown at 37°C until an OD600 of 
0.5-0.7 was reached. The cells were collected by centrifugation at 3000xg for 10 
minutes at 4°C, and then resuspended in 75 mL of chilled, sterile-filtered Inoue buffer 
(10 mM HEPES, pH 6.7, 250 mM potassium chloride, 15 mM calcium chloride, 55 
mM manganese chloride). The cells were collected one more time by centrifugation, 
and then resuspended in 10 mL Inoue buffer. 700 µL DMSO were added dropwise 
with gentle swirling. The cells were aliquoted and flash frozen in liquid N2. 
All steps were performed on ice, in a cold room, or a chilled centrifuge. 
 
Bacterial transformation by heat shock 
 
For transformation of bacterial cells, competent cells (50-100 µL aliquots) were 
thawed on ice, and then mixed with 1 µL of purified vector, or the previously 
described amounts of cloning reactions, incubated on ice for 10-30 minutes, heat 
shocked at 42°C for 45-55 seconds, cooled down on ice for 2 minutes, and then 
given 1 mL of antibiotic-free LB for recovery, and outgrown for 45 minutes to up to 3 
hours. Larger plasmids required longer recovery, and supplementation of the LB 
recovery media with 2% (w/v) sucrose. 
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For vector propagation, 150 µL of the outgrowth culture were plated. For all other 
purposes, cells from the entire outgrowth culture were plated after collection by 
centrifugation at 1000xg for 1 minute, removal of 950 µL of media, and resuspension 
in the remaining volume.  
 
Isolation and verification of recombined plasmids 
 
Single colonies were grown overnight in 50 mL LB cultures, and collected by 
centrifugation at 3148xg at 4°C for 10 minutes. Plasmid DNA was isolated using a 
QIAprep® Spin Miniprep kit (QIAGEN), up scaling the commercial protocol to apply 
on cells from 50 mL cultures instead of 5 mL. 
 
The presence of inserts was verified first with restriction digestion, before sequencing 
the plasmids fully. All plasmids used in this study were sequenced before use to 
ensure absence of random mutations. Sequencing primers were designed to bind 
800 base pairs apart in the forward direction to cover the entire length of genes, and 
300 base pairs from the beginning of genes in the reverse direction, to cover the 
vector-insert transition.  
 
Generation of polypromoter plasmids with multiple genes  
 
The series-438 MacroBac insect cell transfer vectors are amenable to PmeI/SwaI 
LIC subcloning, which is a protocol developed by MacroLab based on the BiobricksTM 
recombination system that allows generation of cassettes with multiple ORFs [92]. In 
this protocol, an ORF-containing acceptor plasmid is linearized with SwaI, which cuts 
at a single site adjacent to the ORF, and a donor plasmid is digested with PmeI, 
which cuts at two sites, located on either side of the polyhedrin promoter-ORF-SV40 
polyadenylation termination sequence. T4 treatment of the SwaI digested vector and 
the PmeI digested cassette gives them complementary sticky ends to allow ligation-
independent annealing. The resultant plasmid contains two ORFs in tandem, each 
with their own promoter and terminator sequence. An unused SwaI site present 
within the incoming PmeI-digested cassette regenerates the SwaI site in the new 
plasmid, which also contains two unused PmeI sites, originating from the acceptor 
plasmid, now flanking the two ORFs. The regeneration of these sites allowed this 
process to be carried out reiteratively, each time adding one or multiple genes to the 
cassette in the same way.  
  
The donor plasmid was digested with pmeI (NEB), and the acceptor plasmid with 
SwaI (NEB), according to the aforementioned vector digestion protocol, and purified 
by gel extraction. The donor and acceptor plasmids were treated with T4 
polymerase, wherein the donor plasmid was treated as the insert and the acceptor 
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plasmid as the vector (as previously). The T4 treated plasmids were annealed 
together as previously described, and used to transform XL1-Blue E.coli cells.   
 
A compilation of recombined plasmids with the cloning methods and 
primer sequences used to generate them 
 
A list of plasmids generated in this study, together with the cloning method and the 
DNA templates used to generate them are shown in table 4.2. For referencing, 
clones are numbered. Clone numbers X/Y/Z in table 4.2, refer to the indicated ORFs 
cloned into acceptor vectors A/B/C, respectively.   
Primer sequences for each primer set indicated in table 4.2 are shown in table 4.3.   
Primers that contain LIC vector-binding sequences and template-binding sequences 
are indicated in bold face and regular, respectively. Primers that contain non-LIC 
vector-binding sequences and template-binding sequences are indicated in capital 
and small letters, respectively. Primers with PTMs are indicated between forward 
slashes.  
 
Table 4.2 | Plasmids cloned and cloning method. A list of all plasmids cloned in this study, including the ORFs, the 
recipient vector, the cloning method used to recombine ORF-containing insert and linearized vector, and a cross-
reference to the corresponding primers (table 4.3) designed to make that possible. 
Clone # ORF(s) Cloning method Template Acceptor vector(s) Primer sets 
1/2 Sc Med12 LIC genome 438-B/C 1 
3/4/5 Sc Med13 LIC genome 438-A/B/C 2 
6 Sc Med13∆ RTH-PCR plasmid 438-A 3 
7/8/9 Sc Cdk8 LIC genome 438-A/B/C 4 
10/11 Sc Cdk8 D286A RTH-PCR plasmid 438-B/C 5 
12/13/14 Sc CycC LIC genome 438-A/B/C 6 
15 Sp Med12 In-fusion/LIC g-blocks (T.ni opt) 438-A 7 
16 Sp Med13 In-fustion/LIC g-blocks (T.ni opt) 438-A 8 
17/18/19 Sp Cdk8 LIC Sp cDNA 438-A/B/C 9 
20/21/22 Sp CycC LIC Sp cDNA 438-A/B/C 10 
23 mCh-Med15(6-651) Gibson plasmids 1B 11 
24 GFP-Gcn4 Gibson plasmids 1B 12 
25 Med15_KIX123 Gibson Plasmid 1C 13 
26/27/28 Sc Cdk8 (ORF1) 
Sc CycC (ORF2) 
Biobricks 
LIC subcloning 
Plasmids 438-A/B/C - 
29 Sc CycC (ORF1) 




Plasmids 438-A - 
30 Sc CycC (ORF1) 
Sc B-Cdk8 (ORF2) 
Biobricks 
LIC subcloning 
Plasmids 438-C - 
31/32 Sc CycC (ORF1) 
438-B-Sc Cdk8 D286A (ORF2) 
Biobricks 
LIC subcloning 
Plasmids 438-A/B - 
33 Sc CycC (ORF1) 
438-C-Sc Cdk8 (ORF2) 
Biobricks 
LIC subcloning 
Plasmids 438-A - 
34/35/36 Sp CycC (ORF1) 
Sp Cdk8 (ORF2) 
Biobricks 
LIC subcloning 
Plasmids 438-A/B/C - 
37 
 
Sc Med12 (ORF1) 




Plasmids 438-B - 
38/39 Sc Med13 (ORF1) 
Sc Med12 (ORF2) 
Biobricks 
LIC subcloning 
Plasmids 438-A/B - 
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Clone # ORF(s) Cloning method Template Acceptor vector(s) Primer sets 
40 Sc Med12 (ORF1) 
438-B- Sc Cdk8 (ORF2) 
Sc CycC (ORF3) 
Biobricks 
LIC subcloning 
Plasmids 438-A - 
41 Sc Med13 (ORF1) 
438-B- Sc Cdk8 (ORF2) 
Sc CycC (ORF3) 
Biobricks 
LIC subcloning 
Plasmids 438-A - 
42 Sc Med13 (ORF1) 
Sc Med12 (ORF2) 
438-B-Sc Cdk8 (ORF3) 
Sc CycC (ORF4) 
Biobricks 
LIC subcloning 
Plasmids 438-A - 
43 Sc Med13 (ORF1) 
Sc Med12 (ORF2) 
438-B-Sc Cdk8 D286A (ORF3) 
Sc CycC (ORF4) 
Biobricks 
LIC subcloning 
Plasmids 438-A - 
44 Sc Med13 (ORF1) 
Sc Med12 (ORF2) 
438-C-Sc Cdk8 (ORF3) 
Sc CycC (ORF4) 
Biobricks 
LIC subcloning 
Plasmids 438-A - 
45 Sc Med13 (ORF1) 
Sc Med12 (ORF2) 
438-C-Sc Cdk8 D286A (ORF3) 
Sc CycC (ORF4) 
Biobricks 
LIC subcloning 
plasmids 438-A - 
 
 
Table 4.3 | Primer sequences used for cloning. A list of all primers used for cloning of the plasmids mentioned in 
table 4.2. 
Primer sets Sequences 
1 
 
5'-TACTTCCAATCCAATGCAAATAACGGTTCTGGTCGATACTT-3' (v1 F) 
5'-TTATCCACTTCCAATGTTATTAATGTGGATTTTTCCTCTCAAAC-3' (v1 R) 




5'-TACTTCCAATCCAATGCAAGTTCTGACGCTTCCACGTA-3'  (v1 F) 
5’-TTATCCACTTCCAATGTTATTATTTATCCGAGAGAATAATTGATGAA-3' (v1 R) 









5'-TACTTCCAATCCAATGCATATAATGGCAAGGATAGAGCACA-3'  (v1 F) 
5'-TTATCCACTTCCAATGTTATTATCTTCTGTTTTTCTTTCGAGATG-3' (v1 R) 




  /Phos/-5'-CTTTGAAACCCGCAAATATAATGGTGACCATAGA-3' 
  /Phos/-5'-CTCGATGAAGCACCCAATTTTGATGAAGATACG-3' 
6 
 
5'-TACTTCCAATCCAATGCATCGGGGAGCTTCTGGACA-3'  (v1 F) 
5'-TTATCCACTTCCAATGTTATTAAATTGCAGATGCTGGTCTAAGA-3' (v1 R) 




5'-TACTTCCAATCCAATGCAAGCAATCGAGATTCAGCAAAC-3' (v1 F) 
5'-TTATCCACTTCCAATGTTATTACCAAAAGGTTGGCTCATACAA-3' (v1 R) 
5'-TACTTCCAATCCAATCGATGAGCAATCGAGATTCAGCA-3' (vBac F) 
8 
 
5'-TACTTCCAATCCAATGCATCATATCAGGTGTGTTTTAAGAAAT-3' (v1 F) 
5'-TTATCCACTTCCAATGTTATTAAGAGGTCACAGGATGTGTAATGTC-3' (v1 R) 
5'-TACTTCCAATCCAATCGATGTCATATCAGGTGTGTTTTAAGA-3' (vBac F) 
9 
 
5'-TACTTCCAATCCAATGCAAAAGACGGTTATAAAATTATTGGGT-3' (v1 F) 
5'-TTATCCACTTCCAATGTTATTAATTTCCTTTAAAACGTTTACTTTCG-3' (v1 R) 
5'-TACTTCCAATCCAATCGATGAAAGACGGTTATAAAATTATTG-3' (vBac F) 
10 
 
5'-TACTTCCAATCCAATGCAGCAGCAAATTACTGG-3' (v1 F) 
5'-TTATCCACTTCCAATGTTATTATTCAATATCCTCAAAATAAT-3' (v1 R) 
5'-TACTTCCAATCCAATCGATGGCAGCAAATTACT-3' (vBac F) 
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Strand annealing of DNA scaffolds 
 
To anneal the strands of DNA scaffold used in various experiments (table 3.3) 
together, sense and antisense strands were dissolved in DNA duplex buffer (30 mM 
HEPES, pH 7.5, 100 mM KOAc, 0.1 mM EDTA) to 100 µM. 2 µL of each were mixed 
and annealed by heating to 95°C for 10 minutes, followed by gradual cooling in steps 
of 2°C over approximately 30 minutes. Annealed DNA was later diluted in DNA 
duplex buffer to 100 nM. 
 
4.2 Insect cell methods 
 
Modifying baculoviral bacmids using insect cell transfer vectors 
 
The series-438 MacroBac Insect cell transfer vectors are designed such that the 
ORF or multiple ORFs of interest are inserted in between Tn7L and Tn7R 
transposition elements that are recognized by the T7 transposase enzyme. As such, 
transformation in DH10αEMBacΥ cells, which is a strain stably carrying a baculoviral 
genome bacmid (bMON14272), and a helper plasmid (pMON7124) encoding the 4 
enzymes of the T7 transposase system [93], allows site-specific transposition of the 
ORF cassette from the transfer plasmid into the baculoviral bacmid. The T7 
attachment site on the bacmid is located within a LacZα gene, meaning that 
successful transposition events cause impaired β-galactosidase expression, and 
thus colonies appear white on X-Gal-IPTG-Gentamycin blue-white selection plates. 
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Preparation of electrocompetent DH10αEMBacΥ E.coli cells 
 
Bacterial cells take up large DNA plasmids more efficiently by electroporation. 
Therefore, electrocompetent DH10αEMBacΥ cells were prepared. A single colony 
from a native selection plate (Amp-Kan-Tet) was grown in 5 mL of LB overnight at 
37°C with the same antibiotics. 1 mL of overnight culture was added per 250 mL of 
SOB media supplemented with the same antibiotics, and the culture was grown 
further at 37°C until an OD600 of 0.5 to 0.7 was reached. The cells were spun down at 
3128xg for 10 minutes at 4°C, and resuspended in 150 mL of chilled water. The 
centrifugation step was repeated twice, the second time resuspending in 5 mL of 
chilled 10% (v/v) glycerol, and the final time resuspending in 5 mL of chilled 5% (v/v) 
glycerol. The cells were aliquoted and flash frozen in liquid N2. 
 
Transformation by electroporation 
 
100 µL of electrocompetent DH10αEMBacΥ cells were mixed with 250-1000 ng of 
insect cell transfer plasmid in a Gene®/MicroTM Pulser cuvette of 0.1 cm width (Bio-
Rad), and then subjected to an electric pulse of 25 µF and 1.8 kV using a 
MicroPulser Electroporator (Bio-Rad). 1 mL of antibiotic-free LB media was added 
and the cells were transferred to a 15 mL culture tube, and recovered for 5 hours at 
37°C. 30 µL of cell culture was then plated on X-Gal-IPTG-Gentamycin plates, and 
grown at 37°C for 18-20 hours. White colonies on blue-white selection plates were 
picked, and restreaked one more time on X-Gal-IPTG-Gentamycin plates. Colonies 
that remained white were used to inoculate 10 mL LB-Gentamycin cultures, which 
were used for bacmid DNA isolation.  
 
Isolation and storage of bacmid DNA 
 
Glycerol stocks were made from bacmid cultures for future bacmid preparations, by 
mixing 750 µL of 70% glycerol with 750 µL of culture in cryotubes, and stored at  
-80°C. Bacmids were isolated from DH10αEMBacΥ by alkaline lysis and isopropanol 
precipitation. For the subsequent steps, buffers from a QIAprep® Spin Miniprep kit 
(QIAGEN) were used, but not the columns. Absolute ethanol was used to prepare all 
ethanol-containing solutions (the quality of the ethanol was critical to avoid undesired 
re-dissolution of precipitated DNA).  
 
The cells from 10 mL cultures were divided into 2x 5mL and collected by 
centrifugation at 3128xg for 10 minutes. The supernatant was removed, and the 
pellets resuspended in 250 µL of resuspension buffer P1 (50 mM Tris, pH 8.0, 10 
mM EDTA, 50 mM glucose, 0.1 mg.mL DNAse-free Rnase-A) and transferred to 1.5 
mL tubes (eppendorf). 250 µL of lysis buffer P2 (0.2 M NaOH, 1% SDS) was added, 
followed by 350 µL of neutralization buffer N3 (4M KOAc pH 5.5). Cell debris was 
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removed by centrifugation at 21,130xg for 15 min. The supernatant was transferred 
to fresh 1.5 mL tubes, and further clarified by centrifugation at 21,130xg for 15 min. 
Finally, 750 µL of the supernatant were transferred to fresh 1.5 mL tubes to which 
750 µL of Isopropanol were added. Isopropanol precipitation was carried out 
overnight at -20°C. 
 
To collect the precipitated bacmid DNA, samples were centrifuged at 21,130xg for 30 
min at 4°C. To wash the pellet, 500 µL of 70% ethanol were added gently to the top 
of the pellet (without resuspension). The samples were centrifuged again at 21,130xg   
for 15 min at 4°C. The supernatant was removed and the wash and centrifugation 
steps repeated one more time. Finally, 30 µL of 70% ethanol were added to 
completely cover the bacmid pellet for storage at -20°C. The remaining half of the 
bacmid prep was dissolved in 100 µL of water, and used as a PCR template to verify 
the presence of the genes of interest before transfection.  
 
Insect cell culture 
 
Sf9, Sf21 and Hi5 insect cells were constantly maintained in liquid culture. Sf9 and 
Sf21 cells were maintained in Gibco® Sf-900TM III SFM media (Thermo Fisher 
Scientific), whereas Hi5 cells were maintained in ESF921TM media (Expression 
Systems). Cells were maintained at a density of 1E6 cells/mL in culture, optimally 
diluting the cells with media once every 24 hours. Stock cultures were never diluted 
below 0.3E6 cells/mL and never allowed to overgrow above 3E6 cells/mL, and were 
transferred to fresh flasks once every 3-4 days. Cultures were maintained in a dark 
windowless climate-controlled room at 27°C with constant shaking at 60 rpm in 
dedicated Innova® 44 Incubator Shakers (New Brunswick). All steps involving open 
cultures (addition or removal of media, addition of viruses and withdrawal of 
samples) were carried out in sterile conditions under a UV-sterilized laminar flow 
hood. All flasks and serologicals brought under the hood were thoroughly wiped with 
70% ethanol first. Glass flasks were washed with 5% acetic acid, twice with milli-Q 
water, autoclaved once with water, and once without, before re-using. 
The flask to culture volume ratio did not exceed 1:10 for Sf9 and Sf21 cultures, and 
1:5 for Hi5 cultures. After infection with viruses, cells could be divided into fresh 
flasks if they were still doubling, but never after proliferation arrest.  
All viruses were stored at 4°C in the dark, for up to one year, and not frozen. 
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Cell density, mean and peak diameter, and cell viability were measured using a 
CASY® Modell TT Cell Counter and Analyzer System, according to the commercial 
protocol for insect cells. Uninfected Sf9, Sf21 and Hi5 cells had an average viability 
range of 85-95%. Sf9 cells had a mean diameter of around 16 µm, which increased 
upon infection. Sf21 and Hi5 cells had a mean diameter of 20-22 µm. 
 
Sf9 cell transfection (V0 production)  
 
To produce the first viruses (V0) from isolated bacmid DNA, the storage ethanol was 
gently removed from the top of the bacmid pellet, and the tube was left open for 10 
minutes under a laminar flow hood to ensure complete evaporation of the storage 
solution. 20 µL of water were added to the top of the pellet with as little agitation as 
possible. 20 minutes were allowed for the pellet to dissolve in water (without mixing).  
 
A transfection master mix containing 10 µL of Xtreme Gene 9 transfection reagent 
(Roche) and 100 µL of Gibco® Sf-900TM III SFM media (Thermo Fisher), per bacmid 
to be transfected, was prepared. After dissolution, 200 µL of Sf-900 III media and 100 
µL of transfection master mix were added gently to each bacmid without mixing, and 
allowed to sit for 60 minutes. 
 
3 mL of Sf9 cell culture at a cell density of 1E6 cells/mL were pipetted per well in 5 
out of 6 wells in sterile 6-well plates (Greiner). 3 mL of media were added to the 6th 
well as a contamination control. 150 µL of the transfection reagent-bacmid mix were 
added dropwise per well. Two V0’s were made per construct. Plates were incubated 
for 2-3 days. The cells adhered to the bottom of the wells, and the infectious 
supernatant (the V0 virus) was collected and stored. 
 
Virus propagation in Sf9 or Sf21 cell culture (V1) 
 
150 µL – 3 mL of V0 virus were added to 25 mL of Sf21 or Sf9 cell culture at a cell 
density adjusted to 1E6 cells/mL, depending on the strength of the V0 virus. Cells 
should divide at least once before the day of proliferation arrest (DPA), but this can 
also take up to 4 days. Cells were grown for an additional 2-3 days after DPA, and 
harvested when their viability dropped below 90%, but was still above 80%. The 
mean cell diameter should have increased by 3-6 µm by the time of harvest, 
indicating virus uptake. Viruses were harvested by centrifugation at 500xg for 20 
minutes. The infectious supernatant (V1 virus) was stored. The cell pellets were used 
to perform V1 expression test pull-downs.   
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Monitoring virus progression  
 
In addition to the baculoviral genome, the isolated bacmids (modified bMON14272) 
contained an EYFP (enhanced yellow fluorescent protein) reporter gene. This 
allowed monitoring of infection status and virus production efficiency by observing or 
measuring YFP fluorescence. For V0 viruses, this was done by looking at the plates 
under the appropriate fluorescence objective filter on an Axiovert inverted 
microscope (Zeiss). Optimal transfection resulted in a “starry night” pattern of 
fluorescence. 
For V1 and V2 viruses, cells were collected from 1 mL of virus-treated cultures by 
centrifugation at 500xg for 10 minutes at 4°C. The media was discarded, and the 
cells were resuspended in 200 µL of PBS, 100 µL of which were transferred into a 
black 96-well plate with clear round bottoms (Greiner) and measured using an 
Infinite® M1000 Pro micro-plate reader (Tecan) using a λ-excitation of 514 nm and a 
λ-emission of 527 nm. An increase in detected fluorescence over the infection period 
confirmed successful infection.  
 
V1 expression test pull-downs 
 
Expression test pull-downs from V1 cell pellets, using Ni-NTA agarose (QIAGEN) or 
amylose beads (NEB), were used to screen for protein expression and solubility from 
many constructs before large-scale protein production (V2).  
Cells from 25 mL V1 culture were resuspended in 1 mL lysis buffer (300 mM NaCl, 
20 mM HEPES pH 7.4, 30 mM Imidazole, 1 mM DTT, 10% (v/v) glycerol and 1x 
protease inhibitor cocktail), and sonicated with a 5-second pulse duration (0.5 
seconds on, 0.5 seconds off) and amplitude of 10%. A 30 µL sample was taken from 
the lysate, and the lysate was clarified by centrifugation at 21,130xg for 30 min at 
4°C. A 30 µL sample was taken from the supernatant. The supernatant was then 
transferred to 250 µL of bead slurry, which had been washed 3 times with 1 mL of 
water, and 3 times with 1 mL of lysis buffer, and resuspended in 500 µL of lysis 
buffer (by centrifugation at 1000xg for 1 minute between washes). Protein was 
allowed to bind to the beads for 30 minutes. The pellet was resuspended in 1 mL of 
lysis buffer, of which a 30 µL sample was taken.  
 
The flowthrough was collected by centrifugation (1000xg for 1 minute at 4°C), and a 
30 µL sample was taken. The beads were washed 3 times with 1 mL of lysis buffer 
(by centrifugation at 1000xg for 1 minute at 4°C between washes). 40 µL of elution 
buffer (300 mM NaCl, 20 mM HEPES pH 7.4, 500 mM Imidazole (or 100 mM maltose 
for amylose-bead pulldowns), 1 mM DTT, 10% (v/v) glycerol and 1x protease 
inhibitor cocktail) were added to the beads, incubated at room temperature for 1 
minute, and then a 30 µL sample was taken. 
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The volume-normalized samples taken from the lysate, supernatant and pellet, as 
well as the flowthrough, wash, elution and bead samples, were analyzed by SDS-
PAGE, allowing assessment of protein expression and solubility from different 
constructs.  
 
Protein expression in Hi5 insect cells (V2) 
 
To start Hi5 expression cultures, Hi5 stock cell culture was expanded to 200 mL in a 
1 L flask on day 1. On day 2, Hi5 cells were expanded to 2X 300 mL in 2X 3 L flasks. 
On day 3, if the cell count had reached 1E6 cells/mL, V1 virus was added in a 1:2500 
ratio of virus to culture. On day 4, cells (which should have doubled) were diluted 
back to 1E6 cells/mL by direct addition of 300 mL of media per flask. This day is 
ideally also the DPA. If not, cells were continually diluted back to 1E6 cells/mL until 
the DPA was reached. On day 5 (first day after DPA), cells showed a 3-4 µm 
increase in mean and peak diameters. On day 6 or day 7, cells experienced a rapid 
drop in viability to below 80%. When this happened, cells were harvested by 
centrifugation at 238xg for 30 minutes at 4°C, resuspended in 20 mL of the lysis 
buffer to be used for purification, and flash frozen in liquid N2.  
 
YFP fluorescence was measured everyday after DPA to monitor infection. When 
establishing new expressions, 1 mL samples were additionally taken each day after 
DPA and analyzed by SDS-PAGE to determine the time needed for sufficient 
expression, but not degradation, of the proteins of interest.       
 
This protocol was for the preparation of a total of 1.2 L of Hi5 protein expression 
culture (V2) and can be scaled up as needed.  
 
4.3 Protein methods 
 
Preparation of chemically competent BL21 (DE3 RIL), Rosetta, or 
LOBSTR cells for protein expression 
 
For protein expression in E.coli, chemically competent BL21, Rosetta or LOBSTR 
cells were prepared in the same way as described for XL1-blue, but with additional 
chloramphenicol in the selection plates and cultures.  
Owing to their variability, individual expression protocols will be detailed under the 
method sections for each of the purified proteins. 
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Large-scale yeast fermentation culture for isolation of endogenous 
complexes 
 
Genetically modified yeast strains were used for isolation of endogenous complexes. 
The doubling time for a given strain was first determined by successive OD600 
measurement in a small-scale 2 L YPD culture, and plotting a growth curve.   
For large-scale fermentation cultures, a colony was used to inoculate a 200 mL YPD 
preculture with the appropriate antibiotics, which was grown overnight at 30°C. 
Based on the calculated doubling time, the appropriate volume of preculture was 
used to inoculate a 2 L culture, such that an OD600 of 2.5 was reached within 7-10 
hours. This is the minimum starting cell concentration, which could then be used to 
inoculate a 250 L fermentation culture in an INFORS-HT fermenter in YPD media 
and the appropriate antibiotics. A sample was checked under a microscope before 
inoculating the fermenter to ensure absence of bacterial contamination.        
 
Cell lysis methods 
 
For protein purification, insect cells were lysed by sonication for 1-2 minutes, with a 
pulse duration of 0.4 seconds on, 0.6 seconds off and an amplitude of 30%, using a 
model 250 Branson Digital Sonifier® (Marshall Scientific), whereas E.coli cells were 
lysed for 15-20 minutes, with a pulse duration of 0.4 seconds on, 0.6 seconds off and 
an amplitude of 40-60%. All sonication was carried out in beakers made of metal or 
non-insulating material on ice, in a cold room.   
 
Yeast cells were lysed by bead beating using 0.5 mm dia. glass beads and a 
BeadBeater (Biospec Products). The metal chamber was filled half with glass beads, 
and half with yeast cells resuspended in ice-cold lysis buffer, and gently mixed with a 
glass rod to remove air bubbles. The chamber was then placed in an ice-water jacket 
in the cold room, and onto the BeadBeater motor base. The BeadBeater was run for 
30-second intervals, and 90-second pauses allowing renewal of the ice jacket, for a 
total of 90 minutes.  
 
Protein buffers and handling 
 
All protein handling steps were carried out at 4°C, in the cold room, or using pre-
cooled equipment. The pH of buffers was always adjusted after mixing of all buffer 
components, and taking into consideration the temperature-dependence of the 
buffering substance. For 5X and 10X buffers (for example, for sucrose gradients or in 
vitro biochemical reactions) the pH was adjusted at 5X or 10X. Please note, that this 





Analysis of purified proteins based on molecular weight was done by addition of 4X 
NuPAGE® LDS sample buffer (Invitrogen) to protein samples, boiling at 95°C for 5 
minutes, and loading onto pre-cast gradient NuPAGE® 4-12% Bis-Tris Protein Gels 
(Invitrogen) together with a Precision Plus ProteinTM prestained standard (Bio-rad), 
as a molecular weight fiducial. The electrophoretic setup was assembled in XCell 
SureLockTM Mini-Cell chambers (Thermo Fisher Scientific). Proteins were separated 
on the gel based on their elecrtokinetic properties, by applying a voltage of 150-200V 
(Biometra Standard Powerpack 25) for 30-60 minutes in a 1X MES or MOPS running 
buffer (Invitrogen). Gels were stained with InstantBlueTM (Expedeon), destained with 




Electromobility shift assays and assessment of crosslinking and the behavior of 
protein compexes were carried out using Native (SDS-free) PAGE. Samples were 
mixed with 20-30% (v/v) glycerol, and loaded onto NativePAGETM 3-12% BisTris pre-
cast gels (Invitrogen) which had been pre-run for 1 hour at 150 V. Gels were then run 
at 90 V for 4-6 hours, and visualized by InstantBlueTM (Expedeon) staining, or, in the 
case of fluorescent proteins, using the appropriate filter on a Typhoon FLA 9500 




All automated chromatographic methods were carried out using an ÄKTATM Pure 
protein purification system (GE healthcare). The commercial recommendations for 
pressures, flow rates and storage of columns and resins were observed. In cases 
where alteration of these parameters was significant to the protein purification 
method in question, the values will be specifically mentioned. Otherwise, standard 
values can be assumed. In cases where complexes were assembled on gel filtration 
for cryo-EM grid preparation, a SuperoseTM 6 Increase 3.2/300 column on an 
ÄKTAmicroTM system was used.     
  
Sucrose gradient ultracentrifugation 
 
A 5X buffer was prepared as needed, and mixed with water and 50% (w/v) sucrose 
to prepare a buffered heavy solution (30% (w/v) sucrose) and light solution (10% 
(w/v) sucrose). Roughly 2.5 mL of light solution were transferred to a 4 mL Thinwall 
Ultra-ClearTM centrifugation tube (Beckman Coulter), and then heavy solution was 
added to the bottom of the light solution using a FINE-JECT 5-cm syringe needle 
(Henke-Sass-Wolf) until the meniscus reached the middle mark. A BioComp 
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Gradient Master 108 (BioComp Instruments) was used to mix the two solutions to 
make a 10-30% sucrose gradient. Up to 140 µL of sample could be added to the top 
of the sucrose gradient. The gradients were ultracentrifuged in an SW60 Ti rotor 
(Beckman Coulter) at 175,000xg for 16 hours at 4°C. After centrifugation, gradients 
were fractionated into 200 µL fractions by gentle pipetting from the top. The same 




Gene sequences were obtained from the Saccharomyces Genome Database (SGD) 
[94]. Protein paramaters (molecular weight, pI and molar extinction coefficient) were 
calculated using ExPASy ProtParam [95]. For large complexes and protein fusions, 
sequences were simply concatenated for parameter calculation. Protein domains and 
secondary structure were found or predicted using the HHPred, PSIPred and 
Quick2D bioinformatics toolkit [96]. IUPred was used for disorder prediction [97]. 




Phos-TagTM SDS-PAGE was used to detect phosphorylation of proteins [99]. In this 
method, Phos-TagTM (Wako Chemicals), a large molecule (chelating two zinc or 
manganese ions), which was structurally modeled on an alkaline phosphatase 
catalytic domain to specifically bind phosphorylated residues (S/T/Y and H/D/K), is 
used to selectively retard the electromobility of phosphorylated proteins in PAGE. 
This allows a clear shift to be seen between phosphorylated and unphosphorylated 
proteins, and between different phosphorylated forms.  
SuperSepTM Phos-TagTM (50 µmol/L), 7.5% 17-well pre-cast polyacrylamide gels 
(FujiFilm) were used to detect phosphorylation in kinase assays where no 
phosphosite-specific antibodies were available. The gels were run in a running buffer 
(100 mM MOPS pH 7.8, 0.1% (w/v) SDS, 5 mM Sodium Bisulfite) freshly diluted from 
a 5X stock, and freshly adding Sodium Bisulfite solution (from a 500 mM stock 
solution stored in the dark at 4°C) before use. Care was taken to avoid EDTA in 
samples, sample loading dyes and running buffers, which would compete away the 
divalent metal cations from the Phos-TagTM chemical. Gels were run as normal SDS-
PAGE gels. For blotting, gels were washed in a 10 mM EDTA solution for 10 
minutes, three times, and then once in EDTA-free transfer buffer before blotting.  
 
Western Blot Analysis 
 
Western blot analysis was used to specifically detect proteins using antibodies 
against proteins or tags. SDS-PAGE was carried out as described, the gels were not 
stained, and electric voltage was used to transfer proteins onto polyvinylidene 
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fluoride (PVDF) or nitrocellulose membranes, using the wet blotting or semi-dry 
Turbo blotting methods.   
For semi-dry Turbo blotting, gels were placed onto a PVDF membrane, sandwiched 
between three filter papers pre-wetted with transfer buffer from both sides using the 
pre-assembled Trans-Blot® TurboTM Mini PVDF Transfer Packs (Bio-Rad). 25 V and 
2.5 A of electricity were then applied for 7 minutes using a Trans-Blot® TurboTM 
Blotting System (Bio-Rad).  
For wet blotting, a piece of Amersham TM ProtranTM 0.2µm nitrocellulose (GE Life 
Sciences) or 0.45 µm PVDF transfer membrane (Thermo Scientific) was cut out, 
together with 6 pieces of similarly sized Rotilabo®-Blotting papers thick 1.0mm, and 
arranged as described into a an XCell II TM Blot Module (Thermo Fisher Scientific), 
and submerged in 1X NuPAGE® Transfer buffer (Invitrogen) in 10% ethanol, placed 
in an XCell SureLockTM Mini-Cell chamber (Thermo Fisher Scientific), and subjected 
to an electrical voltage of 30 V for 1 hour using a Standard Powerpack 25 (Biometra). 
For Phos-TagTM gels, this was carried out at 15 V overnight at 4°C to ensure transfer 
from the retarding matrix. PVDF membranes were activated with ethanol prior to 
blotting.   
Membranes were blocked with 5% (w/v) milk solution in PBS-T (1X PBS, 0.1% 
TWEEN 20) for 30 minutes at room temperature, and then the appropriate dilution of 
primary antibody in 6 mL of 2.5% (w/v) milk solution in PBS-T was added and 
incubated for 1 hour at room temperature, or overnight at 4°C. Membranes were 
washed 3 times for 5 minutes with PBS-T once more, and the appropriate dilution of 
secondary antibody in 6 mL of 0.1%(w/v) milk solution in PBS-T was added and 
incubated for 1 hour at room temperature or overnight at 4°C. Finally, Membranes 
were washed again 3 times for 5 minutes with PBS-T, and developed by adding and 
mixing the two components provided by the PierceTM Enhanced Chemi-
Luminescence Western Blotting Substrate kit (Thermo Fisher Scientific). Membranes 
were imaged using the chemiluminescence filter on an Advanced Fluorescent Imager 
(Intas). For all blots where comparisons are presented, images were taken with 
identical settings of exposure time and signal integration. 
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Fluorescent-labeling of proteins 
 
For fluorescent-labelling, proteins were first dialyzed into a thiol-free reducing 
environment (TCEP, no DTT or β-ME).100 µL of protein were incubated with 10 µL of 
Alexa fluor  647 maleimide reactive dye (Thermo Fisher Scientific) at 10 mg/mL in a 
ratio of 20:1 pmol of dye to protein for 2 hours at room temperature and away from 
light. Excess dye was removed first by dialysis overnight in at least 1000X buffer 
volumes, and then additionally by using a 7K MWCO 0.5 mL Zeba™ Spin Desalting 
Column (Thermo Fisher Scientific) which had been blocked with 2% (w/v) gelatin 
solution and washed 10 times with protein buffer before applying the protein.  
 
4.3.1 Mass spectrometry  
 
Protein identification and phosphosite mapping 
 
Mass Spectrometry was used to confirm the identity of purified proteins. M. Raabe 
and A. Kühn of the H. Urlaub department (Max Planck Institute for Biophysical 
Chemistry, Göttingen) carried out the measurement and analysis, following standard 
protocols of in-gel trypsin digestion and extraction [166], peptide enrichment by size 
exclusion and analysis using an LTQ-Orbitrap Velos or Q-Exactive mass 
spectrometer (Thermo Fisher Scientific). For phosphosite mapping, samples were 
treated the same way but enriched for phosphopeptides after gel extraction. Data 
sets were analyzed with Mascot [167] against the NCBI non-redundant proteome 




80 µg of CKM-cMed in roughly 100 µL were dialyzed overnight into lower salt buffer 
(20 mM HEPES pH 7.6, 250 mM KOAc, 10% (v/v) glycerol, 5 mM β-ME) to allow 
complex formation, then crosslinked with bis-sulfo(succinimidyl) suberate (BS3), 
stored in powder form (BS3, No-weight Format, Thermo Fisher Scientific) and 
dissolved in buffer freshly before use to a 30 mM stock, to a final concentration of 0.1 
mM BS3. Crosslinked samples were separated by Native-PAGE (20 µg per lane) and 
species corresponding to the full CKM-cMed complex were excised from the gel (2 
lanes) and treated by in-gel digestion with trypsin as described [166]. Briefly – the 
excised gel bands were cut to 1 mm2 pieces, reduced with 10 mM DTT, alkylated 
with 55 mM iodoacetamide and digested with trypsin (Sigma-Aldrich) overnight. 
Tryptic peptides were extracted, dried and reconstituted in a solution containing 2 % 
(v/v) acetonitrile and 0.05% (v/v) TFA and subjected to liquid chromatography-
tandem mass spectrometry (LC-MS/MS). LC-MS/MS analyses were performed on a 
Q Exactive HF-X hybrid quadrupole-orbitrap mass spectrometer (Thermo Scientific) 
coupled to a Dionex Ultimate 3000 RSLCnano system. The peptide mixture from 
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each gel lane was loaded on a Pepmap 300 C18 column (Thermo Fisher) at a flow 
rate of 10 µl/min in buffer A (0.1% (v/v) formic acid) and washed for 3 min with buffer 
A. The sample was separated on an in-house packed C18 column (30 cm; ReproSil-
Pur 120Å, 1.9 µm, C18-AQ; inner diameter, 75 µm) at a flow rate of 300 nl/min. 
Sample separation was performed over 120 min using a buffer system consisting of 
0.1% (v/v) formic acid (buffer A) and 80% (v/v) acetonitrile, 0.08% (v/v) formic acid 
(buffer B). The main column was equilibrated with 5% B before application of the 
peptide mixture to the column and the column was washed for 3 min with 5% B. 
Peptides were eluted with a linear gradient over 105 min from 10-45 % B (replicates 
1-3) or 15-50 % B (replicate 4), followed by an 8 min gradient from 90-95 % B and re-
equilibration for 4 min at 5 % B. Eluting peptides were analyzed in positive mode 
using a data-dependent top 20-acquisition methods. MS1 and MS2 resolution were 
set to 120,000 and 30,000 FWHM, respectively, and AGC targets were 5*105 and 
2*105. Precursors selected for MS2 (scan range m/z 380-1580) were fragmented 
using 30% normalized, higher-energy collision-induced dissociation (HCD) 
fragmentation. Allowed charge states of selected precursors were +3 to +7 
(replicates 1, 2, 4) or +2 to +7 (replicate 3) Further MS/MS parameters were set as 
follows: isolation width, 1.4 m/z; dynamic exclusion, 10 sec; max. injection time 
(MS1/MS2), 60 ms/200 ms. The lock mass option (m/z 445.12002) was used for 
internal calibration. 
The .raw files of all replicates from both lanes were searched by the software pLink 
2, version 2.3.1 [168] against a customized protein database containing the 
expressed proteins. Protein-protein crosslinks were filtered with a 1 % FDR and 
plotted using xiNET [169]. Manual validation of identified crosslinks was performed 
by a selection of 8 crosslinks between cMed subunits, mapping them onto the 
S.cerevisiae cMed homology model derived from the S.pombe crystal structure (PDB 
ID: 5N9J). Atomic distances were measured between α-carbon atoms of crosslinked 
residues using PyMol. 
 
4.3.2 Light microscopy methods 
 
mPEGylation of glass slides 
 
To ensure inertness of the underlying glass substrate to phase-separated droplets, 
glass slides were passivated with mPEG silane before use following the method from 
[170]. Glass microscope slides (Thermo Scientific) were washed with 5% Hellmanex 
solution (VWR) for 4 hours, and then rinsed with Milli-Q water and allowed to dry in a 
fume hood. The slides were then etched in 1M NaOH for 1 hour, rinsed extensively 
with Milli-Q water, and dried again in a fume hood. 2x 80 µL drops of 25 mg/mL 
mPEG-silane (Nanosoft polymers) in 95% ethanol were pipetted on to the glass 
slides and allowed to stand overnight. The slides were rinsed once with 95% ethanol 
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and thoroughly with Milli-Q water, and allowed to dry completely in a fume hood for 
3-4 hours before use. 
 
Fluorescence microscopy  
 
Images of liquid droplets on glass slides were taken using a Leica DM6000B inverted 
fluorescence microscope fitted with the following objective filter cubes and excitation 
wavelengths (Exc): 
A4(UV): Exc 360/40, BGR(UV): Exc 420/30;495/15;570/20, GFP(blue): Exc 470/40,  
L5(blue): Exc BP 480/40, N3(green): Exc BP 546/12, 60R (red): Exc HQ 630/20x  
 
All images were taken through the 63X magnification water-immersion objective. 
Images of liquid droplets of unlabeled proteins were taken using the Differential 
Interference Contrast (DIC) setting. GFP-tagged or FAM-labeled proteins were 
imaged through the GFP filter cube. mCherry or Alexa Fluor 647-labelled proteins 
were imaged through the 60R filter cube. There was no bleedthrough signal between 
the GFP and the 60R filter cubes. For all images where comparisons are presented, 
settings of magnification, exposure time, gain and intensity were kept constant 
between the different images.   
 




Electron Microscopy (EM) samples were usually fixated by chemical crosslinking. 
Batch crosslinking was done with bis-sulfo(succinimidyl) suberate (BS3) or 
glutaraldehyde. BS3 was stored in powder form (BS3, No-weight Format, Thermo 
Fisher Scientific) and dissolved in buffer freshly before use to a 30 mM stock. The 
appropriate volume of BS3 to reach the desired final concentration was added to the 
bottom of a 1.5 mL tube (eppendorf), and the larger volume of the protein sample 
was rapidly pipetted on top, to ensure fast and complete mixing. Batch crosslinking 
with glutaraldehyde was done similarly, using a 25% EM grade glutaraldehyde 
aqueous solution (Electron Microscopy Sciences). Ampoules were opened once, 
aliquoted, flash-frozen in liquid N2 and stored at -80°C. Aliquots were only used once. 
 
The majority of samples were crosslinked in a sucrose gradient using the GraFix 
method [100]. Sucrose gradients were prepared as previously described, but with 
addition of glutaraldehyde in the heavy sucrose solution to the desired final 





Glutaraldehyde was quenched after crosslinking by addition of 25-50 mM of 
aspartate, or an apartate/lysine/tris mixture, and incubation on ice for 15 minutes. 




For negative stain EM, commercial carbon-coated copper mesh grids (S160-4; 
Plano), were used. For cryo-EM, carbon grids; Quantifoil® R 1.2/1.3 Cu 300 mesh or 
Quantifoil® 2/1 Cu 200 mesh, or gold grids; UltrAuFoil® R 2/2 Au 200 mesh, were 
used.  
Grids with continuous carbon support were either made by pre-floating carbon foil 
onto the surface of a water reservoir and fishing it from below with a Quantifoil® 
carbon grid, or by directly floating the carbon foil onto the surface of the sample 
before freezing. Pre-floated carbon grids were a kind gift from Carrie Bernecky. 
Carbon foil was either homemade using a Leica EM ACE600 carbon evaporator at 




Negative stain EM grids were glow discharged using a PELCO easiGlowTM glow 
discharger (Ted Pella) for 45 seconds at 25 mA and 0.39 mbar. Cryo-EM carbon 
grids were glow discharged for 80 seconds, and gold grids for 160 seconds with the 
same settings. Pre-floated continuous carbon grids were glow discharged as holey 
carbon grids. Continuous carbon grids made by floating carbon foil on the sample 




5 µL of sample were pipetted onto the surface of a carbon-coated copper grid, and 
incubated for 30 seconds to 2 minutes, depending on the sample concentration. The 
sample was blotted away using a WhatmanTM filter paper (GE Life Sciences). Two 20 
µL drops of water and three 20 µL drops of 2% uranyl formate solution were pipetted 
onto a piece of Parafilm® (Bemis Flexible Packaging). The grid was picked up with 
tweezers, and placed face-down on each of the water droplets and the excess water 
was blotted away, and then on each of the uranyl formate drops, where it was held 
for 20 seconds (a total of 60 seconds). Finally, the excess stain was either blotted 
away, or incubated for an additional 20 seconds to 1 minute, depending on the 







After GraFix, buffer was exchanged into the chosen freezing buffer to remove the 
high concentration of sucrose. Dialysis was done using Slide-A-Lyzer® MINI Dialysis 
Devices, 3.5K MWCO, 2 mL (Thermo Fisher Scientific) or Slide-A-Lyzer® MINI 
Dialysis Units, 20K MWCO, 0.1 mL (Thermo Fisher Scientific). Alternatively, buffer 
was exchanged using ZebaTM Spin Desalting Columns, 7K MWCO, 0.5 mL (Thermo 
Fisher Scientific), by washing them twice with freezing buffer, once with a 2% gelatin 
solution, followed by 10 times with freezing buffer, before applying the protein 
sample.  
We noticed that when dialyzing into freezing buffers containing detergents with low 
critical micelle concentrations (CMC) such as Lauryl Maltose Neopentyl Glycol 
(LMNG, Anatrace), that the detergent did not pass through the dialysis membrane. 
Therefore, for these samples we either added the detergent directly to the dialyzed 
sample before freezing, or used the spin column buffer exchange method.  
We also noticed that, although it doesn’t pass through the dialysis membrane, that 
the volume expansion during dialysis (which was generally at least 3 to 4 times) 
resulting in undesired dilution of the sample, was significantly counteracted in the 
presence of LMNG in the dialysis buffer to almost no expansion at all. This can be 
explained by the osmotic effect caused by the inability of micelles to permeate the 





Cryo-EM grids of samples were made by sample application followed by automated 
plunge freezing into a cryogen tank of liquid ethane immersed in a liquid N2 reservoir, 
using an FEI VitrobotTM (Thermo Fisher Scientific). WhatmanTM filter papers (circular, 
55 mm diameter) were placed in the vitrobot chamber 30 minutes before freezing to 
equilibrate their moisture content. The humidity of the vitrobot chamber was set to 
100% and the temperature to 4°C. A glow-discharged grid was placed on the 
tweezer, which was in turn fixed on the vitrobot tweezer holder and withdrawn into 
the temperature and humidity controlled vitrobot chamber. 3-4 µL of sample were 
pipetted onto one side of the grid. The grid was plunged into the ethane vitrification 
media, quickly transferred to liquid N2 and stored. All handling, transfer and storage 
steps were carried out in liquid N2 or liquid N2 atmosphere conditions.   
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Imaging (Neg stain and Cryo) 
 
Negative stain grids were imaged on a CM120 (Phillips) electron microscope with a 
lanthanum hexaboride (LaB6) cathode, and a spherical aberration of 6.7 mm. 4K X 
4K TIFF Micrographs were taken at a magnification of SA 52,000X.  
 
Cryo-EM grids were imaged on an FEI Titan Krios (Thermo Fisher Scientific) fitted 
with a K2 summit camera and a GIF energy filter, at a magnification of SA 105,000X 
(1.37 Å/pix) or SA 130,000X (1.05 Å/pix). 
 
The CKM cryo-EM dataset was imaged on an FEI Titan Krios (Thermo Fisher 
Scientific) fitted with a Falcon III camera, and without a GIF, at a magnification of SA 





Negative stain images were binned by a factor of 2 (4.4 Å/pix), and particle picking 
was carried out in EMAN2 [101], with a box size of 88 pix and a particle size of 60 
pix. Picked particle coordinates were exported. Particle extraction, Contrast Transfer 
Function (CTF) estimation and 2D classification were carried out in Relion 1.4. The 
particle mask diameter used was 300 Å. 2D classification was run for 50 iterations, to 
sort the particles into 100 2D classes, with a regularization parameter (T) of 2. 3D ab 
initio model building was carried out using CryoSparc [102], using picked particles 
from all the good 2D classes.  
 
Cryo-EM micrographs were pre-processed (Motion correction, CTF estimation and 
Auto-picking) using the on-the-fly pre-processing pipeline Warp [35]. Particles were 
then extracted unbinned (1.06 Å/pix) and processed in Relion 2.0 [103]. The particle 
mask diameter used was 260 Å, and the box size was 290 pix. 2D classification was 
run for 50 iterations, to sort the particles into 100 2D classes, with a regularization 
parameter (T) of 2. The best 2D classes were selected, and 3D classification into 5 
classes was carried out using the ab initio model of CKM as an input reference. 2D 
projections from the best 3D class obtained were used to train the Relion autopicker 
on a small selection of micrographs, and write a Figure of Merit map, which was then 
used to guide re-picking particles more accurately from the entire dataset. Several 
rounds of 2D and 3D classification were carried out with varying parameters of offset 
search step and range, as well as changing the input model to one of the 3D 
volumes obtained from 3D classification. Additionally several rounds of 
homogeneous and heterogeneous refinement were done. There was no 
improvement in the 3D model.  
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4.3.4 Purified proteins 
 
Mediator Cdk8 Kinase module (CKM A or KD) 
 
Clones number 44 for CKM(A) and 45 for CKM(KD) in table 4.2 were the final 
constructs used for making viruses. V0 and V1 viruses were made in Sf9 cells as 
described. V0 viral load was titrated (250 µL, 500 µL, 1000 µL and 2000 µL). V1 from 
the V1 culture with the highest YFP fluorescence read 2 days after DPA was used to 
infect Hi5 cells in a 1:2500 ratio of V1 to Hi5 culture. Cells were harvested 3-4 days 
after DPA, with daily monitoring of viability (which should not drop below 75% at this 
stage).  
 
Pellets from 2.4 L of Hi5 insect cell culture, frozen in lysis buffer (20 mM HEPES pH 
7.6, 400 mM KOAc, 10% (v/v) glycerol, 5 mM β-ME, 1X PI) were thawed in a 
temperate water bath, lysed by sonication for 2X 1 min, with a pulse duration of 0.4 
seconds on, 0.6 seconds off and an amplitude of 30%. The lysate was clarified by 
centrifugation at 27,000 rpm in an A27-8x50 rotor (Thermo Scientific). 
 
60 mL of amylose beads slurry (NEB) were equilibrated with lysis buffer. Supernatant 
containing CKM was added to the equilibrated beads, and bound with nutation for 1.5 
hours. The flowthrough was collected by centrifugation of the beads (1000xg for 5 
minutes) or by gravity flow (PolyPrep gravity flow columns, Bio-Rad). The beads 
were washed with lysis buffer, by adding 3 resin volumes of lysis buffer, 
resuspending the beads, and centrifugation, or by gravity flow. This was repeated 3 
times. Finally, 2 resin volumes of elution buffer (20 mM HEPES pH 7.6, 400 mM 
KOAc, 10% (v/v) glycerol, 5 mM β-ME, 100 mM maltose, 1X PI) were added. The 
beads were incubated with elution buffer for 15 minutes, and the eluate was collected 
by gravity flow. It is not possible to perform this step using an automated 
chromatography system. Moreover, MBPTrap (GE healthcare) columns, showed a 
dramatically lowered complex-binding capacity.  
 
The eluate was diluted 3:1 (eluate to buffer) dropwise with IEX buffer A (20 mM 
HEPES pH 7.6, 10% (v/v) glycerol, 5 mM β-ME), bringing the salt concentration 
down to 300 mM KOAc. (This salt concentration was determined by dropwise dilution 
until first precipitation). The protein was then loaded onto a HiTrapQ HP (1 mL) 
column (GE Healthcare), equilibrated with 30% IEX buffer B (20 mM HEPES pH 7.6, 
10% (v/v) glycerol, 1 M KOAc, 5 mM β-ME), and eluted with a salt gradient from 30% 
to 100% buffer IEX B over 20 column volumes (20 mL). A steep elution gradient in 
this step is critical. The protein-containing fractions were pooled and concentrated 
using an Amicon Ultra-15 centrifugal filter with a 10 kDa MWCO, spun at 2700 rpm 
for 8-minute intervals. Using this type of centrifugal filter (despite the huge 
discrepancy in the cutoff value compared to the size of the complex) was critical, It is 
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not clear why. The complex was dialyzed overnight into gel filtration buffer (20 mM 
HEPES pH 7.6, 400 mM KOAc, 10% (v/v) glycerol, 5 mM β-ME), and then run on 
size-exclusion chromatography on a SuperoseTM 6 Increase (10/300) column (GE 
Healthcare). It is important to concentrate the complex before the dialysis step, and 
not after. Dialysis was critical for stability on any subsequent sizing step. Up to 800 
µg of CKM were obtained per purification. Alternatively, the complex was applied 
onto a sucrose gradient, as previously described, and the buffer was exchanged 
before use.  
The complex was flash frozen in liquid N2 after dialysis, provided a sizing step was to 
be carried out before further use (gel filtration or sucrose gradient ultracentrifugation). 
Otherwise, the complex was purified freshly before use.  
 
Core Mediator (cMed) 
 
Recombinant core Mediator (cMed) was expressed and purified as two separate 
subcomplexes, cMedD4,9 (containing the subunits Med17, Med18, Med6, Med8, 
Med20, Med22, Med11, Med19, Med7, Med21, Med10, Med31, and His(x10) 
Med14(1-745)) and  the Med1,4,9 heterotrimer, that were later reconstituted on gel 
filtration.  
cMedD4,9 was expressed in BL21 (DE3 RIL) cells. A 200 mL preculture in LB-Amp-
Strep-Kan-Cam was grown overnight at 37°C. 24 L (12x 2L LB cultures) were grown 
by inoculating each with 15 mL of overnight culture, and the appropriate amount of 
antibiotics. Cultures were grown at 37°C until an OD600 of 0.7 was reached (3-4 
hours). The flasks were then cooled on ice for 30 minutes, and the incubator shakers 
were cooled down to 18°C. Cultures were induced with 0.5 mM IPTG and grown for 
20-24 hours at 18°C, and harvested by centrifugation at 6000 rpm in a F9-6X1000 
LEX rotor (Thermo Scientific) for 10 minutes. Cell pellet from 8 L of culture was used 
per purification.  
 
Med1,4,9 was likewise expressed in BL21 (DE3 RIL) cells. A 200 mL preculture in 
LB-Strep-Cam was grown overnight at 37°C. 12 L (6x 2L LB cultures) were grown by 
inoculating each with 25 mL of overnight culture, and the appropriate amount of 
antibiotics at 37°C until they reached an OD600 of 0.7 and were then similarly cooled 
down and induced with 0.5 mM IPTG, grown for 20-24 hours at 18°C, and harvested. 
Cell pellet from 4 L of culture was used per purification. 
 
For purification of cMedD4,9, the cell pellet was resuspended in 80 mL of lysis buffer 
(25 mM HEPES pH 7.5, 400 mM KOAc, 10% (v/v) glycerol, 2 mM DTT, 1X PI, 30 
mM imidazole), sonicated for 15 minutes (45% amplitude, 0.4 seconds on, 0.6 
seconds off), and clarified by centrifugation for 60 minutes (27,000 rpm in an A27-
8x50 rotor (Thermo Scientific)). The supernatant was filtered through a Millex® 0.45 
µm PVDF syringe filter unit (Millipore), and then loaded onto a 5 mL HisTrap HP 
	 59	
column (GE Healthcare) which had been equilibrated with 3 column volumes of lysis 
buffer. The column was then washed with 5 column volumes of lysis buffer. 
Contaminants were washed off with a 0-21% elution buffer (25 mM HEPES pH 7.5, 
400 mM KOAc, 10% (v/v) glycerol, 2 mM DTT, 500 mM imidazole) gradient over 10 
column volumes, and the complex was eluted with a step elution to 100% elution 
buffer over 10 column volumes. Protein-containing fractions were pooled, and diluted 
with 3 volumes of IEX buffer A (25 mM HEPES pH 7.5, 100 mM KCl, 10% (v/v) 
glycerol, 2 mM DTT, 1 mM EDTA). 100 µL of 5 mg/mL 3C protease were added and 
incubated for 3 hours at 4°C. The protein was then loaded onto a 1 mL HiTrap Q HP 
column (GE Healthcare), which had been equilibrated with 10 column volumes of IEX 
buffer A. The complex was eluted with a 0-30% salt gradient of IEX buffer B (25 mM 
HEPES pH 7.5, 2000 mM KCl, 10% (v/v) glycerol, 2 mM DTT, 1 mM EDTA)  over 
200 column volumes at a flow rate of 0.75 mL/min. The complex was pooled and 
concentrated to 3 mg/mL (An E1% value of 7.6 was taken for concentration 
measurement). The complex was flash frozen in liquid N2.  
 
For purification of Med1,4,9, cell pellet was processed in exactly the same way until 
3C protease tag cleavage, and was then loaded onto a MonoQ 5/50 GL column (GE 
Healthcare), which had been equilibrated with 10 column volumes of IEX buffer A. 
The trimer was eluted with a 0-30% salt gradient of IEX buffer B over 150 column 
volumes at a flow rate of 0.75 mL/min. The complex was pooled and concentrated to 
1.7 mg/mL (An E1% value of 7.0 was taken for concentration measurement). The 
complex was flash frozen in liquid N2. 
 
cMedD4,9 and Med1,4,9 were mixed together in a 1:1.5 molar ratio, and loaded onto 
a Superose 6 10/30 Increase column (GE Healthcare) run at 0.3 mL/min and taking 
0.2 mL fractions, to resolve the cMed complex from the excess trimer. Fractions 
containing the full complex were pooled and concentrated in a 50K or 100K MWCO 
Vivaspin® 6 centrifugal concentrator (Sartorius) at 15°C, to 3-6 mg/mL and used 
directly or flash frozen (minimization of concentration time as much as possible has a 
large impact on the yield). 300-700 µg of pure cMed were obtained per purification.  
 
Endogenous Mediator (eMed) 
 
Endogenous Mediator was purified using a standard TAP-tag purification. A 300 g 
pellet of cells from S.cerevisiae fermentation culture frozen in a 2:1 volume ratio of 
cells to TEV extraction buffer (50 mM HEPES pH 7.6, 250 mM KOAc, 1 mM EDTA, 
10% (v/v) glycerol, 1X PI, 1 mM DTT) was thawed in a 30°C water bath, then 
transferred together with 220 mL of glass beads into a BeadBeater chamber, and 
lysed by bead beating for 90 minutes. The glass beads were removed, and the 
required volume of 5M KOAc at pH 7.6 was added to bring the final KOAc 
concentration to 600 mM. The lysate was centrifuged for 1 hour at 12,000 rpm in an 
	 60	
F14-6x250y rotor (Thermo Scientific), and then untracentrifuged for 2 hours at 
42,000 rpm in a Ti45 rotor (Beckman Coulter). 
2X 4 mL resin volume of IgG-sepharose beads slurry (GE Healthcare) were washed 
twice with 40 mL of TEV extraction buffer (with 5 minutes of nutation, and then 
spinning for 5 minutes at 3128xg between washes).  
The clarified supernatant was added to the equilibrated IgG beads and allowed to 
bind overnight at 4°C with nutation.  
The beads were collected by centrifugation (3128xg for 8 minutes), the flowthrough 
removed, and the beads washed 3 times with TEV extraction buffer, and once with 
TEV extraction buffer + 0.1% NP-40 (NP-40 Sufact-AmpsTM, Thermo Fisher 
Scientific). Note that using detergent of high quality is essential for this purification. 
The beads were resuspended to roughly 10 mL with TEV extraction buffer + 0.1% 
NP-40. 340 µg of TEV protease were added, and incubated with nutation for 3 hours 
at room temperature. The beads were collected, and the eluate (around 6 mL) saved 
(E1). Two more 6 mL buffer elutions with TEV extraction buffer (E2, and E3) were 
done. Elution fractions were pooled, and calcium chloride was added to a final 
concentration of 3 mM. 2X 1.4 mL of calmodulin resin (IBA) was washed 3 times with 
calmodulin binding buffer (50 mM HEPES pH 7.6, 250 mM KOAc, 1 mM EDTA, 10% 
(v/v) glycerol, 1X PI, 1 mM DTT, 3 mM CaCl2, 1 mM imidazole, 0.01% NP-40). The 
Mediator-containing IgG elutions were added to the equilibrated calmodulin resin and 
allowed to bind overnight at 4°C with nutation.   
 
On the following day, the beads were collected (3128xg, 8 minutes), washed twice 
with 12 mL of calmodulin wash buffer 1 (50 mM HEPES pH 7.6, 250 mM KOAc, 1 
mM EDTA, 10% (v/v) glycerol, 1 mM PMSF, 1 mM TCEP, 3 mM CaCl2, 1 mM 
imidazole, 0.1% NP-40), twice with 12 mL of calmodulin wash buffer 2 (50 mM 
HEPES pH 7.6, 250 mM KOAc, 1 mM EDTA, 10% (v/v) glycerol, 1 mM PMSF, 1 mM 
TCEP, 3 mM CaCl2, 1 mM imidazole, 0.01% NP-40), and then transferred to a 10 mL 
gravity flow column (Bio-Rad). The wash buffer was allowed to flow out, and 6x 0.8 
mL of elution buffer ((50 mM HEPES pH 7.6, 250 mM KOAc, 1 mM EDTA, 10% (v/v) 
glycerol, 1 mM PMSF, 1 mM TCEP, 3 mM EGTA, 1 mM imidazole, 0.01% NP-40)  
were added and collected (E1-E5). Fractions were analyzed by SDS-PAGE. 
Complex-containing fractions were pooled and concentrated in a 100K MWCO 
Vivaspin® 6 centrifugal concentrator (Sartorius), and quantified using Bradford assay 
(PierceTM Coomassie Plus (Bradford) Assay reagent – Thermo Fisher Scientific) 
against a BSA standard curve. 
 
Elutions were used directly or kept at 4°C for 1 day but not frozen. This complex is 
not freeze-thaw stable (we noticed by sucrose gradient ultracentrifugation comparing 
fresh sample, versus sample after freeze-thaw). 100-200 µg of purified eMed were 





BL21 (DE3) RIL chemically competent cells were transformed with the plasmid, and 
used to inoculate a 200 mL preculture in LB medium with the appropriate antibiotics. 
The 200 mL preculture was then diluted to 2L on the following morning with LB and 
the appropriate antibiotics. Cells were induced when they reached an OD600 of 0.5-
0.6 by adding 0.5 mM IPTG and were harvested 4 hours later. Pellets were 
resuspended in 20 mL of lysis buffer (20 mM HEPES, pH 7.4, 500 mM NaCl, 20 mM 
Imidazole, 1x PI, 1 mM β-ME) and flash frozen until needed.  
 
Pellets were thawed and sonicated for 15 minutes at 40% amplitude with a pulse of 
0.4 s on and 0.6 s off. The lysate was clarified by centrifugation at 20,000 rpm for 45 
minutes. 2mL of approximately 50% Ni-NTA agarose slurry (washed once with water, 
and once with 5 volumes of lysis buffer, then resuspended in 2 mL of lysis buffer) 
was added per 2L of culture.  1 hour of nutation was allowed for binding at 4°C. The 
beads were spun down at 500xg for 2 minutes, and then washed 4 times with lysis 
buffer, before adding 5 mL of elution buffer (20 mM HEPES, pH 7.4, 500 mM NaCl, 
500 mM Imidazole, 1x PI, 1 mM β-ME), and incubating for 10 minutes at 4°C. The 
eluate (E1) was collected by spinning down the beads, and this was repeated twice 
(E2 and E3). E1, E2 and E3 were combined and diluted 1:5 with buffer A (20 mM 
HEPES, pH 7.4, 1 mM EDTA, 10% glycerol) to bring down the salt concentration to 
100 mM. The eluate was then loaded onto a 5 mL HiTrap Heparin (GE healthcare) 
column equilibrated in 10% buffer B (20 mM HEPES, pH 7.4, 1 mM EDTA, 10% 
glycerol, 1M KCl), using a sample pump connected to an ÄKTA pure system (GE 
healthcare) at 3 mL/min. The fractions were analyzed with SDS-PAGE using a MES 
buffer. Fractions containing Gcn4 were pooled and concentrated using a 50 mL 
10,000 MWCo Amicon® concentrator by centrifugation at 3000xg for 30 minute 
intervals at 4°C. The total concentration time was 2.5-3 hours. The final protein 
concentration was determined to be 8 mg/mL (258 µM) using an extinction coefficient 




LOBSTR chemically competent cells were transformed with the mEGFP-Gcn4  
plasmid, and used to inoculate a 200 mL preculture in LB medium with the 
appropriate antibiotics. The preculture was diluted 1:30 in 2L on the following 
morning with LB and the appropriate antibiotics. Cells were grown 1.5 hours at 16°C 
and then induced with 1 mM IPTG and were incubated for 5 hours at 37°C. Pellets 
were frozen until needed. 
 
His-mEGFP-Gcn4 was purified following the same buffers and protocol as for His-
Gcn4. After elution from Heparin, fractions containing purified protein were pooled 
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and dialyzed into buffer D (20 mM HEPES, pH 7.4, 300 mM NaCl, 10% glycerol, 





LOBSTR cells were transformed with the mCherry-Med15 plasmid, and one colony 
was used to inoculate a 200 mL preculture in LB medium and the appropriate 
antibiotics. The following morning, cultures were diluted 1:30 in 500 mL LB medium 
with the appropriate antibiotics. Cultures were grown at 16°C, and induced with 1 mM 
IPTG after 1.5 hours, irrespective of their O.D.600. The temperature was raised to 
37°C and the cultures were grown for an additional 5 hours after induction. Cells 
were harvested, flash frozen, and stored at -80°C until needed. 
 
For protein purification, cell pellet from a total of 2L of culture was resuspended in 15 
mL  of Ni-binding buffer (50 mM Tris, pH 7.5, 500 mM NaCl, 10 mM Imidazole, 1 mM 
β-ME, 1x PI), and lysed by sonication using a pulse amplitude of 40% and duration of 
0.4 s on, 0.6 s off, for a total time of 10 minutes. Lysate was clarified by 
centrifugation at 27,000 rpm for 30 minutes. Supernatent was then added to 2 mL Ni-
NTA agarose slurry (Qiagen) that had been washed once with water, and once with 5 
CV of lysis buffer, and nutated for 1 hour at 4°C. The flowthrough was collected by 
spinning down the beads at 500x g for 2 minutes. 15 CV of Ni-binding buffer were 
then added to resuspend the beads, and the slurry was transferred to a gravity flow 
column. The protein was eluted with 2 CV E50 (50 mM Tris, pH 7.5, 500 mM NaCl, 
50 mM Imidazole, 1mM β-ME, 1x PI), followed by 2 CV E100 (50 mM Tris, pH 7.5, 
500 mM NaCl, 100 mM Imidazole, 1mM β-ME, 1x PI), then 3 CV E250 (50 mM Tris, 
pH 7.5, 500 mM NaCl, 250 mM Imidazole, 1mM β-ME, 1x PI). The fractions were 
visualized by SDS-PAGE in MES buffer. Fractions containing the protein were 
pooled and concentrated in a 15 mL Amicon® centrifugal filter (Merck-Millipore) with 
a 50,000 MWCO by centrifugation at 3300 rpm for 15 minute intervals until the 
volume was reduced to 150 µL. It was then dialyzed overnight in 1L dialysis buffer 
(20 mM HEPES, pH 7.4, 300 mM NaCl, 10% glycerol, 1 mM TCEP) using a 2 mL 
Slide-A-Lyzer MINI dialysis device, 3.5 MWCO (Thermo).  Concentration was 
calculated based on parameters computed using the ExPASy ProtParam tool; molar 
extinction coefficient of 58,790 and a molecular weight of 102 kDa. Note that the 
concentration is approximate due to the partial purity of the protein purified in this 




The plasmid was used to transform BL21 (DE3 ril) chemically competent cells. One 
colony was used to inoculate a 200 mL preculture in LB medium with the appropriate 
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antibiotics. 20 mL were then taken and diluted to 2L with LB and the appropriate 
antibiotics. Cells were induced with 0.5 mM IPTG when they reached an OD600 of 
0.5-0.6, and harvested after 3 hours of induction. Cells were flash frozen and stored 
at – 80°C until use. 
 
Cell pellet from 3L of culture was resuspended in 90 mL of Ni-binding buffer (50 mM 
HEPES, pH 7.0, 500 mM NaCl, 40 mM Imidazole, 10% glycerol, 1x PI, 1 mM β-ME) 
and sonicated for 10 minutes, with an amplitude of 40% and a pulse duration of 0.4s 
on, 0.6s off. The lysate was then clarified by centrifugation at 27,000 rpm for 40 
minutes. 2x 2 mL Ni-NTA agarose beads slurry (Qiagen) were washed once with 5 
CV of water, and once with 5 of CV Ni-binding buffer by spinning at 500x g for 2 
minutes between washes, and resuspended in 2x 2mL Ni-binding buffer. Clarified 
lysate was added to the beads, and nutated for 1 hour at 4°C for binding. 
Flowthrough was collected by spinning down the beads at 500x g for 2 minutes. The 
beads were washed 3 times, each with 5 CV of Ni-binding buffer, by spinning at 500x 
g for 2 minutes between washes. 20 mL elution buffer (50 mM HEPES, pH 7.0, 500 
mM NaCl, 500 mM Imidazole, 10% glycerol, 1x PI, 1 mM β-ME) were added to the 
beads, and nutated for 10 minutes. The elution was collected by centrifugation, and 
30 mL of Heparin buffer A (50 mM HEPES, pH 7.0, 10% glycerol, 1x PI, 1 mM β-ME)  
were added to the eluate to bring down the salt concentration to 200 mM NaCl. 
  
The eluate was then loaded onto a 5 mL HiTrap Heparin (GE healthcare) column 
equilibrated in 20% buffer B (50 mM HEPES, pH 7.0, 10% glycerol, 1M NaCl, 1x PI, 
1 mM β-ME), using a sample pump connected to an ÄKTA pure system (GE 
healthcare) at 3 mL/min. The column was then washed with 5 column volumes of 
20% buffer B, and eluted in a gradient of 20 – 50% buffer B over 10 column volumes, 
followed by a step of 100% buffer B for 5 column volumes. Fractions were analyzed 
by SDS-PAGE in MES buffer. Fractions containing the protein were pooled and 
concentrated in a 15 mL Amicon® centrifugal filter (Merck-Millipore) with a 50,000 
MWCO by centrifugation at 3300 rpm for 15 minute intervals until the volume was 
reduced to 150 µL. The sample was then dialyzed overnight in 1L dialysis buffer (50 
mM HEPES, pH 7.0, 10% glycerol, 300 mM NaCl, 1 mM TCEP) using a 2 mL Slide-
A-Lyzer MINI dialysis device, 3.5 MWCO (Thermo). The sample was concentrated 
again using a 0.5 mL Amicon® centrifugal filter (Merck-Millipore) with a 50,000 
MWCO at 5,500 rpm for 15 minute intervals to a final concentration of 17.3 mg/mL 
(170 µM). Values were calculated using a molar extinction coefficient of 89,300 and a 
molecular weight of 102 kDa (the MBP tag was not cleaved). 
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CTD of RNAPII  
 
GST-tagged RNAPII CTD was purified as in [20]. 
 
RNAPII and transcription initiation factors  
 
RNAPII and the GTFs; TFIIA, TBP, TFIIB, TFIIF and TFIIE were purified essentially 




Two reactions were set up with active versus dead CKM in a total volume of 20 µL. 
The appropriate volume of components were pipetted to have 10 µM GST-hCTD, 0.4 
µM CKM(A or KD),1X of 5X buffer (100 mM HEPES pH 7.5, 1.5M KOAc, 25 mM b-
ME),10 mM MgCl2 and [10 mM ATP – added later] in the final reaction. The volume 
was brought up to 20 µL with water.   
 
All components except for ATP were mixed together on ice, and then transferred to a 
30°C heat block, with 300 rpm shaking (eppendorf ThermoMixer C). Tubes with 8 µL 
4x LDS buffer were prepared for quenching by denaturation of protein reaction 
components. 1 µL of the starting reaction was transferred to the time point 0 
quenching tube. Then, ATP was added, and 2 µL samples from the reaction were 
taken and quenched after 5, 10, 20, 30, 60 and 120 minutes.  
 
1 µL from each time point, for both the CKM(A) and CKM(KD) reactions, was run in 
MES buffer on an SDS-PAGE gel and blotted with the CTD Ser5 phosphosite 
specific antibody. The same was repeated for blotting with CTD Ser2, Ser7 and Tyr1 
phosphosite specific antibodies (a kind gift from Dirk Eick). 
 
The RNAPII kinase assay was performed in exactly the same way, but using roughly 
6.5 µM RNAPII in the reaction, which had been dephosphorylated by treatment with 
λ-phosphatase for 1 h at 4°C before gel filtration within the standard RNAPII 
purification. 
 
The Gcn4 kinase assay was peformed essentially as described, but using 13 µM of 
His(x6)-Gcn4 and 0.5 µM CKM(A) in the kinase reaction, or 13 µM His(x6)-Gcn4 + 20 




40 µL of Dynabeads® MyOneTM Streptavidin T1 beads (Life Technologies) per 
planned reaction (x) = Y µL were transferred to a 2 mL tube (eppendorf). Using a 
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DynaMagTM magnetic rack (Life technologies), buffer was removed. Beads were 
washed three times with Y µL of streptavidin binding buffer (20 mM HEPES pH 7.5, 
150 mM KOAc, 5-10% glycerol, 5 mM BME, 10 mM MgCl2, 0.05% NP40), and then 
resuspend in Y - x µL buffer, with x µL of biotinylated scaffold DNA (sc1) at 40 µM. 
Beads were incubated with DNA for 25 minutes at 25°C, and washed once with Y µL 
of streptavidin binding buffer to remove excess scaffold, and resuspend in Y µL. 
Resuspended beads were divided into 40 µL per reaction tube.  
 
Seven reactions were set up; (1) Scaffold + CKM(KD), (2) Scaffold + cMed, (3) 
Scaffold + cMed-CKM(KD), (4) Scaffold + PIC factors + cMed, (5) Scaffold + PIC 
factors + cMed-CKM(A), (6) Scaffold + PIC factors + cMed-CKM(A) +ATP, (7) 
Scaffold + PIC factors + cMed-CKM(KD) + ATP. 
 
For PIC-containing reactions, the PIC factors were mixed such that 40 pmol each of 
TFIIA, TFIIB and TBP, 10 pmol of RNAPII, 20 pmol of TFIIF and 60 pmol of TFIIE are 
present per reaction. The volumes required for 4 reactions were mixed together, 
made up to 40 µL with buffer, or with buffer – volume of additional components. For 
reactions (4), (5), (6) and (7), 10 µL of PIC mix was added. To reaction (1), 15 pmol 
of CKM(KD) were added. To reaction (2) and (4), 22.5 pmol of cMed were added. To 
reactions (3),(5),(6) and (7), 15 pmol CKM(A or KD as indicated) and 22.5 pmol 
cMed, dialyzed to lower salt buffer (20 mM HEPES pH 7.6, 250 mM KOAc, 10% (v/v) 
glycerol, 5 mM β-ME) to allow complex formation, were added. To reactions (6) and 
(7), ATP to a final concentration of 2.5 mM was added.  
 
Reactions were pipetted into the respective tubes, and the final volume was adjusted 
to 40 µL with streptavidin binding buffer, and incubated for 10 minutes at 25°C. Buffer 
was removed from the beads and the reactions added to the respective tubes, mixed 
and incubated at 25°C for 45 minutes. 
The flowthrough (unbound) was collected, and the beads were washed 3 times with 
streptavidin binding buffer. 24.5 µL of streptavidin binding buffer + 0.5 µL of 100 U/µL 
EcoRV-HF® (NEB) were added per tube, and incubated at 28°C for 75 minutes to 
allow the restriction enzyme to cleave off the DNA from the beads.10 µL and 5 µL of 
4x LDS loading dye were added to the unbound and elution fractions, respectively. 
Fractions were analyzed by SDS-PAGE.  
 
CKM Phosphoproteomics of the PIC 
 
Buffers and experimental setup were exactly as described for the immobilized 
template assay, with the only difference being that 15 pmol per reaction of cMed 
were added (in a 1:1 ration with CKM), instead of 22.5 pmol. 
Three reactions were set up; (1) scaffold + cMed + PIC, (2) scaffold + cMed + PIC + 
[CKM(A) + ATP] later, (3) cMed + PIC + CKM(A) + ATP + [scaffold] later 
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The difference between reaction (2) and (3) is that, in reaction (2) PIC-cMed was first 
assembled on the DNA scaffold, washed, and then CKM(A) was added, whereas in 
reaction (3) PIC components were incubated with CKM(A) and ATP first on ice for 30 
minutes, before adding in the bead-bound scaffold for the assembly reaction. 
 
All unbound and elution fractions were run on an SDS-PAGE gel. Full lanes from the 
gel were cut out, the proteins were extracted, digested, phosphor-enriched and 
subjected to mass spectrometric analysis to identify phosphorylations on PIC 
components. 
 
CKM-cMed-PolII competition assay 
 
Storage buffer was removed from 400 µL of amylose magnetic beads (NEB) using a 
magnetic rack in a 2 mL eppendorf tube, and the beads were washed once with 400 
µL of water, and then blocked with 600 µL of 1 mg/mL BSA solution in binding buffer 
1 (20 mM HEPES, pH 7.5, 300 mM KOAc, 10% glycerol, 5 mM β-ME) at 37°C for 20 
minutes with vigorous shaking. The blocking solution was then removed and the 
beads were washed 3 times with binding buffer 1. 440 µg of CKM(KD) in storage 
buffer (240 µL) were adjusted to a total volume of 800 µL, and then added to the 
beads, and shaken at 800 rpm for 1 hour at 4°C to bind MBP-tagged CKM to the 
blocked amylose beads. After binding, the flowthrough was discarded, and the beads 
were washed twice with binding buffer 1, then twice with binding buffer 2 (20 mM 
HEPES, pH 7.5, 250 mM KOAc, 10% glycerol, 5 mM β-ME to lower the salt 
concentration in preparation for the addition of cMed. 880 µg (360 µL) of cMed (2x 
molar ratio compared to CKM) adjusted to 800 µL in binding buffer 2 were added and 
shaken together at 800 rpm with the amylose-CKM beads at 4°C. After binding, the 
flowthrough was discarded and the beads were washed 12 times with 400 µL of 
binding buffer 2 (the number of washes had been previously determined in a 
preliminary experiment where all washes were blotted with the same antibody used 
in this experiment to determine the times after which equilibrium is reached – there 
was always a trace of cMed detected, but after about 10 washes, the level of 
detected cMed became constant). All previous steps were carried out in a single 
tube. After the washes, the beads were then resuspended in 410 µL of binding buffer 
2. The beads were then divided into 50 µL of resuspended beads per tube. Six 
solutions with varying concentrations of polymerase were prepared. 0, 0.2, 0.4, 1, 2 
and 10 µL, respectively, of purified RNAPII at 9.45 µM were adjusted to 200 µL in 
binding buffer 2. This corresponded to a molar excess of RNA-polymerase II over 
bead-bound CKM-cMed of 0x, 0.5x, 2x, 5x, 10x, and 50x, respectively, approximated 
from the theoretical binding capacity of the amylose beads based on their binding to 
MBP5-paromysinΔSal. CKM-cMed-amylose beads were incubated with polymerase 
at room temperature for 1 hour with shaking. The beads were then removed, and 30 
µL from the 200 µL wash volume were taken and mixed with 10 µL of 4x LDS loading 
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dye. 18 µL were then loaded onto a 4-12% SDS-PAGE gel (NuPAGE) run in MES 
buffer. The gel was then blotted onto a nitrocellulose membrane (Biorad) and then 





0.18 µL  (0.02 µL + 0.15 µL) of MgCl2 (1M)-ATP (100 mM, pH 7.4), 1.5 µL of CKM(A) 
or CKM(KD) - at 4.2 mg/mL (ca. 8.7 µM) and 3.85 µL of GST-yCTD at 130 µM were 
mixed and incubated together at 30°C for 4 hours. 26% dextran solution in water was 
diluted to 20% such that the final solution contained 20 mM HEPES (pH 7.4) and 175 
mM NaCl. 2 µL of the CTD-CKM(A) and the CTD-CKM(KD) reactions were then 
directly mixed with 8 µL of the 20% dextran solution. The final mixture contained 16% 
dextran, 20 mM HEPES pH 7.4 and 200 mM NaCl.  
 
TFIIF: 
3.85 µL of purified TFIIF (5.7 mg/mL) were mixed with 1.5 µL of CKM(A) or CKM(KD) 
and 0.18 µL of MgCl2-ATP. The reactions were incubated for 4 hours at 30°C to 
ensure complete phosphorylation. 2 µL from each reaction were mixed with 8 µL 
20% dextran solution in HEPES, pH 7.4 and 100 mM NaCl, so that the final droplet 
buffer conditions were 16% dextran and 120 mM NaCl.  
 
Gcn4 with FAM-DNA:  
DNA strands at 100 µM in DNA duplex buffer (30 mM HEPES pH 7.5, 150 mM 
KOAc, 0.1 mM EDTA) were annealed as described previously in a total volume of 4 
µL. 1 µL of annealed DNA was then diluted with 9 µL of water, to a final 
concentration of 10 µM. 3 µL of purified His-Gcn4 at a concentration of 258 µM were 
mixed with 3 uL of 10 µM annealed DNA scaffold diluted in water, such that the His-
Gcn4 concentration was brought down to approximately 130 µM, and the final salt 
concentration was 150 mM NaCl. In the control reaction, 1 µL DNA duplex buffer 
mixed with 9µL water substituted annealed DNA.  10 minutes on ice were allowed for 
binding. 1 uL of 20% dextran (2.85% in the final droplet formation buffer) in 100 mM 
NaCl, HEPES pH 7.4, was gently mixed with each reaction to avoid the introduction 
of any air bubbles. 
 
mCherry-Med15 with GFP-Gcn4: 
1.925 µL of purified GFP-Gcn4 adjusted to 81 µM in dilution buffer were mixed with 
1.925 µL of purified mCh-Med15 (81 µM), 1.5 µL CKM(A) or CKM(KD) and 0.18 µL 
MgCl2-ATP. The reactions were incubated for 4 hours at 30°C to ensure complete 
phosphorylation. The tubes were then centrifuged for 5 minutes at 4°C at 15,000 
rpm. 3 µL of each reaction were mixed with 3 µL of 20% dextran solution in 100 mM 
	 68	
NaCl, HEPES pH 7.4. As such, the final conditions in the droplet formation buffer 
were 200 mM NaCl, 10% dextran and 30 µM of each of the two proteins.  
 
8 µL (CTD) or 5 µL (all others) of the droplet solutions were pipetted on to the surface 
of an mPEGylated glass slide, covered with a cover slip, and the edges were sealed. 
The slides were then imaged using an inverted fluorescence microscope in 
differential interference contrast mode, or using the appropriate filter cube.   
 
Fluorescence anisotropy of Gcn4-DNA 
 
Buffer 1 (20 mM HEPES, pH 7.6, 300 mM KOAc, 10% glycerol) 
Buffer 2 (20 mM HEPES, pH 7.6, 300 mM KOAc, 5 mM BME) 
Buffer 3 (5X buffer 2: 100 mM HEPES, pH 7.6, 1.5 M KOAc, 25 mM BME) 
Buffer 4 (2X assay buffer: 20 mM HEPES, pH 7.6, 300 mM KOAc, 10% glycerol, 0.2 
mg/mL BSA) 
DNA duplex buffer (30 mM HEPES, pH 7.5, 100 mM KOAc, 0.1 mM EDTA) 
 
5’- 6-FAM (Carboxyfluorescein) labeled sense strand and unlabeled antisense strand 
were dissolved in DNA duplex buffer to 100 µM. After annealing, DNA was diluted in 
DNA duplex buffer to 100 nM.  
 
Preparation of phosphorylated and unphosphorylated Gcn4: 
400 µL of amylose magnetic beads (NEB) were divided equally between two 2-mL 
eppendorf tubes. The storage buffer was removed and the beads were washed once 
with 200 µL buffer 1. 400 µL of 1 mg/mL BSA in buffer 1 were then added to each 
tube, and incubated for 20 minutes at 37°C to block the beads. The beads were then 
washed twice with buffer 1 and twice with buffer 2. In the first tube, the beads were 
resuspended in 95 µL buffer 2 and 5 µL of active CKM at 4.2 mg/mL (21 µg) were 
added. In the second tube, the beads were resuspended in 90.14 µL buffer 2 and 
9.86 µL kinase dead CKM at 2.13 mg/mL (21 µg) were added. After a one-hour 
incubation period at 4°C to immobilize the complex on the beads, any excess 
unbound CKM was washed away by washing the beads ten times with 200 µL buffer 
2. This is important because the differential affinity of the kinase dead mutant and the 
active kinase to the substrate may influence the outcome of the anisotropy 
experiment. The immobilized enzyme was then used to phosphorylate Gcn4 (or not, 
in the case of the kinase dead mutant) in a phosphorylation reaction with 50 µL of 
258 µM Gcn4, 20 µL of buffer 3, 2 µL of 100 mM MgCl2, 2 µL of 100 mM ATP (pH 
7.4) and 26 µL of water. The reaction was incubated for 4 hours at 30°C, and then 
overnight at 4°C to ensure complete phosphorylation which might be slower due to 
the restricted mobility of the enzyme. An additional 1 µL of 100 mM ATP (pH 7.4) 
was added at approximately half time.  
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The beads were removed using a magnetic rack, the supernatants were transferred 
to fresh tubes, and the process was repeated again to ensure the complete removal 
of the beads.  
 
Fluorescence Measurement: 
Phosphorylated and unphosphorylated Gcn4 were diluted in a log(0.5) dilution series. 
13.6 µL from each supernatant were transferred to 30 µL of buffer 2. 13.6 µL of that 
were then, in turn, transferred further to 30 µL of buffer 2, and so on. In this way, 12 
different concentrations were prepared, with the first one being the supernatant 
without any dilution, and the last one buffer only with no added protein.  
 
In each well, 7.5 µL of phosphorylated or unphosphorylated Gcn4 of the respective 
dilution were mixed with 2 µL of DNA at 100 nM, 3 µL of water, and 12.5 µL of buffer 
4 (the final assay conditions contained 150 mM potassium acetate, 0.2 mg/mL BSA, 
8 nM DNA and Gcn4 at the respective concentration). 18 µL of the 25 µL reactions 
were then transferred to 384-well plates, and fluorescence was measured with an 
excitation wavelength of 470 nm and bandwidth of 5 nm, and an emission 
wavelength of 518 nm and bandwidth of 20 nm. A gain value of 75 and a Z-position 
of 26050 µm were set, and measurement was carried out on a TECAN Infinite 
M1000 Pro multi-well plate reader.  
 
Fluorescence intensity was measured in triplicate for each Gcn4 concentration to 
average out pipetting errors. Fluorescence polarization (FP) and anisotropy (r) were 
calculated according to the following equations; 
 
!" = $ ∥ 	−	$ ⊥$ ∥ +	$ ⊥  
 
* =	 $ ∥ 	−	$ ⊥$	+ 	 
 
Where $ ∥ is the fluorescence intensity in the parallel direction 
 $ ⊥ is the fluorescence intensity in the perpendicular direction 
 $	+ is the total fluorescence intensity 
 
Mean fluorescence anisotropy was plotted against log(Gcn4 concentration) for 
phosphorylated and unphosphorylated Gcn4. Curves were fitted using the fitting 
equation from Reference. 
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Electromobility shift assay of Med15_KIX123 and GFP-Gcn4 
 
0.58 µL of GFP-Gcn4 at 130 µM were mixed with 0.5 µL of CKM(A) or CKM(KD) at 
4.2mg/mL, 0.7 µL Mg-ATP and 2 µL CKM buffer. The reactions were incubated for 2 
hours at 30°C to ensure complete phosphorylation. After the completion of the 
reaction, the volumes were adjusted to 100 µL with dilution buffer, to adjust the final 
concentration of GFP-Gcn4 to 0.75 µM.  
To verify phosphorylation, 5 µL from each reaction were loaded onto a Phos-Tag gel 
(Wako Chemicals). The gel was run at 130 V for 2.5 hours at room temperature, and 
then imaged through the EGFP channel on a Typhoon FLA 9500 biomolecular 
imager (GE healthcare). 
 
MBP-M15KIX123 was diluted in a 2-fold dilution series in dilution buffer from 3.75 µM 
to 117 nM. 3 µL of phosphorylated or unphosphorylated GFP-Gcn4 were mixed with 
3 µL MBP-M15KIX123 dilution or dilution buffer only, and allowed to bind for 10 
minutes on ice. 2 µL 70% glycerol were added to each tube, and the samples were 
loaded onto a (pre-run for 1h at 150 V) 3-12% Bis-tris Native PAGE gel (NuPAGE), 
and run at 120 V in 1X NativePAGE buffer for 5 hours at 4°C. The gel was then 







5.1 PART I: SAMPLE PREPARATION 
 
5.1.1 A strategy for recombinant expression and purification of CKM 
 
A major hurdle towards solving the structure of the Mediator Cdk8-kinase module 
(CKM), whether on its own or together with the core Mediator complex (cMed), and 
towards its thorough biochemical characterization, was obtaining sufficient amounts 
of pure, homogeneous and stoichiometric complex.  Here, we were able to solve this 
problem by establishing and optimizing a heterologous expression system for the 
S.cerevisiae CKM in insect cells. We chose S.cerevisiae as a model organism, 
consistent with all previous efforts to elucidate S.cerevisiae transcription initiation 
complexes [87].    
 
We chose insect cells as the expression host to accommodate the large size and 
elaborate interaction interfaces of the complex that likely require chaperone-assisted 
folding, as well as post-translational modifications. Moreover, overexpression of 
active kinases is notoriously toxic to E.coli [104].  
 
5.1.2 Cloning of the complete S.cerevisiae CKM on a single vector 
 
We cloned the S.cerevisiae CKM (which contains the four subunits Med12, Med13, 
Cdk8 and Cyclin C) from genomic DNA into insect cell transfer vectors. In situations 
where individual genes were too large to be amplified all at once from genomic DNA, 
fragments were amplified separately and stitched back together by homologous-
recombination-based cloning. All the DNA sequences used were the natural 
sequences from the S.cerevisiae genome (not codon-optimized for the insect cell 
expression host). We found that expression of the complex was only possible when 
all subunits were assembled together on a single vector.  
 
The final transfer plasmid approached 20,000 base pairs in length (figure 5.1), and 
encoded an N-terminal Polyhistidine-Maltose Binding Protein (MBP)- fusion tag on 
the Cdk8 subunit connected via a flexible linker containing a TEV protease cleavage 
site. All remaining subunits were untagged. Two versions of the plasmid were made; 
the first encodes a wild-type Cdk8 subunit, and the second encodes a kinase-dead 
mutant, in which a crucial aspartate residue in the catalytic center (D286) was 
mutated to an alanine, with the remainder otherwise identical. Wild-type CKM is 
henceforth designated ‘CKM(A)’, and the catalytically inactive mutant, ‘CKM(KD)’. 
The sequence containing all genes was transferred onto a baculoviral bacmid, which 
was isolated and used to transfect Sf9 insect cells to package the first viruses (V0), 
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which were further propagated in Sf9 cells (V1) to reach the appropriate titer for 




5.1.3 A baculovirus expression vector system for CKM 
 
CKM(A) and CKM(KD) were expressed in the Hi5 insect cell line. We found that 
modulating the strength of the V1 expression virus is imperative for adequate 
expression. Fresh virus (not older than three months) should always be used. On the 
other hand, virus that was too strong resulting in a too-rapid drop in insect cell 
viability was also detrimental to expression. In this case, it was necessary to lower 
the initial viral load to allow enough time for expression of the larger subunits.  
Expression over 4-5 days, such that the cells double on the first day after infection 
and then arrest proliferation, with the viability remaining above 80% for at least three 
more days before harvest, was optimal.  
Expression was also tested in Sf9 cells, which may confer different post-translational 
modifications than Hi5 cells, but this provided no observable advantage on the level 
of expression or purification. 
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5.1.4 A purification strategy yielding pure, stoichiometric CKM 
 
We established a novel purification method for recombinant CKM yielding pure and 
stoichiometric complex. In order to set up this method, we tested a range of salts and 
salt concentrations for insect cell lysis. We found that a range of 350-450 mM 
potassium acetate in the lysis buffer strikes a good balance between solubility and 
stability of the complex. Nickel affinity capture using a Polyhistidine tag (His(x6)) on 
the N-terminus of Cdk8 isolated an intact complex, but the complex disintegrated 
upon gradient imidazole elution on an ÄKTA chromatography purification system. 
Batch binding and step elution, on the other hand, allowed stable elution of CKM, but 
the complex was unstable on all forms of subsequent ion exchange chromatography 
(cation exchange, anion exchange, or heparin resins) due to its sensitivity to salt, 
which lead to persistent protein and nucleic acid contamination that could not be 
resolved. Although unsuccessful, these trials indicated that the N-terminus of the 
Cdk8 subunit allows accessible and non-disruptive tagging.  
 
Having exhausted most conventional purification resins, we resorted to re-cloning the 
complex to introduce a His(x6)-MBP tag to the N-terminus of Cdk8. Affinity 
enrichment on amylose resin with maltose elution reproduced the capture of an intact 
complex, further validating the suitability of this tagging position even for larger tags. 
Adding a nickel-affinity capture step before or after the amylose affinity capture 
conferred no detectable advantage. Presence of a solubility tag allowed lowering of 
the salt concentration to a minimum of 285 mM potassium acetate for subsequent ion 
exchange, below which the complex visibly precipitated. Tag cleavage also resulted 
in precipitation of the complex and was therefore omitted.   
 
In our final purification protocol (figure 5.2), cells are lysed in 400 mM potassium 
acetate followed by affinity capture of CKM on amylose beads and maltose elution. 
This led to stably eluting CKM together with an overstoichiometric Cdk8-CycC 
subcomplex. The salt concentration was then lowered to 300 mM potassium acetate 
by direct dilution for binding to an anion exchange column. This resolved the 
overstoichiometric Cdk8-CycC subcomplex, which did not bind the anion exchange 
column at this salt concentration. The complex was then eluted by a steep gradient 
from the anion exchange column (from 300 mM to 1M potassium acetate over 20 
mL), and then dialyzed back into 400 mM potassium acetate, before sizing by gel 
filtration or sucrose gradient ultracentrifugation, in the same salt concentration. It is 
important to note that using a shallow salt elution gradient or omission of the dialysis 
step results in total disintegration of the complex upon size exclusion 
chromatography.  A partially overlapping chaperone (hsc70) contamination leads to 
wasting about a third of the eluting gel filtration peak. On the other hand, this 
contamination was completely resolved if a sucrose gradient was used instead 
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(figure 5.2 B), but this necessitates an additional buffer exchange step before further 
processing. 
 
Using our method, purification from 1.2 L of Hi5 insect cell culture yields 200-300 µg 
of pure CKM(A), and 400-600 µg of pure CKM-KD. This purification method can be 









5.1.5 Design of a catalytically inactive CKM 
 
To catalytically inactivate the Cdk8 subunit of CKM, we designed a mutant in which 
an aspartate residue in the catalytic cleft, which is highly conserved among all cyclin-
dependent kinases (CDKs) [105], was replaced by an alanine residue. By virtue of its 
negatively charged side chain, this aspartate can coordinate one of the two 
magnesium ions in the cleft, which in turn bind the α and β phosphates of the 
incoming ATP substrate, to allow subsequent transfer of the γ phosphate to the 
phosphorylation target [106]. Based on co-crystallization with ADP, this residue was 
identified as Asp 127 in Cdk2 shown in figure 5.3 (PDB ID: 4l3Z). To find this residue 
in Cdk8, we aligned the sequences of human Cdk2 and S.cerevisiae Cdk8, and 
found the corresponding aspartate to be Asp 286. Therefore, in our kinase dead 




5.1.6 Verification of the integrity of recombinant CKM 
 
Recombinant CKM is catalytically active on known substrate 
 
A hallmark of correct folding of recombinant complexes is their ability to fulfill their 
catalytic function. Therefore, we tested the ability of our recombinantly purified 
CKM(A) to phosphorylate the C-terminal domain (CTD) of Rpb1, the largest subunit 
of RNA polymerase II (RNAPII), which is one of its known phosphorylation targets 
[19]. To do that, we used purified human Glutathione-S-Transferase tagged CTD 
(which has an identical heptad repeat sequence to the yeast CTD sequence 
(YSPTSPS), but contains 52 repeats of the heptad instead of 26). GST-CTD was 
mixed and incubated with 25-fold less CKM(A) or CKM(KD) by molar ratio, and 
supplemented with ATP and magnesium ions. Samples were taken over definite time 
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intervals, and immunoblotted using CTD phosphosite-specific antibodies against 
Serine 5, Serine 2, Serine 7 or Tyrosine 1(figure 5.4 A). The appearance, and 
increase in intensity along the reaction coordinate, of bands that correspond to the 
various CTD phosphorylation sites confirms the activity of our recombinant CKM(A). 
Furthermore, their absence when the same was carried out using CKM(KD) instead 
of CKM(A), confirms that our chosen active site mutation successfully abolished 
Cdk8-kinase activity. In addition to the purified CTD, we also confirmed activity using 
the complete, endogenously purified RNAPII as a substrate, which had been treated 
with lambda-phosphatase prior to the reaction to remove any endogenous 





Negative stain electron microscopy of recombinant CKM is consistent 
with endogenous CKM 
 
While generally an essential validation for recombinant purifications, the catalytic 
activity of the CKM accounts for only approximately 25% by mass of the complex. 
The remaining 75% constitutes the large polypeptides Med12 and Med13, which are 
challenging to express, and the first to be affected by suboptimal expression 
conditions. Furthermore, the recombinant expression of these subunits in yeast had 
never been reported. Therefore, to verify the integrity of our purified particle, and the 
efficacy of the purification setup that we established, we performed negative stain 
electron microscopy. CKM(KD) was purified as described, concentrated after gel 
filtration, then fixated with glutaraldehyde during sucrose gradient ultracentrifugation 
according to the GraFix protocol [100]. Fractions containing CKM were then 
quenched with aspartate and incubated on carbon-foil-coated EM grids, and stained 
with uranyl formate. The grids showed homogeneous particles, evenly distributed 
over the surface of the grid with no aggregation even at high particle densities (figure 
5.5 A). Approximately 300 micrographs were collected, from which 60,000 particles 
were picked, and used to perform 2D classification in RELION and 3D ab initio model 
building in CryoSparc. 
 
The 2D classes showed that the majority of the particles were intact, confirming the 
homogeneity and quality of the sample (figure 5.5 B). There was a clear preferential 
orientation as shown by the abundance of side views compared to top views, which 
is not unexpected given the elongated shape of the particle. The ab initio 3D model 
calculated from the picked particles, and not biased by any input model, generated 
an elongated volume with three prominent wedges forming an overall shape similar 
to the capital letter “E” (figure 5.5 C,D), which is consistent with the low resolution 
cryo-EM densities reported for endogenously purified CKM [82],[107]. This indicated 
that recombinant expression and purification of CKM improved its yield and purity, 
gave us more control over biochemical conditions, and facilitated generation of 
mutants, while still preserving the overall architectural integrity of the complex.  






5.1.7 Purified proteins toolbox  
 
For both structural biology and biochemical characterization studies, which will be 
encountered in the following sections, several additional proteins and multi-protein 
complexes were purified. All the proteins used in this study are S.cerevisiae proteins. 
These include the 16-subunit core Mediator, cMed, comprising the Mediator head 
and middle modules, the 20-subunit endogenous Mediator, eMed, comprising the 
Mediator head, middle and tail modules, and different parts of the Mediator tail 
subunit Med15, the subunit implicated in numerous Mediator-activator interactions. 
Additionally, the activator General control protein 4 (Gcn4) the C-terminal domain of 
Rpb1 (CTD), and the pre-initiation complex components; general transcription factors 
(GTFs) and RNAPII, all of which are involved in the interplay of factors that regulate 
transcription initiation, were needed (figure 5.6).  
  
CKM (A or KD) was expressed and purified from insect cells. cMed was expressed 
and purified from e.coli as two separate subcomplexes; Med1,4,9 and cMedΔ4,9, 
and then reconstituted on gel filtration using a protocol modified from [71] to allow 
stoichiometric incorporation of the Med1 subunit. 
eMed was purified from a genetically modified yeast strain by a standard TAP-tag 
purification. All other factors were expressed and purified in e.coli yielding purified 
protein quantities in the order of milligrams. RNAPII and the GTFs were purified by 
Carina Burzinsky [71]. 
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5.1.8 Complex formation of CKM with cMed 
 
The binding of CKM to cMed was evident by a shift in the complex-containing 
fractions to higher density fractions upon sucrose gradient ultracentrifugation (figure 
5.7). However, the complex was not gel-filtration-stable, without prior 
hyperstabilization by chemical crosslinking. Moreover, this complex could only form 

















5.2 PART II: CHARACTERIZATION OF CKM-CMED BINDING 
IN THE CONTEXT OF TRANSCRIPTION INITIATION 
 
5.2.1 CKM is not a part of the transcription pre-initiation complex 
 
Having isolated CKM, and CKM-cMed, we asked whether these complexes 
participate in the transcription pre-initiation complex (PIC). To approach this 
question, we set up an immobilized template assay (ITA) using a DNA scaffold 
containing a promoter sequence modeled on the yeast HIS4 promoter, with a TATA-
box and a transcription start site (TSS), as a platform for PIC assembly. Biotinylation 
on the 3’ end allowed immobilization of the template on streptavidin beads, and an 
EcoRV restriction site downstream of the promoter sequence allowed elution by 
endonuclease cleavage. CKM(A or KD) in the presence or absence of ATP were 
incubated on the immobilized template together with purified cMed and purified PIC 
components; RNAPII and the general transcription factors TFIIA, TFIIB, TFIIE, TFIIF 
and the TFIID subunit TBP. Excess factors were washed away, and the DNA 
template was eluted by restriction digestion from the beads. The elutions were then 
analyzed by SDS-PAGE to investigate what remained bound to promoter DNA 
(figure 5.8). 
 
CKM alone showed no background binding to the DNA template, but some 
unspecific binding was seen in the presence of cMed. In the presence of the PIC 
components, cMed bound stoichiometrically to the PIC, but CKM binding did not 
exceed background levels, indicating that CKM is excluded from the PIC, whereas 
cMed binds to the PIC. Moreover, this was so, irrespective of whether active kinase-
containing complex CKM(A) or the dead mutant CKM(KD) were used, demonstrating 
that this effect is predominantly a steric, structural effect, rather than an effect 





5.2.2 CKM directly competes with RNAPII for Mediator binding 
 
To investigate whether the CKM-cMed and the cMed-RNAPII complexes are 
mutually exclusive, we performed an in vitro competition assay with purified CKM, 
cMed and RNAPII. In this assay, we took advantage of the MBP-tag on the CKM 
complex to immobilize it on amylose beads. Having determined that the exclusion of 
the CKM from the PIC is a structural effect, we used CKM(KD). After binding of CKM 
to beads, overstoichiometric amounts of cMed were added to ensure binding 
saturation. The beads were then copiously washed to remove any unbound cMed. 
Finally, wash buffer with increasing concentrations of RNAPII was added, and the 
washes were analyzed by western blot analysis using an antibody against Med17 
(alternatively called Srb4 in yeast), one of the subunits of cMed. Presence in the 
washes of increasing amounts of Med17, hence cMed, correlating to increasing 
added RNAPII is an indication that RNAPII competes with CKM for cMed binding 
(figure 5.9). The first lane is a buffer control, where no RNAPII was added. As an 
additional control, the same experiment was carried out, without addition of cMed. 
The rationale behind this control was to ensure that the observed effect is not simply 
due to trace amounts of co-purifying cMed subunits from the RNAPII endogenous 
purification, resulting in an increasing signal as RNAPII is added in increasing 
concentrations, or from a cross-reactivity of the antibody to any of the other 
experimental components. This experiment provides corroborating evidence in 
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support of the notion that cMed can interact with the CKM or with RNAPII, but not 
with both simultaneously, and allowed us to identify RNAPII as the PIC component 




5.2.3 A shared binding interface of CKM and RNAPII on Mediator 
accounts for their mutually exclusive binding behavior 
 
To investigate the mode of binding of CKM to cMed, we performed crosslinking-mass 
spectrometric analysis (XL-MS) of the CKM-cMed complex. To do that, CKM and 
cMed were mixed together in a 1:1 ratio, dialyzed into lower salt to allow the complex 
to form, and then crosslinked with 1 mM bis(sulfo)succinimidyl suberate (BS3), after 
having titrated the crosslinker concentration to a concentration just below complete 
crosslinking. The crosslinked complex was then run on a native gel to separate the 
CKM-cMed complex from the two component sub-complexes. CKM-cMed was 
extracted from the gel, trypsin digested, enriched for crosslinked peptides and 
subjected to mass spectrometric analysis. The analysis was carried out with a false 
discovery rate (FDR) cutoff of 1%. The generated crosslinking network (figure 5.10 
A), showed extensive crosslinking within the CKM and cMed subcomplexes, but also 
several high confidence crosslinks between CKM and cMed.   
 
To validate the interaction map, crosslinks between cMed subunits, for which the 
structure is already known, were mapped onto the structure. Crosslinks used for 
validation are shown on the interaction map in black, together with the measured 
atomic distances (figure 5.10 A; 5.11 A). The appearance of many crosslinks within 
the expected distance constraints confirmed the validity of the crosslinking network 
(figure 5.11 A).  
 
In addition to crosslinks within cMed, several high confidence crosslinks between 
CKM and cMed were found. These crosslinks were mapped onto the cMed structure 
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(figure 5.10 B), and are indicated by red spheres, and corresponding red lines on the 
interaction network. Crosslinks that could not be mapped exactly, due to their 
presence in flexible regions that were not visible in the structure, were mapped to the 
closest structured residue and are indicated by pink spheres, and corresponding pink 
lines on the interaction network. This means that pink spheres indicate approximate 
crosslinking locations, and red spheres indicate exact locations, whereas both pink 
and red spheres refer to high confidence crosslinks. Dashed lines connected to the 
spheres indicate the complementary residues on CKM. Crosslinks for which more 
than one unique match was found are emphasized in bold face. 
 
An overwhelming majority of crosslinks between CKM and cMed fall on the RNAPII-
binding face of cMed, with a larger number of crosslinks to the cMed middle module, 
than to the head. In particular, a clustering of crosslinking sites to the CKM subunits 
Med12 and Med13 is seen on the knob and hook domains of cMed. On the other 
hand, Cdk8 and CycC contact the head module spine and moveable jaw, 
respectively.  
 
In figure 5.11 B, the RNAPII-cMed interaction within the PIC is shown. RNAPII is 
rendered with low opacity to allow seeing through the polymerase into the 
polymerase-Mediator interfaces. These interaction interfaces are between the 
Rpb4/7 stalk of the polymerase and arm/spine domain of the cMed head module, 
between the polymerase dock and the moveable jaw of the cMed head module 
(made up of the Med18/Med20 heterodimer), and an additional transient interaction 
between the polymerase foot and the mobile plank domain (Med4/Med9) of the cMed 
middle module (not shown). These interfaces contain conserved residues, and 
suggest a conserved nature of the RNAPII-mediator interaction across species. The 
presence of crosslinks directly on, and in close spatial proximity to, these interfaces, 
as shown in figure 5.11 B, is unequivocal proof of mutually exclusive binding. 
Moreover, it provides a structural framework to explain the observed biochemical 
competition behavior, by demonstrating that RNAPII and CKM share an overlapping 










5.3 PART III: CKM IN VITRO PHOSPHOPROTEOMICS 
 
Having established the structural effect of CKM in steric occlusion of cMed from 
binding to RNAPII and the PIC, we asked what is the function of the kinase activity of 
CKM? To address this question, we first set up a series of exploratory studies to 
identify novel phosphorylation targets of the CKM within transcription initiation 
complexes. Once targets are identified, questions can then be posed about the 
specific functions of these phosphorylations. 
 
5.3.1 CKM undergoes extensive autophosphorylation 
 
By comparing phosphosites on CKM(KD) and CKM(A), by phosphopeptide 
enrichment and mass spectrometry, we found that CKM undergoes extensive 
autophosphorylation. We mapped the phosphosites onto the CKM subunits (figure 
5.12). Based on their localization probability, phosphosites were divided into two 
classes; p(STY) class I contains phosphosites with a localization probability greater 
than or equal to 0.75, whereas p(STY) class II contains phosphosites with a 
localization probability between 0.25 and 0.75. Phosphorylations found only in the 
CKM(A) sample, but not in the CKM(KD) sample, and therefore attributed to 
autophosphorylation, are represented in orange. Dark orange represents those 
sorted into p(STY) class I, and light orange represents those sorted into p(STY) class 
II. Phosphorylations found in the CKM(KD) sample as well are represented in teal, 
with dark and light teal likewise representing phosphorylations sorted into p(STY) 
class I and II, respectively. Phosphorylations present in both samples are deposited 
by the insect cell expression host during recombinant expression. A large number of 
autophosphorylations occur on the long unstructured insertion of over 500 amino 
acids within the Med13 subunit. Notably, this region constitutes a large part of the 




5.3.2 CKM phosphoproteomics of the PIC 
 
To explore the phosphorylation targets of CKM within the PIC, we set up an 
experiment similar to the previously described immobilized template assay, using the 
same DNA template. In this experiment, three reactions were set up. In the first 
reaction, purified PIC components; RNAPII and the general transcription factors 
TFIIA, TFIIB, TFIIE, TFIIF and the TFIID subunit TBP, as well as cMed were mixed 
together with the immobilized template, washed, and eluted by restriction digestion. 
In the second reaction, PIC-cMed was similarly assembled on the immobilized 
template, excess components were washed, and then CKM(A) and ATP were added 
and incubated together with the pre-assembled PIC, and eluted by restriction 
digestion. In the third reaction, the PIC components and cMed were incubated with 
CKM(A) and ATP before addition of the immobilized template (I.e. before PIC 
assembly). Box 5.1, shows a schematic depiction of the experimental concept. The 
elution fractions from the first, second and third reactions are called E1, E2 and E3, 
respectively. The unbound fractions from the first and third reactions are called U1 
and U3, respectively. The unbound fraction from the second reaction before addition 





We separately identified and mapped the phosphosites in each of the unbound 
fractions (U1, U2, U2-2 and U3) and the elution fractions (E1, E2 and E3).  
Phosphorylations present in U2-2, U3 or E2, E3 but not in U1, U2 or E1 (where no 
CKM was added), are henceforth designated “CKM-dependent” phosphorylations. 
Among these, two groups were clearly discernable. The first group includes 
phosphorylations that are present in both U (U2-2,U3) and E (E2,E3) fractions; i.e. 
CKM-dependent phosphorylations that do not inhibit binding to the PIC. The second 
group includes phosphorylations that appear consistently only in U fractions but not 
in E fractions; i.e. CKM-dependent phosphorylations that inhibit binding to the PIC. 
To simplify the analysis of this complex, multiprotein system, only phosphorylations 
for which the localization probability was greater than 0.75 were considered. Our 
findings are detailed in the following sections.    
 
CKM phosphorylates Mediator and impairs its binding to the PIC 
 
Phosphorylations on cMed were found exclusively in the U3 fraction, but not in other 
unbound or elution fractions, indicating that these sites are a) not accessible when 
mediator is bound to the PIC, and b) inhibit subsequent binding to the PIC. Mapping 
these phosphorylations onto cMed within the known PIC structure [35] revealed sites 
on the hook and knob domains of the mediator middle module (figure 5.13). In 
addition, sites were found on the arm domain of the head module (Med8 and Med17) 
in close proximity to the Rpb4/7 stalk of the RNAPII, one of the main interaction hubs 
between mediator and the RNAPII, and on the scaffolding subunit Med14, close to 
the head module jaws, which also contact RNAPII. Furthermore, phosphorylation 
sites were found on the mobile plank domain of the mediator, which forms a transient 
interface with the RNAPII foot.  
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The interfaces between Mediator and RNAPII are hydrophilic in nature. Presence of 
phosphorylations at, and close to, the Mediator-RNAPII interaction interfaces, 
resulting in dramatically altered surface chemistry in these regions, may explain why 







CKM phosphorylates PIC components TBP and TFIIF and does not 
affect their PIC binding 
 
Other CKM-dependent phosphorylation sites found on components of the PIC 
appeared in both unbound (U2-2,U3) and elution (E2,E3) fractions. I.e. these 
phosphorylations did not interfere with PIC binding. Those were found on the TFIID 
subunit TBP, which defines the assembly site for transcription initiation, and the 
largest subunit of general transcription factor TFIIF, which intimately associates with 
RNAPII (figure 5.14). Note that, the smallest subunit of TFIIF (Tfg3), which is highly 
unstructured, has been omitted from our preparations for ease of expression. 
Additionally, the CKM also phosphorylates the C-terminal domain (CTD) of Rpb1 on 
serines 2, 5 and 7, which is not detected in MS-based phosphosite mapping due to 
the absence of trypsin digestion sites on the CTD, but has been shown earlier by 
immunoblotting (please refer to section 5.1.5) 
 Mapping these phosphosites onto the known PIC structure [35] revealed that they 
were located exclusively on unstructured loops (indicated by dashed lines in the 
same color as the factor of interest) that were not visible in the structure. The 
presence of these phosphorylations on flexible loops that extend from the PIC, and 
do not take part in structured interfaces, explains why their presence does not 
perturb the assembly of the PIC. Not only that, but it also explains why these 
phosphorylations can be deposited by the CKM indiscriminately, whether it has free 
access to the PIC components (U3,E3), or receives a pre-assembled PIC as a 
substrate (U2-2, E2).    
Seeing as these phosphorylations do not influence PIC assembly, this calls into 
question what their function may be. 
 
5.3.3 PIC components form liquid-like droplets that dissolve upon CKM 
phosphorylation 
 
To address the question of the function of CKM-dependent phosphorylations that 
appear in unstructured regions of PIC components, and do not influence PIC binding, 
we resorted to liquid-liquid phase separation studies. At high concentrations, many 
intrinsically disordered proteins are known to undergo liquid-liquid phase separation. 
We asked whether this was true for the PIC components in vitro, and whether 
phoshphorylations deposited by CKM may have an effect on this phenomenon.  
 
To examine the effect of CKM-dependent CTD phosphorylation on its phase 
separation propensity, we mixed N-terminal GST tagged yeast CTD (GST-yCTD) at 
a high concentration, which had been pre-treated with 25-fold less of either CKM(KD) 
or CKM(A) and ATP, with dextran (figure 5.15). As a high molecular weight 
substance, dextran acts as a crowding agent that simulates the crowded 
environment in the cell by engaging a large number of solvent molecules, and 
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thereby increasing the effective concentration of the protein of interest (solvent 
exclusion effect). The presence of liquid droplets of GST-yCTD when it is pre-treated 
with kinase dead CKM, and the absence thereof when GST-yCTD is pre-treated with 
active CKM, demonstrates that CKM-dependent phosphorylation of the Rpb1 CTD 
dissolves these condensates. 
Likewise, TFIIF pre-treated with CKM(KD) versus CKM(A) showed a similar pattern, 
albeit less stark (figure 5.15). These observations indicate that CKM-dependent 











5.4 PART IV: CHARACTERIZATION OF THE FUNCTION OF 
THE CKM IN ACTIVATOR-DEPENDENT TRANSCRIPTION 
 
5.4.1 CKM targets the activator Gcn4 for phosphorylation 
 
Several transcription activators, particularly ones involved in response to stress and 
nutrient deficiency, are known targets of the CKM kinase Cdk8 [77], committing them 
to proteasomal degradation. At upstream activating sequences, chromatin-bound 
activators recruit the Mediator complex, which in turn contacts the PIC on promoters 
to activate transcription by stimulating promoter escape. In in vitro biochemical 
binding terms, this means that activators at upstream activating sequences are part 
of a ternary interaction; contacting DNA on one side, and Mediator on the other. We 
asked whether phosphorylation of activators by CKM has an effect on this DNA-
activator-Mediator ternary interaction, schematically depicted in figure 5.16 A.  
 
Apart from global turnover effects, we asked what are the direct effects of CKM-
dependent phosphorylation of activators. To address that, we purified the yeast 
activator General control protein 4 (Gcn4), one of the best-characterized yeast 
activators. Gcn4 is a typical activator, with a distinct structured DNA-binding domain, 
and a long, disordered activation domain. We set up a kinase assay to test in vitro 
phosphorylation of Gcn4 by CKM. Figure 5.16 B shows that Gcn4 phosphorylation by 
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Cdk8 can be recapitulated in vitro, and can occur on free or DNA-bound Gcn4 as a 
substrate, with no visible effect on the kinetics of the phosphorylation reaction.  
 
Having established CKM-dependent phosphorylation of Gcn4 in vitro, we went on to 
investigate the effect this may have on the DNA-activator-Mediator ternary 




CKM phosphorylation of Gcn4 impairs its genomic binding 
 
First, we investigated the effect of CKM phosphorylation on the ability of activators to 
bind their cognate binding sites on DNA (figure 5.17). To do that, we employed a 
combination of complementary assays. On an immobilized template assay, we used 
a DNA template modeled on the upstream sequence adjacent to the yeast HIS4 
promoter, which contains five binding sites for the activator Gcn4 in the natural 
sequence. We used a truncated version, which contained only three Gcn4 binding 
sites with a biotinylation on the 3’ side. The DNA scaffold was immobilized on 
streptavidin beads, and Gcn4 was bound to the DNA scaffold, the unbound excess 
Gcn4 was washed away, and then the Gcn4-DNA complex was incubated with 
CKM(A or KD), and ATP (figure 5.17 B), and then eluted by restriction digestion. 
Strikingly, we saw a remarkable reduction in affinity upon phosphorylation, indicating 
that CKM phosphorylation can actively dislodge Gcn4 from its genomic binding site.  
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This could be confirmed by measurement of the affinity of CKM-phosphorylated 
versus unphosphorylated Gcn4 to a fluorescein-labelled DNA scaffold containing a 
Gcn4 binding site by fluorescence anisotropy, which showed that unphosphorylated 
Gcn4 had close to double the affinity to DNA than its phosphorylated counterpart 
(figure 5.17 C). Please note that the Kd values presented here are not meaningful in 
absolute terms, but only in relative terms, due to the nature of the experimental 
setup, which allowed only relative concentrations to be determinable (please refer to 
the methods section for experimental details).  
 
Mapping the phosphorylation sites by phosphopeptide enrichment and mass 
spectrometry revealed sites within the disordered activation domain of Gcn4, as well 
as one site in the DNA-binding domain (figure 5.17 E). Mapping this site onto the 
crystal structure of the Gcn4 DNA-binding domain (DBD) [108], showed that it occurs 
within the highly hydrophobic interface of the leucine zipper formed by dimerization of 
the DBDs of two Gcn4 molecules, providing a potential explanation for the loss of 
affinity to DNA upon phosphorylation.    
 
Gcn4 and other activators with low complexity activation domains have been shown 
to undergo liquid-liquid phase separation in vitro and in vivo [52]. To test the effect of 
DNA-binding on droplet formation, we mixed Gcn4 with or without fluorescein-
labelled DNA containing a Gcn4 binding site with dextran, as previously described. 
DNA was incorporated into Gcn4 droplets, as evident by detection of green 
fluorescence within the droplets, and resulted in markedly bigger droplets than Gcn4 
alone (figure 5.17 D). Having separately shown that CKM phosphorylation of Gcn4 
impairs its DNA binding, and that DNA binding enhances liquid droplet formation, it 







CKM phosphorylation impairs the interaction of Mediator with activators 
and dissolves activator/mediator liquid droplets  
 
Next, we looked at the interaction between activators and Mediator (figure 5.18). Our 
recombinant cMed does not contain the tail module, which is responsible for the 
majority of activator-Mediator interactions in yeast, and contains many characteristic 
low complexity sequences, which impart a high degree of structural plasticity, which 
is conserved from yeast to human. Technically, this also means that this Mediator 
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module is difficult to recombinantly express and purify. Owing to the difficulty of 
performing biochemical studies with the minute amounts of purified endogenous 
Mediator that contains a tail module, we resorted to recombinantly expressing and 
purifying only the part of the complex that has been reported to interact with the 
Gcn4 activator. We capitalized on the wealth of knowledge available about the Gcn4-
Mediator interaction, which has been meticulously characterized by heteronuclear 
single quantum coherence spectroscopy and XL-MS [109]. This study showed that 
Gcn4 binds the Mediator tail subunit Med15 at four distinct structured binding 
domains called KIX, ABD1, ABD2 and ABD3, which are interspersed between 
disordered polyglutamine (polyQ) and polyglutamine/polyalanine (polyQ/A) linkers. 
The binding of the Gcn4 activation domain to all of the Med15 structured domains led 
to the description of this interaction as a “fuzzy free-for-all” rather than a defined 
interaction.  
 
Knowing that the four Med15 structured domains are sufficient for Gcn4 binding, we 
purified a Med15 variant, Med15_KIX123, where we removed all the polyQ and 
polyQ/A linkers and concatenated the four binding domains together. To test the 
effect of CKM-phosphophorylation of Gcn4 on the  binding of Gcn4 to Med15, we 
performed an electrophoretic mobility shift assay (EMSA), in which a constant 
amount of phosphorylated or unphosphorylated GFP-tagged Gcn4 was titrated 
against increasing concentrations of Med15_KIX123. We found that phosphorylation 
of Gcn4 weakens this interaction (figure 5.18 B).   
 
It has also been reported that Gcn4 and Med15 undergo liquid-liquid phase 
separation and colocalize in the same droplets [52]. To test the effect of Gcn4 
phosphorylation on Med15-Gcn4 phase separation (figure 5.18 C), we reproduced 
the experiment in this study, by purifying the N-terminal half of Med15 (residues 6-
651), this time with its polyQ and polyQ/A linkers, with an mCherry fusion tag. We 
purified mCherry-Med15 as in [52]. This purification is crude - expression levels are 
minute due to the extensive polyQ and Q/A linkers - but the presence of a fluorescent 
tag allowed unambiguous detection of the protein.  
  
We incubated a 1:1 mix of GFP-Gcn4 and mCherry-Med15 with CKM(KD or A) and 
ATP, and then added dextran and visualized the formed phase-separared droplets 
under a fluorescence microscope. Our results show that phosphorylation by CKM 
attenuated these droplets (figure 5.18 C).  
 
Taken together, the weakening of the Med15-Gcn4 interaction, and the shrinkage of 
Med15-Gcn4 droplets, upon CKM phosphorylation, is an indication of CKM-mediated 
release of Mediator at upstream activating sequences, and a resolution of local 






5.5 PART V: CRYO-EM OF CKM AND CKM-CMED 
 
The structure of CKM, both in isolation and in complex with cMed, has endured as 
one of the big open questions in the Mediator structure field. The current study 
confirms the magnitude of the challenge that this task presents.  
 
In the following sections, the attempts we made to solve the structure of CKM and 
the CKM-cMed complex will be presented, as well as an analysis of what can be 
learned from these trials. The majority of our efforts focused on finding good cryo-EM 
grid conditions for both complexes, which was the major bottleneck for further 
progress. Significant improvements were seen, but despite extensive trials, we were 
not able to solve either of these structures at this time. We hope that the experience 
gathered through our attempts, however, will provide the foundational knowledge to 
guide future studies, and narrow down the conditions needed for cryo-EM of these 
complexes.     
 
5.5.1 Cryo-EM of CKM 
 
The general strategy for preparation of cryo-EM grids of CKM was to purify the 
complex, crosslink it in batch or GraFix, and to apply a sizing and/or buffer exchange 
step to bring the complex to the desired freezing buffer conditions. Parameters at 
each of these steps were varied. 
 
Trials to obtain homogeneous single particles of CKM are presented in tabular form 
(table 5.1 and 5.2), describing the main altered parameters and their outcomes. To 
navigate these tables, the following information is given. All numbers, apart from 
values of pH, refer to concentration in mM units. The non-standard abbreviations GA, 
conc., sp.col., dial., sucr., phosph., cont., GeFi, and exch. stand for glutaraldehyde, 
concentration, spin desalting column, dialysis, sucrose, phosphorylation, continuous, 
gel filtration and exchange, respectively. ‘Jbf’ means added just before freezing. 
 
Experiments are numbered from 1 through 55. The columns headed ‘crosslinking’, 
‘quencher’ and ‘GraFix’ describe whether samples were crosslinked or not, and in 
what conditions (crosslinker/quencher identity and concentration, and in batch or 
GraFix). ‘Buffer exchange’ refers to the method used to remove excess quencher 
and/or sucrose after crosslinking, when the last step before freezing was not gel 
filtration. Conditions in which gel filtration and GraFix are checked mean that CKM 
was first applied on gel filtration chromatography as a part of its purification protocol, 
and then applied to GraFix for fixation. Conditions in which gel filtration is not 
checked were conditions where the gel filtration step in the purification protocol was 
omitted, and GraFix was used for concomitant sizing and fixation. Conditions in 
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which neither is checked mean that the sample was used directly after ion exchange 
chromatography.  
 
‘Concentration’ refers to concentration of the sample in spin filter concentrators after 
crosslinking and buffer exchange. Due to the huge loss of protein observed, 
compared to only marginal increase in concentration, this was frequently omitted.       
 
‘Detergent’ and ‘additives’ refer to added potentially stabilizing substances; the 
nonionic detergent LMNG, the ATP transition-state analogue (ADPBeF3), a small 
percentage of sucrose intentionally left over from GraFix by incomplete buffer 
exchange, or glycerol added to the freezing buffer. ‘Lower LMNG’ refers to the LMNG 
concentration when LMNG was added to the dialysis buffer. We noticed, by 
comparing negative stain grids of LMNG-containing samples prepared by dialysis 
versus spin column, that detergent micelles were present in the latter only, implying 
that the detergent does not efficiently pass through dialysis membranes. Therefore, 
we do not know the final LMNG concentration in these conditions, but grids prepared 
in the same way were assumed to have the same final concentration.  
 
Phosphorylation and auto-phosphorylation refer to addition of an active Cdk8-CycC 
subcomplex during the CKM(KD) purification, or ATP before the final step of CKM(A) 
purification, to impart phosphorylations on the complexes, to alter their surface 
charge distribution.  
 
Finally, the salt, pH and the version of CKM used (A or KD), and type of cryo-EM grid 
used are also stated. For pH’s 7.6-8.4, HEPES buffer was used, whereas Tris and 
BisTris was used for pH 8.5 and 6.5, respectively.  
 
Heavy aggregation of CKM on cryo-EM grids compared to negative stain 
grids 
  
Heavy aggregation of CKM paritcles on cryo-EM grids was a recurrent outcome of 
our trials under most standard conditions. This was as opposed to negative stain 
grids, where particles distributed homogeneously when applied directly after GraFix, 
or showed only minor aggregation when applied after buffer exchange.  
 
Systematic solution condition testing 
 
To check whether aggregation was a problem occurring already in solution before 
grid preparation, we systematically screened different buffering components using 
the ProteoPlex technology [110]. 
Characteristically shaped two-state thermal unfolding curves without an early 
shoulder confirmed that there were no aggregates in solution under the used 
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conditions. Furthermore, the results showed that, while the standard condition at pH 
7.6 was among the top four best conditions, lowering the pH to about 6.5 had a 



































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Effect of pH 
 
At pH 7.6 and 6.5, despite being the most favorable solution conditions, CKM 
particles invariably aggregated on cryo-EM grids. On the other hand, at pH 8.4, 
single particles were seen. This points to pH as the single most influential parameter 
for CKM aggregation on cryo-EM grids.  
 
To reconcile the discrepancy between the optimal pH for stability (6.5), and the only 
pH where there is no aggregation on cryo-EM grids (8.4), in experiments 44 and 45, 
we performed the GraFix step at a pH of 6.5, and then changed the pH to 8.4 only in 
the final buffer exchange step, but this resulted in complete denaturation of the 
complex on grids. 
 
In conditions where grids were prepared directly after ion exchange chromatography, 
to arrive at a pH of 8.4 for freezing, the pH of the high salt ion exchange buffer B was 
adjusted to 8.4. Coincidentally, we noticed that this pH/salt elution washed away an 
overlapping chaperone and resulted in a drastic improvement of the CKM yield.    
 
Effect of crosslinker concentration 
 
At different pH conditions, the concentration of crosslinker added to the GraFix heavy 
sucrose solution made a remarkable difference on particles’ tendency to aggregate. 
This necessitated titration of crosslinker concentration in GraFix, and the use of the 
minimum sufficient concentration to fixate the complex. We noticed that at different 
pH’s, this concentration varied for the same crosslinker (figure 5.19 A).  
 
Effect of buffer exchange method and detergents 
 
Dialysis as the final buffer exchange step consistently resulted in disintegration of the 
complex. On the other hand, using a blocked spin desalting column resulted in intact 
particles in some conditions.  
 
Figure 5.19 B shows micrographs of CKM crosslinked with the minimum titrated 
crosslinker concentration (for the respective pH) at pH 6.5 versus pH 8.4, using the 
same buffer exchange method, demonstrating the dramatic effect of pH. Panel B 
shows the difference between two grids at pH 8.4, where one was prepared by 
crosslinking followed by gel filtration, in contrast to GraFix followed by spin desalting 
column buffer exchange, highlighting the effect of different buffer exchange methods. 




Our findings place pH at the top of the parameter influence hierarchy, as the 
parameter to be optimized first. Next, the use of gentler biochemical preparation 
conditions (GraFix instead of gel filtration), and faster buffer exchange, seems to be 
important for delicate complexes like the CKM. Finally, the use of a mild detergent 
such as LMNG may help prevent particle denaturation at the air-water interface.      
 
A cryo-EM grid condition with homogeneous single particles of CKM 
 
Condition number 38 in table 5.1 was the only condition that showed a homogeneous 
distribution of single particles of CKM, and was reproducible across different 
preparations.  
Preliminary data collection and processing showed that particles only partially 
aligned in 2D using standard EM processing software, and further collection and 
processing, and/or grid optimization, which was beyond the scope of this work, is 
required. 
 
5.5.2 Cryo-EM of CKM-cMed 
 
In addition to CKM on its own, structural investigation of the mode of binding of CKM 
to cMed would provide valuable insights into the function of the CKM complex in the 
context of transcription initiation. We asked whether CKM within the CKM-cMed 
complex demonstrates more stable behavior on cryo-EM grids, particularly because 
the long unstructured insertion in the CKM subunit Med13 is involved in the CKM-
cMed binding surface, according to our XL-MS findings and previous reports [82]. 
Moreover, this region harbors Molecular Recognition Features (MoRFs), which are 
sequences that are bioinformatically predicted to have a high propensity for protein-
protein interaction, and may acquire structure in the presence of a binding partner 
[73]. 
 
The quality of our recombinant cMed preparation had been previously verified in the 
context of the PIC [35],[71]. Despite being present in roughly 15% of the classes 
only, it could be resolved to a local resolution of around 8-9 Å.    
However, the cMed sample showed a high degree of aggregation behavior on EM 
grids, when on its own, in the absence of the globular stabilizing polymerase core.  
 
The general strategy was assembly of the CKM-cMed complex by mixing and 
dialysis into lower salt, crosslinking in batch followed by sizing, or in GraFix, buffer 
exchange and grid preparation. At each of these steps, parameters were varied. 
Similarly structured tables to the ones for CKM, tables 5.3 and 5.4, present a 
compilation of the tested cryo-EM grid conditions for the CKM-cMed complex, and 
their results.  
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The same givens as for the CKM tables can be assumed, with the following 
addenda. Experiments are numbered from 1 through 43. GeFi refers to gel filtration 
after the assembly and crosslinking of the CKM-cMed complex. ‘ATP(before)’ means 
ATP was added and incubated before the final sizing step, to allow for auto-
phoshphorylation of the complexes, but was washed away and no longer present in 
the final freezing buffer. ‘Gradient (no Fix)’ means that the complex was assembled 
and crosslinked in batch, and then applied onto a sucrose gradient which did not 
contain any additional crosslinker, to separate the full complex from its component 
subcomplexes. TEV then GraFix means that TEV protease was added to the 
assembled complex to cleave off the MBP tag on CKM, before application on GraFix. 
The MBP tag on CKM is normally uncleavable when CKM is on its own because the 
complex precipitates, but can be cleaved in the presence of cMed.  
 
In conditions 42 and 43, endogenously purified complete Mediator complex eMed 
(containing the head, middle and tail modules) was used instead of cMed, and 
assembled with recombinant CKM-KD and the tail-interaction activator Gcn4. 
 
So far, no homogeneous particle condition for CKM-cMed has been found, but 






























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































In this study, we demonstrated a new method for the heterologous expression and 
purification of the S. cerevisiae Mediator Cdk8 kinase module (CKM) in insect cells, 
and validated this method by testing the catalytic activity and structural integrity of 
our recombinant particle. 3D reconstruction from negative stain images of CKM 
purified according to our method was consistent with previously published densities 
of endogeneously purified S.cerevisiae CKM [82],[107], meaning that our method 
markedly improved the yield and homogeneity, facilitated generation of mutants, and 
provided rigorous control over biochemical conditions, while still preserving the 
architectural integrity of the complex.   
 
We found that the CKM did not bind cMed-PIC assembled in vitro from purified 
components on template DNA containing a promoter sequence. Using a biochemical 
competition assay, we confirmed that CKM directly competes with RNAPII for cMed 
binding. Moreover, by conducting XL-MS on the CKM-cMed complex, we could offer 
an explanation for these observations by showing that the CKM binds to cMed on the 
RNAPII-interacting face, which would sterically block the cMed-RNAPII (hence cMed-
PIC) interaction.  
 
Furthermore, we investigated the role of the Cdk8-kinase activity of the CKM. By 
comparing active and kinase dead CKM, we found that CKM undergoes extensive 
autophosphorylation. We set up an exploratory in vitro phosphoproteomics study to 
seek out novel targets of CKM phosphorylation within the PIC, which identified the 
general transcription factors (GTFs) TFIIF and TBP as novel targets, apart from the 
previously identified C-terminal repeat domain (CTD) of the RNAPII. These 
phosphorylations did not affect the binding of these factors to the PIC, but attenuated 
their phase separation. On the other hand, we found phosphorylations deposited by 
CKM on cMed that appear to weaken the interaction of cMed with the PIC.   
  
Next, we looked at the effect that CKM phosphorylation of activators has on their 
binding to the genome, and to Mediator, by a combination of biochemical binding 
experiments and phase separation studies. We found that CKM phosphorylation 
disrupts activator-DNA and activator-Mediator association, and resolves their 
condensates.  
 
Lastly, we tried to solve the structure of CKM and CKM-cMed by cryo-EM, but were 
not successful. In the following sections, we will discuss the implications of our 
findings and how they relate to published data, and propose a new integrative model 
of CKM function. Additionally, we will discuss new experiments that are needed to 
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substantiate this model and guide future directions for both functional and structural 
studies.   
 
The structural effect of CKM 
 
The observation that CKM is not a part of the transcription Pre-Inititation Complex 
(PIC) formed on immobilized DNA templates, and that it directly competes with 
RNAPII for Mediator binding, corroborates a growing body of evidence pointing 
towards a similar conclusion. A recent mass spectrometry-based interactomics study 
of the S. cerevisiae Mediator complex revealed interactions between Mediator with 
GTFs and RNAPII when the core Mediator (cMed) subunit Med17 was used for co-
immunoprecipitation from yeast cells, but a striking lack thereof when the CKM 
subunit Med13 was used instead, supporting the idea that the binding of CKM to 
Mediator abolishes interactions with the PIC [111].  
 
Furthermore, although previous studies had been inconclusive, showing overlaps 
between all Mediator subunits [112],[113], and even Mediator complex association 
with gene bodies [61],[114],[115],[37] the latest chromatin immunoprecipitation 
(ChIP) studies of the Mediator complex in S. cerevisiae provided clear insights into 
the composition of Mediator complexes and their differential localization on the 
genome. In ChIP-seq experiments, DNA-bound proteins are physically captured onto 
their genomic locus in cells by formaldehyde crosslinking. Using an antibody against 
the protein of interest, the protein-DNA complex is precipitated, fragmented, the 
crosslinks reversed, and the associated DNA fragment sequenced and mapped back 
to the genome to identify the genomic locus from which it originates. This gives rise 
to protein occupancy profiles as a function of genomic location; in which mapped 
sequences and the number of sequencing reads denote positions and amplitudes, 
respectively. Many years of Mediator ChIP experiments had been confounded with 
antibodies of poor specificity, making it difficult to draw unambiguous conclusions. 
The advent of highly specific antibodies, and the discovery that inhibition of the TFIIH 
kinase kin28 to block RNAPII escape was needed to retain Mediator long enough at 
promoters to obtain a ChIP signal [37],[116], imbued the latest Mediator ChIP studies 
with unprecedented clarity. In two recent studies, ChIP of various Mediator subunits 
showed that while the Mediator head, middle and tail modules were found on both 
upstream activating sequences (UAS’s) and promoter sequences, the CKM was 
found exclusively on UAS’s, implying that ejection of the CKM is necessary before 
Mediator-PIC interactions can take place [80],[117].  
 
Similar observations of mutual exclusivity from low-resolution structural studies in the 
yeast S.pombe [118], and in vitro biochemical reconstitution of transcription from 
chromatinized templates in human [79], suggest that what we observe is a core, 
conserved feature of CKM function, rather than a peculiarity.  
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Our crosslinking/mass spectrometry analysis of a highly purified CKM-cMed complex 
provides an underlying structural framework to account for these observations, by 
showing that CKM binding spans the entire length of the RNAPII-binding face of the 
Mediator complex from the middle module hook domain to the head module jaw 
domains, and thereby sterically blocks RNAPII binding when present. This is in 
agreement with averaged 2D EM images of S.cerevisiae CKM-Mediator which 
showed longitudinal binding in the majority of classes [82]. In contrast, human CKM 
reportedly showed a different binding mode to Mediator, where it was anchored to a 
protrusion of the Mediator tail module via the Med13 subunit only, with the rest of 
CKM extending perpendicularly [82],[79]. Due to their poor resolution, however, 
these studies, like all Mediator EM structural studies before 2014, completely 
misassigned the Mediator modules, and should therefore be interpreted with caution 
[119].        
 
Collectively, our data, and others’, converge on the following mechanistic take-home 
message: at gene promoters where the CKM is present, CKM binding to Mediator at 
UAS’s prevents the interaction of Mediator with RNAPII and the assembled 
transcription initiation machinery on promoters by physical occlusion, independent of 
the kinase function. Release of Mediator from CKM binding is necessary for the 
interaction of Mediator with the RNAPII initiation machinery, to stimulate transcription 
by stabilizing the PIC and by stimulating the TFIIH kinase [120], which 
phosphorylates the CTD of RNAPII resulting in promoter escape [10].  
 
The kinase activity of CKM  
 
Apart from its structural effect, the CKM contains a Cdk/cyclin pair, which is the only 
catalytic activity within the Mediator complex. Like the TFIIH kinase kin28 (or Cdk7 in 
human), the CKM kinase Cdk8 targets the CTD of RNAPII for phosphorylation at 
serines 2 and 5, according to immunoblot assays [76], and at serine 5 only, 
according to more reliable mutagenesis studies, where the serine residues in 
question were mutated to alanines, and the effect of that on phosphorylation was 
probed [18]. This is consistent with what we observed using our CKM preparations.  
Besides the RNAPII CTD, we identified two additional targets of the Cdk8 kinase 
within the PIC complex; the TFIID subunit TBP, and TFIIF. Phosphorylation by Cdk8 
did not affect the ability of these factors to bind to the PIC. However, they lowered 
the propensity of TFIIF, and the RNAPII CTD to undergo liquid-liquid phase 
separation. We have not yet tested the effect of TBP phosphorylation. We also found 
novel Cdk8-dependent phosphorylations on cMed that inhibited its binding to the 
PIC. 
 
Further reported CKM phosphorylation targets in yeast include a variety of gene-
specific transcription activators, such as the histidine deficiency response activator 
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Gcn4 and the multistress response regulator Msn2, committing them to proteasomal 
degradation, and nuclear exclusion, respectively [121]. In response to nutrient 
limitation, yeast cells grow pseudohyphae and transition to a filamentous type. Cdk8 
was found to phosphorylate two key activators involved in this process, Ste12 and 
Phd1, similarly marking them for increased turnover, and preventing this transition 
[122],[123]. Conversely, Cdk8 phosphorylation of a transcriptional regulator of 
gluconeogenesis, Sip4, was found to be necessary for activation of transcription 
[124]. Likewise, Cdk8 phosphorylation of the stress responsive activator Skn7 is 
needed for gene activation [125], and Cdk8 phosphorylation of Gal4 is necessary for 
galactose-inducible transcription [126],[127],[128],[129],[130].  
 
We found that Cdk8 phosphorylation can actively disengage Gcn4 from its cognate 
UAS binding site, and that this may be due to a phosphorylation in its DNA-binding 
domain leucine zipper, disrupting essential hydrophobic contacts needed for 
homodimerization [131]. Additionally, we found that Cdk8 phosphorylation of Gcn4 
decreases its binding to Mediator. The Gcn4-Mediator interaction is dependent on 
hydrophobic contact, despite the acidic nature of the Gcn4 acitvation domain [132]. 
Given that, it is not surprising that phosphorylation may disrupt this interaction. 
Lastly, we found that the CKM undergoes Cdk8-dependent autophosphorylation at its 
Mediator binding interface, which hints at a possible Cdk8-dependent release of 
CKM from the CKM-cMed complex.  
 
Phase separation  
 
Although an age-old concept, a recent renaissance of phase separation as a 
paradigm for compartment-free organization of cellular biochemistry was met with a 
surge of enthusiasm. The attractiveness of this model lies in its potential to explain 
how cells control biochemical reactions in space and time, alter their kinetics, and 
prevent undesired crosstalk [133]. In particular, transcription-related complexes have 
been shown to phase separate, and these condensates were found near actively 
transcribing regions of the genome [85]. Phase separation of RNAPII has been 
attributed to its disordered CTD [20]. In our study, we showed that the effect of Cdk8 
phosphorylation on CTD phase separation in vitro was identical to that observed 
upon its phosphorylation by the TFIIH kinase Cdk7 [20]; phosphorylated CTD could 
no longer form condensates. We also showed that the GTF TFIIF can phase 
separate in vitro, and that this is also attenuated upon Cdk8 phosphorylation. Given 
the intimate association between RNAPII and TFIIF [134],[87], and their co-
recruitment [32], it is imaginable that the two can share a condensate, although this 
has not been tested in vitro or in vivo. The effect of Cdk8 phosphorylation on the 
abovementioned PIC condensates can be interpreted in multiple ways. Depending 
on whether phosphorylation occurs before or after assembly of the PIC, attenuation 
of condensates can either repress transcription by undermining recruitment, or 
	 116	
activate it by liberating assembled PIC complexes from anchoring condensates, as 
construed for the Cdk7 kinase [20].  
 
Furthermore, the Mediator complex has been shown to form phase separated 
condensates in vivo, which overlap with RNAPII condensates intermittently [85],[86]. 
Mediator was also found in condensates with the activators oct4, Gcn4 and the 
estrogen receptor [52]. Long disordered activation domains, a salient feature of many 
activators, were found to be responsible for their phase separation capacity. This led 
the authors to conclude that, because activation domains are required for gene 
activation and for phase separation, transcription factors therefore “activate genes 
through the phase-separation capacity of their activation domains”. Conspicuously 
absent logical link notwithstanding, this study provided the basis for a view of 
Mediator and activators as liquid condensates at UAS’s. We reproduced essentially 
the same experiment shown in this study, using the N-terminal half of the Mediator 
tail subunit Med15 and Gcn4 as a model for Mediator-activator phase separation, 
and tested the effect of Cdk8 kinase activity on these condensates. Remarkably, we 
found that Cdk8 phosphorylation of Gcn4 attenuates these condensates. Once 
again, whether this is interpreted as disruption or release, depends on the timing and 
extent of occurrence. In contrast, we did not observe any effect of Cdk8 




In this work, we identified and mapped various phosphorylation events using 
phophopeptide enrichment-mass spectrometry.  Mass spectrometry is a powerful tool 
to assay phosphosites on proteins. However, while instructive about positions of 
phosphosites, all information about stoichiometry is lost. That is to say, if a rare 
phosphorylation occurs only a few times on a particular residue, whereas an 
abundant phosphorylation occurs many times on another residue, they will appear as 
equals, provided they are both present above the detection threshold, and have the 
same localization probability within a digested peptide. This should be kept in mind 
when considering phosphorylation data in general, but even more so for in vitro 
phosphorylation data, where the exposure of purified substrates to kinases in high 
concentrations may result in unspecific phosphorylations, particularly in unstructured 
loops.    
 
Another consideration pertains to phase separation studies. The fact that some 
proteins exhibit phase separation behavior in a highly purified system in vitro, owing 
to the physicochemical properties of their disordered regions, does not necessarily 
mean that such liquid droplets have any physiological relevance. Rather, these 
experiments give us first clues about what to look for in vivo. Moreover, some in vitro 
condensates were found to unspecifically incorporate other phase-separating 
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components. To this end, we have supplemented all multi-component phase 
separation data that we show in this work with classical biochemical binding 
experiments such as electrophoretic mobility shift assays or fluorescence anisotropy 
experiments.  
 
It is not inconceivable that parts of our observations are in vitro artifacts, which occur 
due to missing important contextual influences, or unnaturally shifted equilibria. 
Therefore, as with any in vitro biochemical study, we advise the reader to take the 
outcomes of these experiments with a healthy dose of skepticism, and with a 
backdrop of information provided from functional studies, and emphasize that, unless 
reinforced by concurring observations in vivo, this data is not inherently meaningful. 
 
The value of our experiments, however, comes from their ability to isolate direct 
effects in a controlled environment, which is not possible in vivo. Another point of 
consideration is that our in vitro biochemical experiments reveal natures of effects, 
and not the extents to which they occur. For example, phosphorylation often elicits a 
certain function whereas hyperphosphorylation frequently marks the end of this effect 
(as has been shown for the RNAPII CTD [135]), and this cannot be distinguished in 
our experiments. Information about extents is implicit, and can only be derived from 
the intersection between biochemical and functional observations. Ultimately, a 
coalition of the two is needed to paint a complete picture, which is why we have 
drawn on in vivo functional studies in building our model, and suggest more 
functional studies to validate it. Keeping all of the above in mind, we will present what 
we believe is a fitting interpretation of our data. 
 
An integrative model of CKM function 
 
Since its discovery [75], several models have been put forth to describe the function 
of CKM throughout the various stages of data availability, with the majority describing 
it as a general repressive molecule. One model in this direction aptly describes the 
CKM in analogy to a ‘rheostat’ [79]. In this model, CKM controls the degree to which 
transcription is activated, in much the same way that the resistance in a rheostat 
controls the passage of electric current. The kinase activity supports the structural 
effect, and together the two act as a repressive taskforce; the structural effect by 
steric blockage of the Mediator-RNAPII interaction, and the kinase by 
phosphorylating the RNAPII CTD before PIC assembly [18], rendering it 
transcription-incompetent [135],[136], and by phosphorylating various activators and 
increasing their turnover [121],[123],[122]. In this way, the CKM acts a resistor 
against uncontrolled transcription, and the cell can control the degree of resistance 
by controlling the level of CKM expression. Viewed from this angle, our data 
confirmed the steric effect in a purified system and provided a structural explanation 
for it, on the one hand, and contributed additional novel mechanisms by which the 
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kinase activity can exert its repressive influence, on the other. These constitute 
impairing the ability of the cell to concentrate polymerases, and the PIC factor TFIIF, 
needed for transcription, phosphorylating Mediator to inhibit its RNAPII binding, and 
dissolving activator-DNA and activator-Mediator condensates. A new version of the 
rheostat model extended to include our findings is presented in figure 6.1. According 
to this model, a dynamic balance between transcriptional activation and repression 
dictates transcriptional output.  
 
While appealing in its simplicity, however, we argue that this model is inadequate 
insofar as it fails to account for the numerous gene-activating effects that have been 
also observed as a result of Cdk8 phosphorylation. Indeed, the discovery of the Cdk8 
kinase was driven by the realization that mutating it led to decreased galactose 
induction from a GAL promoter [75].   
 
The notion of CKM as a purely repressive molecule originates from an early study of 
its interaction with the RNAPII CTD [18]. The experimental cornerstone underlying 
this idea was the observation that the Cdk8 kinase ostensibly phosphorylated the 
RNAPII CTD before PIC assembly in vitro, whereas the activating TFIIH kinase could 
only do that after PIC assembly. However, this has since been refuted, because high 
quality preparations of the TFIIH kinase readily phosphorylate the RNAPII CTD in 
vitro without the need for prior PIC assembly (Thesis Schilbach 2017).   
 
Moreover, in the same study, surprisingly, using nuclear extract could not reproduce 
the same effect; pre-incubating the transcription machinery in nuclear extract from 
Cdk8 active or inactive mutant strains with ATP invariably did not repress 
transcription, indicating that the reported effect does not occur in vivo, and calling 
into question the relevance of this finding. Furthermore, this argues that Cdk8 is 
inhibited under normal conditions in cells. 
 
The authors also justified a repressive effect of Cdk8 on grounds of artificial 
recruitment experiments. Fusion of active or inactive Cdk8 to the DNA-binding 
domain LexA to forcibly recruit it to a LexA binding sequence upstream of a reporter 
gene showed that the active kinase repressed reporter expression compared to the 
wild-type, whereas the inactive one did not. Although seemingly straightforward, 
interpretation of artificial recruitment experiments has proven to be only deceptively 
simple. Huge discrepancies in the outcomes of these experiments have been 
observed, depending on the nature of the reporter, its presence on a plasmid versus 
genomic integration [137], the presence or absence of overexpression of the fusion 
[138], the exact position of the fusion tag on the protein [139], as well as the need for 
chromatin marks or remodeling [140]. Moreover, the absence of a repressive 
structural influence, which we are now fairly certain of, in the Cdk8 artificial 
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recruitment experiment shown in this study is a strong indication that Cdk8 alone was 
being recruited rather than the full CKM complex, creating an unnatural context.  
 
We thus demonstrate that the basis for the view of Cdk8 as purely repressive kinase 
was not foolproof, and the evidence for it is weak at best. Indeed, another study 
showed that both the Cdk8 and the Cdk7 kinases are functionally redundant in vitro 
and in vivo, because only inhibition of both simultaneously resulted in maximal 
inhibition of transcription as measured by ChIP occupancy of RNAPII on genes [19].  
Furthermore, apart from the reported repressive effects of the Cdk8 kinase in vivo 
[18],[121],[123],[122], diverse studies showed additional activating effects in both 
yeast [124],[125],[126],[127],[128],[129], and human [141],[142],[143],[144], on a 
scale that can no longer be dismissed.  
 
We do not doubt that the CKM has a repressive aspect to its function. However, in 
light of both our own findings, and the new data that has become available since 
then, we beg to differ from the traditional repressive model. Instead, we propose a 
new model of CKM function, which unifies the two seemingly contradicting 
observations of CKM-mediated activation and repression in a single explanatory 
scheme: a conditional repression model of CKM function.  
 
Our model (figure 6.2) stipulates that, at the genes on which CKM is present (highly 
regulated genes), activators, Mediator and the transcription machinery are 
assembled at UASs and poised for activation, but prevented from premature firing 
under normal conditions by the presence of CKM. In these complexes, the Cdk8 
kinase is inactive. Upon signaling, the Cdk8 kinase is activated, and phosphorylation 
results in rapid release of this UAS condensate, freeing the Mediator block, and 
concomitantly activating transcription and promoter escape (by RNAPII CTD 
phosphorylation). As such, rapid actuation of preset programs of gene transcription 
can take place in response to stress or developmental signals. These programs are 
encoded in a) the localization of CKM on a certain subset of genes, and b) the 
specific response of gene-specific activators to phosphorylation by the Cdk8 kinase. 
For example, the Gal4 activator requires phosphorylation by Cdk8 to be functional 
[128], whereas phosphorylation of Gcn4 removes it from its binding site (this study) 







CKM is thus a conditional repressor, preventing activation until the time is right. Our 
model emphasizes a duality in the CKM function; a general repressive kinase-
independent function by virtue of its bulky structure; and a kinase-dependent release 
function followed by gene-specific downstream effects mediated by the interaction of 
the CKM with different transcription activators as substrates, which triggers gene-
specific effects within pre-defined transcription programs. We propose that stress, 
development, and nutrient status signaling switch from the former mode (repression) 
to the latter (release), because the CKM targets activators involved in response to 
these stimuli, and because CKM has been found to be directly under the influence of 
signaling pathways, such as the Ras/PKA [145] and the Wnt-β-catenin [146] 
pathways. Notably, these pathways target residues on Med13 and Med12, 
respectively, implying an allosteric transmission of the signal through the CKM 
complex to the kinase, in our model. This idea is consistent with the characterized 
function of Mediator as a central processor of signals, receiving environmental 
inputs, and processing them into transcriptional outputs; other subunits of the 
Mediator complex are targeted by the thyroid, insulin, fatty acid sensing, stress, and 
infection response signaling pathways [62],[147]. 
 
Moreover, we believe that such a model in which kinase activation brings about a 
discrete, rapid effect, is more fitting to the nature of phosphorylation as a post- 
translational modification (PTM), which results in a dramatically altered chemical 
microenvironment, than a model in which phosphorylation is involved in a mildly 
tuned dynamic equilibrium effect.  
 
Because stress and development response genes that would need to be amenable 
to this form of activation, also need to be activated in a controlled and time-limited 
manner by necessity, prolonged phosphorylation of activators by CKM would also 
mark the end of the activation cycle, rendering these genes refractory to further 
stimulation, and committing the activators to subsequent ubiquitylation and 
proteasomal degradation. 
 
The co-recruitment of CKM and Mediator to UASs supports our idea of pre-assembly 
[80],[117]. The transience of the interaction between CKM and Mediator, as shown 
by ChIP-re-ChIP experiments, supports our idea that CKM can sometimes be 
released from the CKM-Mediator complex [61]. In these experiments, Mediator ChIP 
fractions were ChIPed once more using an antibody against CKM. A discrepancy in 
their relative occupancy is evidence for transience (whereas a stable interaction 
would show an equal occupancy for both).  
 
Furthermore, the absence of global effects on gene expression upon Cdk8 inhibition 
supports our idea of conditional, rather than global, repression [148]. Similarly, the 
upregulation of certain gene products, and the downregulation of others, upon Cdk8 
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inhibition supports our idea of reprogramming, although this has only been shown 
conclusively so far in human [143]. Also, the observation that Cdk8 in nuclear extract 
is not able to phosphorylate the RNAPII CTD supports our idea that Cdk8 is normally 
inhibited [18]. Our model would also explain the non-lethality of CKM mutants under 
normal conditions [148], but only under non-permissive conditions such as cold-
sensitivity, when Cdk8 activation would be needed to initiate response programs 
All of the above is ample evidence that our conditional repression hypothesis is worth 
entertaining, but perhaps the strongest argument yet is the uncoupling between 
Mediator binding and transcription activation, as evident by its indiscriminate ChIP 
localization to active and inactive genes [61]. Following the same rationale, the 
constitutive presence of some activators on the UASs of some of their target genes, 
even though these genes are not constitutively active further attests to the notion of 
uncoupling [149],[44]. This means that there must be a player repressing this 
activation until needed. As opposed to repression by heterochromatinization, 
repressive histone marks, or more committing forms of repression, this argues for a 
form of repression that is dependent on the underlying genes being active (have 
activators bound to their UASs), and ready to quickly switch to a transcribing state. 
We argue that this player is the CKM, and its responsiveness to signaling brings 
about this switch. 
 
Composite effects such as the one we propose for the CKM function are hard to 
detect. What is empirically observed are the divergent outcomes. Our new model 
resolves the paradox of two seemingly opposite outcomes, and provides a new and 
exciting possibility to understand transcriptional reprogramming in response to 
signals of stress, development and nutrient availability. One of the most important 
selection pressures that direct evolution is the ability to rapidly adapt to a changing 
environment, and we propose that the CKM can contribute to making that possible, 
explaining its relatively early occurrence in evolution (for a “repressive” molecule), 
and its conservation from yeast to human [150].   
 
Naturally, our model is not free of shortcomings. Notably, we cannot explain our own 
observation of phosphorylations on Mediator that inhibit its PIC binding and what role 
that could play. It is plausible that auxiliary factors are involved, which are not 
present in our preparations, such as phosphatases, which confer an additional level 
of regulation, and can extend this model, but we cannot comment on that at this time. 
Additionally, if true, our model begs the question, what activates the Cdk8 kinase? 
This needs further investigation. Moreover, gene activation can still be incorporated 
into the equilibrium repression model as a secondary effect. Direct repression of 
genes that alter the expression of downstream genes in a negative or positive way 
may still be able to give rise to specific transcriptional programs. Equilibrium 
repression can also be refined into a local equilibrium repression model due to gene-
specific CKM recruitment, to explain the lack of global effects. The key point that 
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distinguishes our model and cannot be incorporated as an extension to the 
equilibrium repression model, is the notion of stable Mediator-CKM-activator 
complexes at UASs, and their signaling-induced kinase-dependent release, and the 
resulting paradigm of rapid activation. Both models are hypothetical, contain the 
same number of assumptions, and have unique advantages. To determine which 
one is closer to the truth, the arbiter will undoubtedly be functional data. 
 
Experiments needed to test this model 
 
Our model generates hypotheses about CKM function concerning recruitment and 
release, which can be translated into experimental questions. If our idea is true that 
the uncoupling between the presence of activators and Mediator at UASs from 
activation of transcription is a function of CKM presence, then ChIP occupancy of 
CKM should correlate with lack of activation from genes at which Mediator and 
activators are present.   
 
Moreover, if our idea is true that the activity of the Cdk8 kinase releases this block, 
then inhibition of the Cdk8 kinase should increase the residence time of CKM at 
UASs, manifested by an increase in the amplitude of its ChIP peak at a given 
genomic locus. This can be tested using an analogue-sensitive version of the Cdk8 
kinase. The analogue-sensitive (AS) kinase technology is based on engineering a 
space-creating mutant in a kinase’s ATP binding pocket [151]. This allows specific 
inhibition of the kinase if an ATP analogue with a bulky adduct is used, while still 
allowing it to function normally under normal conditions. Comparing CKM occupancy 
profiles from inhibited and uninhibited Cdk8-AS would answer this question.  
 
Next would be to test whether that correlates to the effect of environmental stresses 
such as starvation or heat shock. If our model holds true, then directly following a 
pressure, CKM occupancy at UASs should drop, and be re-established when 
conditions normalize. This effect should disappear if the residues involved in signal 
transduction are mutated.   
 
While the localization of CKM relative to other mediator subunits on some gene 
promoters has recently been shown, to our knowledge, its genome-wide localization 
has not been thoroughly characterized. If our idea of preset programs activated by 
the CKM kinase is true, then CKM should be found on the specific subset of genes 
that are affected by its Cdk8 kinase activity. On the other hand, global presence of 
CKM on genes would rather support subtle global effects as is in the equilibrium 
repression model. This can be tested by ChIP and next generation sequencing of the 
associated genomic fragments.  
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After testing effects on CKM localization, we would need to test effects on the 
transcriptomic level. Some knowledge about that is already available from yeast and 
human, which gives us the knowledge resource to ask targeted questions. Knowing 
that some genes are positively regulated while others are negatively regulated upon 
Cdk8 inhibition, the question is whether this happens directly or indirectly, and what 
are the mechanisms. To test whether the effects of the Cdk8 kinase on transcription 
are direct or indirect, the UAS of one upregulated, and one downregulated gene can 
be taken as an example. Fusing this UAS to a reporter gene on a plasmid, and 
transforming yeast cells from strains of active or inactive kinase, would allow us to 
study the effect of the identity of the activator, on the response to Cdk8 kinase 
activity. If upregulation and downregulation are direct effects, then reporter 
expression should decrease upon kinase inhibition in the case of upregulated genes, 
and vice versa. A deviation from this pattern would indicate that upregulation or 
downregulation are secondary effects.   
 
Newer technologies also allow direct detection of newly transcribed mRNA by 
exposing cells to 4-thiouridine (4SU) [152]. This labels newly transcribed mRNA, 
which incorporates the modified Uridine. Total RNA can then be extracted, and the 
newly transcribed mRNA selectively isolated by biotinylation and streptavidin affinity 
purification. In this way, more accurate information about transient upregulation and 
downregulation of genes upon Cdk8 inhibition can be obtained as opposed to studies 
of total mRNA, which had been previously reported [148]. These newly synthesized 
transcripts can subsequently be reverse transcribed, and upregulation and 
downregulation from specific genes of interest can be assayed using primers against 
those transcripts to perform quantitative PCR.  
 
If we find that, indeed, upregulation and downregulation are direct effects of Cdk8 
kinase inhibition, this would raise the question of how activators on upregulated and 
downregulated genes differ to bring about these disparate outcomes. So far, we 
studied Gcn4 in binding and phase separation assays with Mediator and DNA. To 
answer this question, we would need to study at least one additional activator from a 
gene that is affected in the opposite way, to investigate how that compares to the 
effects on DNA binding, Mediator binding and phase separation, that we observed for 
Gcn4.    
   
Also eminently missing from our in vitro data so far is a true functional readout. This 
can be attained by reconstituting activated transcription from a DNA template, using 
all the purified components, which we can now produce. Using a DNA template 
containing a UAS, a TATA-box and a TSS, the transcription machinery can be 
supplemented with nucleotides and allowed to transcribe. In the presence of 
Mediator (eMed) and activators, transcription from the template should be stimulated. 
Pre-incubating activators with immobilized active CKM would allow us to assay 
	 126	
phosphorylations deposited by CKM, without the physical presence of CKM. This 
would make it possible to disentangle the structural effect, which we have now 
elaborately characterized, from the kinase effect, highlighting the unique advantage 
of our in vitro system. In case eviction of activators from DNA is an inadvertent 
hyperphosphorylation effect, we can study the effect of phosphorylations in the 
activation domain only (excluding the ones in the DBD) by using a phosphomimetic 
mutant of the activator. Due to chemical similarity to phosphorylations, serine 
residues that are targeted for phosphorylation (which we have identified by mass 
spectrometry) can be mutated to aspartates, and the effect of that on the stimulation 
of transcription assayed.    
 
Additionally, if the CKM is found on some genes, and not on others in ChIP 
experiments, this can be hypothesized to be due to an affinity of CKM to certain 
gene-specific activators, but not others. We can test this idea using our established 
in vitro CKM purification, to test binding to various activators, and see if this mirrors 
its in vivo distribution. If so, this will provide a mechanism for its asymmetric 
presence on genes, and further support our idea of pre-defined transcription 
programs. Collectively, these experiments will help us solve the mechanism of gene-
specific effects brought about by CKM.  
 
Last, but not least, to validate our phase separation paradigm, we need to find these 
components together in the same droplets in vivo. This can be done by fluorescent 
labeling and live cell imaging of CKM and Mediator, activators and RNAPII, to see 
whether they localize to the same droplets, and how this is affected by inhibition of 
the Cdk8 kinase. If what we observe in vitro is true, then Cdk8 inhibition should 
stabilize activator-Mediator-CKM droplets, and the reverse should happen in 
response to environmental cues. For this, the yeast system is no longer applicable, 
because the yeast nucleus is too small, and a switch to human cells would be 
necessary. This will be facilitated by genome editing techniques that can now be 
routinely used to manipulate proteins of interest, for example, by insertion of a 
fluorescent fusion tag.  
 
Structural and unstructural biology of CKM and CKM-cMed 
 
The initial goal of this study was to solve the structures of CKM and CKM-cMed, with 
the aim of elucidating the mode of binding of CKM to Mediator, in order to derive 
mechanistic implications about its function. Highly homogeneous samples, as 
demonstrated by negative stain EM, could be obtained from the recombinant 
expression and purification setup we established. Although still limiting, the 
substantial improvement in the yield of recombinant CKM, as opposed to 
endogenously purified CKM [82], has made it possible for the first time to thoroughly, 
and systematically optimize biochemical conditions. Nevertheless, despite achieving 
	 127	
significant milestones to this end, we have been unsuccessful at solving either 
structure so far. Knowledge from our trials can hopefully inform future work, and 
narrow down the conditions needed to be tested. 
 
Systematic testing of conditions for the CKM sample showed a pH of 6.5 as the most 
stable solution pH. However, the only single particle condition we found for CKM on 
cryo-EM grids was at pH 8.4. On the contrary, we did not find any homogeneous 
particle conditions for the CKM-cMed complex. Learning from these trials, we now 
believe that the CKM-cMed sample is not the most stable for structural 
characterization.  
 
Guided by the results of our biochemical experiments, we believe that the UAS 
complex of CKM, Mediator and activators may be the stable form of this complex, 
especially considering reports about huge allosteric structural rearrangements in the 
Mediator complex brought about by activator binding [119]. Endogenously purified 
Mediator, containing a tail module, an activator bound to a DNA scaffold containing a 
UAS sequence, and CKM with an inactive kinase, would make up our new complex. 
Re-thinking our structural target based on our new model of CKM function may hold 
the key to obtaining a stable sample, that is amenable to structural characterization 
by cryo-EM.  
 
Preliminary attempts to assemble the complex in this way, using a biotinylated 
scaffold with a single Gcn4 binding site on beads were not successful, but western 
blot analysis proved that the recruitment was possible, only inefficient. This means 
that, in principle, our idea could work, and can be made more efficient by increasing 
the concentration of the sample, lowering the salt, or artificially adding more activator 
binding sites to the UAS.   
 
The aggregation problem  
 
A common feature of our cryo-EM grids was heavy aggregation. Normally, particles 
may aggregate on grids if they are damaged during biochemical purification resulting 
in partial exposure of buried hydrophobic interiors. This is exacerbated by the 
stabilizing effect that the hydrophobic air-water interface has on these metastable 
forms [153]. However, the realization that CKM still aggregated in its most stable 
solution condition, after the sample passed all quality control checks, including 
negative stain EM, may be an indication that what we observe is an inherent 
behavior of the CKM sample. Of its approximately 500 KDa mass, more than 100 
KDa is composed of a long unstructured insertion in the subunit Med13. Indeed, we 
found that the CKM complex undergoes liquid-liquid phase separation under a 
variety of conditions, when mixed with the crowding agent dextran (figure 6.3).  
Shifting the pH to a high pH, at which all the acidic groups are charged, and the basic 
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groups are not, imparting a net negative charge to the particle, was the only solution 
we found to reversing this behavior. Another alternative would be truncating this 
insertion, but this is only possible for the CKM sample, because this region is directly 
involved in Mediator binding, and would impair the CKM-cMed interaction if removed. 
 
 
CKM from yeast to human 
 
Macromolecular machines have a conserved functional essence within the 
eukaryotic lineage. Using the yeast system makes it possible to abstract the 
fundamental principles governing gene regulation, from a simpler system where the 
functional essence is less convoluted by higher levels of regulation. The relative ease 
of genetic manipulation and molecular biology techniques is likely to maintain the 
yeast model at the forefront of discovery for years to come.  Nonetheless, there are 
additional metazoan-specific effects that diversify possibilities of regulation.  
 
Similar to the yeast system, human CKM showed a kinase-independent effect that 
inhibits transcription [79], and phosphorylates the RNAPII CTD [154]. Also like in 
yeast, the RNAPII CTD phosphorylation was not possible with endogenous CKM, 
implying that the Cdk8 is kept normally in an inactive state. On top of that, additional 
metazoan-specific targets of Cdk8 have been identified; the TFIIH cyclin H, resulting 
in repression, and the histone H3, resulting in activation [154]. The discovery of a 
specific inhibitor for the human Cdk8 kinase has allowed its targeted inhibition [155]. 
Using this inhibitor, an exhaustive proteomic study characterized the effect of human 
Cdk8 inhibition, and found groups of targets that increased or decreased, but there 
were no marked global effects [143]. Like in yeast, the human Cdk8 was also found 
to play a role in activation of sugar utilization responses [141], and hypoxia-induced 
responses [142]. Conversely, it was found to repress super-enhancer associated 
genes [156], among a variety of other targets. This disparity in repression and 
activation is highly reminiscent of the yeast system, indicating a general, conserved 
functional modality that our conditional repression model attempts to explain.  
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Moreover, genetic experiments in S.cerevisiae, C.elegans and D.melanogaster, 
show that deletion of the CKM has no impact on cell viability (yeast), but is 
detrimental to organismal viability [148],[157],[158], highlighting a powerful 
evolutionary advantage given by the presence of CKM due to a conferred 
responsiveness to environmental signals; in this case, developmental cues that are 




Understanding how the CKM works has important implications for human disease.  
Mutations in CKM subunits have been linked to neurodevelopmental diseases, such 
as X-linked mental retardation, and to the development and progression of cancers, 
such as colorectal carcinomas, uterine leiomas, breast cancers and melanomas 
[159]. The survival of tumors is contingent on their ability to utilize sugar by aerobic 
glycolysis, and to respond to hypoxia. It becomes clear then, from our viewpoint of 
CKM function, that the CKM is advantageous to tumours, and helps them respond 
better to the stresses and deficiencies they face. Indeed, Cdk8 has been identified as 
an oncogene, which is dysregulated in many cancers [144],[160], and development 
of Cdk8-targetting drugs is currently underway [161],[162]. 
 
Cdk8 is an appealing drug target, compared to the other transcriptional kinases 
CDK7 and CDK9, against whom drugs are also under development [163], because 
inhibition of CDK8 allows targeting specific transcriptional programs, as opposed to 
global transcription. On the other hand, targeting CDK7 and CDK9, which targets 
global transcription, is likely to be more cytotoxic, but to also have devastating side 
effects, like the overwhelming majority of cytotoxic anticancer drugs. Understanding 
CKM function will undoubtedly open up new avenues for therapeutic intervention, in 




To truly understand gene activation, we have to get comfortable with disorder. 
Nuclear magnetic resonance (NMR) techniques such as heteronuclear single 
quantum coherence spectroscopy (HSQC) are powerful for studying unstructured 
interactions in isolation at single amino acid resolution.  
 
Phase separation studies are also likely to remain instrumental. However, their low 
exploratory potential may rapidly become a hindrance. In the early days of 
biochemical purification, isolation of complexes with varying degrees of stringency 
allowed the discovery of novel interactors. Similarly, fractionation of cellular 
compartments allowed the isolation and identification of their contents. A major 
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limitation with phase separation studies is the lack of a physical separation principle 
to allow the isolation of droplets. Chromatographic methods necessarily resolve 
phase separated droplets, and density-based methods are unfruitful because liquid 
droplets, usually transient and in the order of only a few micrometers in diameter, are 
not sufficiently dense, or distinguishable from one another. 
 
So far, the gold standard for phase separation studies has been reconstitution of 
droplets using purified components and crowding agents, complemented by finding 
the same effect when this component is labeled and imaged in live cells. While 
informative, this also means that one always gets only exactly what one set out to 
look for, and nothing more. How can we find out what else is in these droplets? The 
need for development of methods to make that possible is likely to motivate future 
research.  
 
One idea could be to optimize proximity labeling live-cell proteomics methods for this 
problem. Proximity labeling is based on tagging a protein of interest with an 
enzymatic activity, such as a modified ascorbate peroxidase, engineered to use 
biotin-phenol as a substrate [164]. Because the product is a radical (biotin phenoxy 
radical), this creates rapidly reacting and short-lived biotin labels, which selectively 
target only proteins in the direct vicinity of the tagged bait in a spatially and 
temporally resolved manner. Subsequent proteomic analysis would then allow the 
identification of the labeled proteins. This method has been implemented to study 
events at neuronal synapses [165], and may also prove useful for purposes of phase 
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